Next Article in Journal
Hypertension-Related Status and Influencing Factors among Chinese Children and Adolescents Aged 6~17 Years: Data from China Nutrition and Health Surveillance (2015–2017)
Previous Article in Journal
Effects of Mung Bean Water Supplementation on Modulating Lipid and Glucose Metabolism in a Diabetic Rat Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 16
Issue 16
10.3390/nu16162682
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review

by
Rajasekharan Sharika
1,2,
Kuljira Mongkolpobsin
1,2,
Panthakarn Rangsinth
3,
Mani Iyer Prasanth
4,5,
Sunita Nilkhet
1,2,
Paweena Pradniwat
1,6,
Tewin Tencomnao
4,5 and
Siriporn Chuchawankul
1,2,*
1
Immunomodulation of Natural Products Research Unit, Chulalongkorn University, Bangkok 10330, Thailand
2
Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
3
Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
4
Natural Products for Neuroprotection and Anti-Ageing Research Unit, Chulalongkorn University, Bangkok 10330, Thailand
5
Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
6
Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(16), 2682; https://doi.org/10.3390/nu16162682
Submission received: 14 July 2024 / Revised: 29 July 2024 / Accepted: 10 August 2024 / Published: 13 August 2024
(This article belongs to the Section Phytochemicals and Human Health)
Browse Figures
Versions Notes

Abstract

:
Mushrooms have garnered considerable interest among researchers due to their immense nutritional and therapeutic properties. The presence of biologically active primary and secondary metabolites, which includes several micronutrients, including vitamins, essential minerals, and other dietary fibers, makes them an excellent functional food. Moreover, the dietary inclusion of mushrooms has been reported to reduce the incidence of aging- and lifestyle-related diseases, such as cancer, obesity, and stroke, as well as to provide overall health benefits by promoting immunomodulation, antioxidant activity, and enhancement of gut microbial flora. The multifunctional activities of several mushroom extracts have been evaluated by both in vitro and in vivo studies using cell lines along with invertebrate and vertebrate model systems to address human diseases and disorders at functional and molecular levels. Although each model has its own strengths as well as lacunas, various studies have generated a plethora of data regarding the regulating players that are modulated in order to provide various protective activities; hence, this review intends to compile and provide an overview of the plausible mechanism of action of mushroom-derived bioactives, which will be helpful in future medicinal explorations.

1. Introduction

Mushrooms are abundant and diverse in nature, with an enormous impact on human wellbeing and health. They have been used in medicines and diets by humans worldwide from time immemorable throughout various civilizations [1]. Oriental medicine continuously relies on mushrooms for their various medicinal concoctions. Mushrooms are “macrofungi” that consist of a fruiting body, called a basidiocarp, stipe, and mycelium. They are composed of 90% water and the remaining 10% is accounted for by proteins, amino acids, vitamins, fatty acids, carbohydrates, fiber, ash, and essential minerals [2,3]. Apart from the nutritional value, dietary uptake of mushrooms as a whole or as its derived metabolites, such as polysaccharides, lectins, phenols and polyphenols, ceramides, ergosterols, and terpenoids, which have been identified for their pharmaceutical activities, has shown desirable qualities, such as antioxidant, anti-microbial, anti-inflammatory, antihyperlipidemic, anticancer, anti-allergic, antiviral, immunomodulatory, neuroprotective, and prebiotic properties [1,2,3,4,5,6,7,8,9,10,11,12,13], which makes mushrooms a good choice for novel drug discovery against various diseases associated with oxidative stress, such as cancer, cardiovascular diseases, aging-associated disorders, and diabetes. Hence, there has been an increase in the number of scientific studies aiming to understand the molecular mechanisms underlying the various medicinal properties exhibited by diverse mushroom species.
The past few decades have seen a tremendous increase in mushroom production, owing to the awareness of health and their nutritional benefits. They are currently widely consumed as an alternative to animal protein and products [14]. Among the 16,000 species of mushrooms identified, only 4% are considered to be safe for consumption, although only around 60 species are cultivated commercially [4]. Applying present technological advances to traditional know-how in the elucidation of the structural and biochemical compositions of secondary metabolites isolated from mushrooms has made it possible for the evaluation of their therapeutic properties using in silico, in vitro, and in vivo approaches.
The multifunctional activities of several mushroom extracts have been evaluated by both in vitro and in vivo studies using cell lines along with invertebrate and vertebrate model systems to address human diseases and disorders at functional and molecular levels (Figure 1). Although, each model has its own strengths as well as lacunas, various studies have generated a plethora of data regarding the regulated players that are modulated in order to provide various protective activities; therefore, this review intends to compile and provide an overview of the plausible mechanisms of action of mushroom-derived bioactives, which will be helpful in future medicinal explorations.

2. Commonly Explored Models in Mushroom Research

Mushrooms are known to produce large numbers of compounds that are known to have a verity of pharmacological importance in combating or reducing various human pathologies. Model systems also play an important role in assessing the toxicological and pharmacological biokinetics of these therapeutically important mushrooms (extracts and their derived bioactives). Both in vitro and in vivo models have been used to understand the underlying mechanisms of action and protective effects of the various bioactives, such as polysaccharides, proteins, terpenes, cordycepin, ceramides, and phenolic compounds, in different disease conditions [6,8,12,13,14]. To simplify and distinguish the protective mechanisms of mushrooms and their bioactives, the available reports have been compiled based on the model used for the study and the mode of action involved.

2.1. In Vitro Studies

Edible mushrooms are a rich source of antioxidants; therefore, several in vitro studies have focused not only on their anticancer and immunomodulatory effects but also on the anti-aging and anti-neurodegenerative effects of their extracts and isolated derivatives. Each mushroom exhibits its own unique modulatory mechanism in various cells lines; therefore, some of the well-explored mushrooms have been tabulated below along with the derivatives and specific cell lines used and modulatory mechanisms (Table 1). Although there are several advantages of in vitro systems, including high throughput and cost efficacy, they do not fully mimic the conditions of an organism, thereby lacking to produce a whole picture [15]. Furthermore, several popular mammalian and non-mammalian animals, such a rat, mouse, fish, drosophila, and Caenorhabditis elegans, serve as in vivo models for human diseases due the presence of either or both physiological or pathophysiological aspects being similar to those of humans. Investigation of several parameters, such as drug efficacy, safety, and toxicological analysis, provide data that could be extrapolated for humans as pre-clinical studies. Furthermore, deep understanding of the molecular mechanism can also be extended to the development of therapeutic drugs against diseases in humans as well as in animals [16].

2.2. In Vivo Studies

2.2.1. Mammalian Models

Mouse and rat are the most popularly used animal models due to their close resemblance in physiological and molecular aspects to humans. Both of these animals are social in nature and are efficiently used in understanding various scientific queries regarding nutrition, genetics, immunology, neuroscience, infectious disease, metabolic and lifestyle-related diseases, and behavior. Easy manipulation of physiological conditions through oral or surgical methods or genomic manipulation using CRISPR_Cas9 to manifest desired disease conditions mirroring the human condition is an added advantage [16,150] in analyzing the therapeutic activity of many naturally available bioactives. Table 2 details the various disease models used and the therapeutic as well as regulatory mechanisms of different mushroom derivatives. In mouse models, mushroom derivatives have exhibited antitumor, anti-angiogenic, antidiabetic, anti-allergic, antioxidant, anti-inflammatory, anti-obesity, neuroprotective, wound-healing and gut microbiome protective activities. Similarly, in rats, different mushrooms have been able to modulate tumor growth, activate immunomodulatory activity by regulating the levels of WBC, induce antidiabetic activity by regulating plasma glucose, reduce total cholesterol levels, and enhance learning and memory along with improved neuronal growth, apart from inducing antioxidant effects, which has been explained in detail in Table 2.

2.2.2. Danio Rerio

Danio rerio (commonly known as zebrafish) have gained popularity as one of the most suitable non-mammalian vertebrate models for screening potential drug candidates among bioactives and secondary metabolites [269]. The cellular and biochemical similarity between zebrafish and humans have enabled researchers to evaluate the toxicity of small molecules as well as its impact on organs such as the heart, liver, brain, pancreas, and reproductive system. The transparency of the embryo also facilitates studying the interaction between bioactives and regulatory molecules using staining methods or tagging of specific molecular markers [269]. Different mushrooms are able to activate antioxidant mechanisms, reduce lipid accumulation and triglyceride levels, promote larval development and skeletal repair, improve memory, and reduce anxiety, along with reducing the pigmentation and melanin content. The interactions between various mushrooms derivatives and zebrafish have been tabulated below in Table 3.

2.2.3. Drosophila melanogaster

Drosophila melanogaster, or the fruit fly, has been a valuable tool for understanding the fundamentals of genes and genetic inheritance. Several biochemical pathways that regulate cellular function, as well as about 75% of human disease-related genes, are conserved between human and drosophila. Furthermore, it is easy to manipulate the genetic background to imitate pathogenic conditions to investigate the efficacy of potential drug molecules and targets. Hence, drosophila has been used as an invertebrate model for studying genetic disorders including rare Mendelian genetic disorders, neurodegenerative disorders, immune system regulation, and behavioral studies [286,287]. Various studies have reported that mushrooms can extend the lifespan of both male and female flies, improve AD levels, learning, and memory, as well as regulate apoptosis. They are also known to induce antioxidant activity, and the detailed actions of mushroom derivatives on disease-like conditions studied have been tabulated below in Table 4.

2.2.4. Caenorhabditis elegans

Caenorhabditis elegans is another popular invertebrate model in the field of genetic research, which was introduced by Sydney Brenner in 1970’s. Due to the presence of a high degree of homology between C. elegans and human pathways, such as insulin signaling, MAPK, and TGF-β pathways, it has been used as a model to investigate various conditions, such as aging, neurodegeneration, inflammation, and immune responses. It is also a promising tool to study the mechanism of action of phyto- and myco-chemicals isolated from natural sources [295] (Figure 2). Mushroom derivatives were reported to extend the lifespan of nematodes under normal as well as stress conditions, which includes oxidative, heat, heavy metal, and high sugar stress. Additionally, mushrooms were able to exhibit antioxidant and neuroprotective effects. All of the effects were modulated by key pathways, which include the DAF-16-mediated pathway, MAPK-mediated pathway, and SKN-1-mediated pathway. The action of mushroom derivatives on C. elegans have been tabulated below in Table 5.

2.2.5. Clinical Trials

Clinical trials have been performed on many different medicinal mushrooms, including Agaricus bisporus [309], A. blazei [310,311,312], A. sylvaticus [313,314], Antrodia cinnamomea [315], Coriolus versicolor [316,317], Ganoderma lucidum [318,319], Grifola frondose [320,321,322], Hericium erinaceus [323], Lentinus edodes [324,325,326,327], Phellinus rimosus [328], Pleurotus ostreatus [329], and Poria cocos [330]. Clinical studies in cancer patients undergoing chemotherapy reported that complementary use of mushroom polysaccharides, including lentinal, have improved the survival and quality of life of colorectal cancer patients [331]. A study in Japan also reported the higher response rate of lentinan-administered patients to cancer chemotherapy for solid tumors [332,333,334,335,336,337]. Schizophyllan has been reported to improve the overall survival rate of head and neck-related cancer [338]. Clinical trial reports suggest that schizophyllan consistently improved the overall survival of stage II cervical cancer patients; this, however, was not the case with respect to stage III patients [339,340,341]. Oral intake of G. frondosa polysaccharide extracts in 34 postmenopausal breast cancer patients led to a disease-free condition after primary treatment as part of a phase I/II trial, with marked increases in TNF-α, IL-2, and IL-10 production and a one-fifth reduction in IFN-γ production [320]. A single dose of Hericium erinaceus in a healthy, young adult cohort resulted in quicker output on the Stroop task at 60 min post dose, thereby improving the speed of performance and reducing subjective stress [323].
A clinical trial on Taiwanofungus camphoratus reported that 8 weeks of oral supplementation of mycelium could make significant reductions in systolic and diastolic blood pressures, probably through interaction with the renin angiotensin system to lower blood pressure by inhibiting renin secretion [342]. Golden T. camphoratus administration was also capable of reducing AST, ALT, and TG levels with no significant effects on general safety parameters, suggesting its use as a safe and effective hepatoprotective agent [343]. However, the extract also exhibited negative effects, including gastrointestinal discomfort and a reduction in platelet counts within a month of treatment, even though the role of mushrooms in these effects still remains unclear [315].
Inonotus obliquus exhibited immune-promoting effects, indicating its efficacy in the context of molecular mechanisms of action in immunological disease driven by TNF-α, which pertains to conditions such as psoriasis, along with noticeable relief or complete resolution of gastrointestinal tract symptoms [344,345]. The mushroom was also capable of reducing pain related to peptic ulcers, with more substantial effects seen at higher doses [346]. Tropicoporus linteus regulated immunomodulatory effects by extending natural killer cell activity and elevating IL-6, IgG1, IgG2, and IgM levels in patients with upper respiratory infections [347], reduced knee arthritis symptoms and pain [348], and increased patient adherence to postoperative chemotherapy [349]. However, there is still a wide gap in exploring the role of different mushrooms in human systems, which must be reduced with more clinical trials [350].

3. Mushrooms against Aging- and Lifestyle-Related Disorders

3.1. Neuroprotective Activity

Neuronal dysfunction comprises neuro-degenerative disorders, neuro-psychiatric disorders, and also neuronal inflammatory disorders. The trigger for the commencement of brain-related dysfunction or disorder can be attributed to genetics, natural aging, an injury, stress, the effect of certain drugs, infection, toxins, as well as other known and unknown factors [351]. Systemic level effects are detected or manifested as either loss of neuronal function, amnesia, gradual or rapid degeneration of neurons, abnormal presence or absence of neurotransmitters, or loss of function of an organ, but they share common cellular and molecular level pathologies, such as the accumulation of misfolded proteins, neuronal inflammation, mitochondrial disfunction, glutamate toxicity, cellular infiltration, and ROS production, which impair neuronal cellular homeostasis [351].
Mushroom-derived nutraceuticals that can stimulate neuroprotective activity in general, as well as disease conditions, via modulation of intrinsic factors are valuable and could transform the present mode of treatment approaches. Several neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, were found to have reportedly dysfunctional or reduced neuronal growth factors (NGFs) [352]. NGFs play a vital role in the maintenance, differentiation, and survival of the nervous system, as well as maintenance of the cholinergic system [353]. The two unique low-molecular-weight terpenoids, namely, hericenones and erinacines, isolated from the fruiting body and mycelia of Hericium erinaceus (HE) reportedly have the ability to cross the blood–brain barrier and have in vitro neurotrophic activity via the stimulation of NGFs, are capable of synthesis of NGFs, enhancement of neurite outgrowth in neuroblastoma-glioma cell line NG108-15, as well as enhanced myelination of mature neurons [352,354,355].
Polysaccharide preparations from HE were reported to have free radical inhibitory and scavenging activity by regulating antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase, as well as improving the cholinergic system [356,357]. Oral administration of hot water polysaccharide prepared from HE induced enhanced restoration and recovery of damaged peripheral sensory neurons in Sprague–Dawley rats via the Akt and p38 MAPK pathways, comparable to mecobalamin, a drug used for treating traumatic injury that reportedly has gastrointestinal and dermatological side effects [358]. HE polysaccharides were also found to improve damaged visual cognitive memory and spatial short-term memory in an Aβ-induced mouse model [88,359].
The neuroprotective effect of Ganoderma lucidum (GL) on spinal cord injury by restoration of GHS, a significant decrease in MDA, the reversal of many histopathological parameters, as well as suppression of inflammatory and oxidative stress has been demonstrated in vivo [360,361]. GL polysaccharides were found to suppress neuronal apoptosis, decrease the expression of caspase-3, Bax, and Bim, and increase the expression of Bcl-2, hence enhancing the neuroprotective effect [362,363]. GL aqueous extracts were found to rescue an animal model from hippocampal damage and vasogenic cerebral edema by ameliorating the levels of neurotransmitters and improving neuroplasticity by upregulating CREB/p-CREB/BDNF through the induction of ERK1/ERK2 [364]. Secondary metabolites from the GL fruiting body, methyl ganoderate G1 (a lanostane triterpene), lingzhine E, and lingzhine F (aromatic meroterpenoids), were found to be effective in scavenging Aβ-induced ROS as well as in reducing neurotoxicity, thereby imparting neuroprotectivity [365]. An anti-epileptic effect was observed in both in vitro and in vivo studies using extracts from GL. Spore-form GL was found to enhance the expression of neurotrophin-4 and stimulation of CaMK IIα in hippocampal neurons while inhibiting n-cadherin expression and accumulation of Ca2+. NF-κB expression was also found to be inhibited in the epileptic rat brain. These studies indicate the potential of GL extracts in the protection of neurons and in aiding a therapeutic approach toward decreasing the secondary damage caused by oxidative stress [366,367,368].
Dietary supplementation of Lentinula edodes LE β-glucan revealed alleviated neuroinflammation and BDNF deficit as well as synaptic impairment in long-term high-fat diet-fed mice [369]. Methanol extract from the fruiting body found to significantly reduce β-secretase activity [370].
A study by Han et al. [371] demonstrated that Inonotus obliquus (IO) polysaccharide administration protected HT22 cells from L-glu-induced damage by improving cell viability through decreasing intracellular ROS accumulation and caspase-3 activity. IO polysaccharide treatment resulted in the restoration of MMP by increasing Bcl-2 levels and suppression of Bax-2. Alleviation of oxidative stress was also observed, as polysaccharide-induced increases in Nrf2 levels were observed. The in vivo administration of IO polysaccharide improved AD-like symptoms in APP/PS 1 mice, as revealed by MWM tests, and immunohistopathology also revealed significant reductions in the deposition of Aβ 1-42 and P-Tau. 3,4-Dihydroxybenzalaceton, a catechol-containing compound isolated from IO, showed improved survival of SH-SY5Y cells exposed to PD-related neurotoxin 6 hydroxy dopamine by activating the Nrf/glutathione antioxidant pathway and expression of Akt/PI3K inhibitors [372]. Furthermore, the newly discovered flavan derivative enantiomers and four drimane sesquiterpene lactones isolated from IO also showed enhanced neuroprotective activity in SH-SY5Y cells against H2O2-induced stress [373].
Interestingly, an aqueous extract of Trametes veriscolor reportedly exhibited strong antiradical and AChE inhibition activities in an in vitro study [374].
The therapeutic potential of cordycepin, from Cordysepes sp., has been widely reported for its anti-inflammatory neuroprotective activity by suppression of the NF κB/AKT/MAPK pathway [375] and pro-inflammatory cytokines, including IL-1β, iNOS, MPOS, and MMP-9, promotion of anti-inflammatory factors [376], inhibition of neutrophil infiltration, amelioration of the BBB, and promotion of anti-inflammatory activity [377]. Oral administration of the low-molecular-weight peptide cordymine increased antioxidant activity, thereby boosting the defense mechanism against cerebral ischemia as well as significantly decreasing cellular infiltration [378].
Lignosus rhinoceros (LR) reportedly induced neurite outgrowth in a differentiating Neuro-2a cell line, implicating its neuroprotective activity [116]. In vivo analysis showed the reduction of intracellular ROS and a protective effect offered by the ethanol extract of LR on induced oxidative stress by the administration of juglone in wild-type C. elegans. LR extracts also reduced the expression of heat shock protein 16.2 and glutathione S transferase GFP protein expression in transgenic C. elegans TJ375 and CL2166, respectively. Super dismutase was also found to be enhanced in a dose-dependent manner against the control in CF1553 C. elegans. The study demonstrated the activation of antioxidant activity via the DAF-16/FOXO pathway [114]. In vitro and in vivo neuroprotective activity was offered by the LR extract by alleviating glutamate-induced toxicity in HT22 cells and prevention of neurotoxicity in C. elegans, respectively. The supplementation of LR extracts showed enhanced expression of antioxidant genes, as well as the decrease in aggregation of PolyQ40 and improved chemotaxis index in C. elegans [308]. A recent study on human embryonic stem cell-derived neuronal lineage cells demonstrated the neuroprotective and neurogenerative activities of LR methanol extract via activation of the Akt signaling pathway [115].
Sarcodonin sp. isolates showed significant neurite outgrowth activity in PC12 and NG108-15 cells, a hybrid neuronal cell obtained from mouse neuroblastoma and rat glial cells. The neurite outgrowth induced by SG-ME revealed the PKC-mediated pathway, whereas cyrneine A showed enhanced Rac1 (a small GTPase protein) activity influencing actin dynamics and assembly of F-actin at the tip of the neurite [379,380,381,382,383,384].
Yadav et al. [384] reviewed the neuroprotective efficacy of antroquinonol, a very valuable compound derivative of tetra hydro-ubiquinone isolated from Antrodia camphorate (AC). It was shown to improve cognitive skills in APP mouse during oral administration. Allevation of oxidative stress and inflammatory cytokines by stimulating the Nrf2 pathway, which acts through activation of the expression of antioxidant genes and reduction of inflammatory cytokines, which are common pathologies of Alzheimer’s disease. The ability to cross the BBB has made it a plausible choice for bioactives that can influence the neuronal pathway. Another bioactive that can cross the BBB is adenosine, isolated from AC, which can provide neuroprotective activity against neurophysiological disorders, as it binds to the A2A receptor, which results in post-synaptic depolarization.
Uridine, a key isolated bioactive isolated from Pleurotus gigantus, induced in vitro neurite outgrowth in a dose–time-dependent manner in PC12 cells, regulated via the MEK/ERK and PI3K pathways [385,386].
Inflammation is a double-edged sword, beneficial or damaging depending upon the intensity of its onset. The glial cells, comprising astrocytes and microglial cells, are the main players that regulate the inflammatory response in the CNS. Neuroinflammation is known to be the common pathophysiology seen during neurodegenerating diseases [387,388,389], including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, epilepsy, brain injury, infection, and other neuropsychiatric disorders, as well as metabolic disorders that can have an impact on the CNS via the gut–brain axis. The various bioactives isolated from mushrooms tend to target neuroimmune modulation to bring about a reduction in the inflammatory response by glial cells and to enhance antioxidant activity both in vitro and in vivo, thereby promoting neuronal outgrowth and enhancing neuroprotectivity (Figure 3). Most mushrooms have been used in common diets and as dietary supplements; it is important to perform intensive pre-clinical and clinical studies to validate their use as therapeutic agents as neuroprotectants in patients suffering from neurodegenerative disorder.

3.2. Antidiabetic Activity

Diabetes is one of the rapidly growing health concerns globally. It is mainly characterized by the increase in blood glucose levels due to insulin deficiency or sensitivity. If neglected, over time it results in defective functioning of the heart, kidney, eyes, blood vessels, liver, and brain, which can result in higher chances of mortality [390]. Several drugs are used in the treatment of diabetes at present, with metformin, a biguanide, being the first line of treatment [391]. Interestingly, guanidine, which is closely related to biguanides, was detected in mushrooms; also, the lectins isolated from Agaricus sp. stimulated enhanced insulin secretion from the Islets of Langerhans [392]. Partially pancreatectomized mice were found to have hyperplasia of β-cells along with functional attributes with time of treatment with Agaricus bisporous lectins, attributed to the increased expression of D-type cyclin, Cdk4, leading to the hyperphosphorylation of Rb in the islets, resulting in increased PDX-1 and Ngn-3 expression [393].
Aqueous extracts from Agarius sp. were found to decrease hyperglycemia and stimulate insulin secretion. Ethyl acetate extract from A. blazei was found to induce strong inhibition of α-glucosidase. It was also found to improve glucose uptake in HepG2 cells [394]. Esculetins from A. bisporous also were reported to exhibit enhanced α-glucosidase inhibitory activity [395]. Isolates from Hericium erinaceus were also found to have α-glucosidase inhibitory activity [396]. α-glucosidase inhibitors are known to suppress the influx of glucose from the intestinal tract to the blood vessels, resulting in a decrease in postprandial glucose levels, hence lowering blood glucose levels [394]. Dietary supplementation of A. blazei revealed protective effects against glucose intolerance and insulin resistance in high-fat diet-fed rats [397]. The antidiabetic activity of oligosaccharides isolated from Agaricus sp. was found to be twice as potent as that of the β-glucan isolated from the same [398]. Auricularia sp. induced modulation of both the antioxidant system and NF-κB signaling pathway as a protective mechanism against diabetes [399]. An interesting study by Chen et al. [400] revealed that the polysaccharides isolated from A. auricularia were found to rescue glucose metabolism through modulation of PDX1/GLUT2 in the pancreas and the JNK signaling pathway in the liver of 60Co-γ-radiated mice. Similar to α-glucosidase inhibitors, α-amylase inhibitors are also known to reduce postprandial glucose by preventing digestion of polysaccharides, which was observed with A. polytricha dietary fibers [401].
Molecules isolated from Antrodia sp. were also found to exhibit antidiabetic activity. Antcin K, isolated from A. camphorata, improved glucose tolerance in high-fat diet-fed mice by modulating the expression of TNF-α, IL-6, and PPARγ [402]. Antrodin C, isolated from A. cinnamomea mycelia, ameliorated hyperosmotic glucose-induced deleterious effects through stimulation of the Nrf-2-dependent cellular antioxidant defense system [403]. Flammulina velutipes polysaccharides and isolates from Inonotus obliquus were found to be effective in inhibiting diabetic nephropathy progression [404,405]. Active isolates from Ganoderma sp. are known to have protective effects against type I and II diabetes mellitus (T1DMand T2DM) as well as other chronic and acute complications associated with diabetes through the regulation of gluconeogenesis and the glycogenolysis process [406]. Alleviation of diabetic neuropathy was observed in vivo post oral administration of Hericium erinaceus [407], and various studies also revealed the hypoglycemic activity and protective effect of polysaccharides from Hericium erinaceus in promoting antidiabetic activity [408]. Polysaccharides extracted from Trametes versicolor were found to mitigate the development of diabetic complications as well as to strengthen and reduce the cortical porosity of bines during diabetic conditions [409,410].

3.3. Cardiovascular Protection

The most common pathophysiology of cardiovascular diseases is the development of atherosclerosis, primarily due to physical inactivity and high calorie diets. Atherosclerosis is an associated risk factor common among other metabolic disorders, hypertension, and diabetes [411,412]. Several edible varieties of mushrooms have been identified to have antihypercholesterolemic activity, exhibited through the suppression of HMG-CoA reductase [413]. Foods rich in soluble and insoluble dietary fibers have demonstrated efficacy in regulating hyperlipidemia. Mushrooms are rich in β-glucans, which have the ability to modulate the intestinal microbiota as well as influence cholesterol metabolism, lipid absorption, and regulate immunity, along with general health improvement [412,413]. Reduced expression of adhesion molecules (endothelial-leukocyte adhesion molecule-1 [E-selectin], vascular cell adhesion molecule-1 [VCAM-1], and intercellular adhesion molecule-1 [ICAM-1]) and reduced monocyte binding to human aortic endothelial cells are two indications that L-ergothioneine, a diet-derived amino acid, had cardioprotective effects in an in vitro atherogenesis model [414].

3.4. Cosmeceuticals and Nutricosmetics

Aging is a natural cellular mechanism that affects not only the skin (external appearance) but also the internal organs with the passage of time, though the most striking and noticeable changes occur in the skin as wrinkles, age spots, lack of elasticity, etc. External triggers like pollution and exposure to solar radiation can also result in the production of ROS, causing promotion of collagen breakdown through upregulation of matrix metalloproteinases (MMPs). Biomolecules with effective mechanisms to actively eradicate ROS and reduce the visible changes of aging are being actively researched at present, and mushrooms are one of the most interesting candidates due to their rich antioxidant, anti-inflammatory, antityrosinase, antimicrobial, anticollagenase, antielastase, and antihyaluronidase (moisturizing effect) properties [415]. The various mushroom species that have been traditionally used and commercially marketed have been extensively reviewed by Wu et al. [416] and Srivastava et al. [417].

4. Toxicity

There are thousands of mushroom species known to mankind throughout the world, among which a few hundred are edible. However, there are around 150 species reported to be poisonous in the European region, among which some can have a fatal impact [418]. Mushroom toxicity has been determined as a significant cause of concern in modern medicine because a few wild mushrooms that are traditionally consumed, especially in Asia and Eastern Europe, are subject to suspicion due to possible mutagenicity and myotoxicity [419].
The major potentially toxic elements identified in edible mushrooms include metal(loid)s and radionuclides originating from geogenic and anthropogenic sources, which are nonbiodegradable, not easily leachable, with long half-lives. These elements are seen naturally in the environment, and the percentages of these elements are determined by the geology of the region, such as erosion, volcanicity, and weathering [420]. Alpha-emitting radioisotopes are the most toxic among all radionuclides, which are seen in natural and anthropogenic origins in wild mushrooms from around the world. Mushrooms bioaccumulate a range of mineral ionic constituents and radioactive elements to different extents and are therefore considered as suitable bioindicators of environmental pollution. Several natural radionuclides, such as 210Po, accumulated at the highest levels were reported in Ukrainian mushrooms, which may expose consumers to highly radiotoxic decay particles produced by alpha emitters [421].
Mushroom foragers consume poisonous mushrooms either out of ignorance or after confusing them with edible ones [418]. However, the toxicity studies performed so far have had contrasting outcomes, leading to vague information about the overall safety of the mushrooms. Added to it, secondary contamination of the mushrooms could also occur during storage or transportation, which also leads to contradictory outcomes regarding consumption [419]. Finally, the limited data on the impact of geochemical anomalies of the soil material on accumulation of toxic elements in mushrooms are hurdles in determining mushroom toxicity.

5. Future Perspectives and Conclusions

Edible mushrooms are well known for their immense commercial and medicinal benefits. Mushroom-derived bioactives hold tremendous promise for addressing aging-related and lifestyle-associated diseases, offering a natural and holistic approach to health and wellness. Different innovative healthcare products have been developed from mushrooms, including mushroom coffee, mushroom collagen, mushroom memory enhancers, and many more. Mushroom-based leather can be made, which is durable and biodegradable, as an alternate to animal leather [422]. Mushrooms can be employed to break down and metabolize a wide range of pollutants, including hydrocarbons, pesticides, heavy metals, and even some radioactive materials, thereby aiding in bioremediation [423]. They can also aid in replacing some construction materials, acting as natural binders used in conjunction with more fibrous forms of agricultural waste, such as wood chips, straw, or hemp fibers [424].
The available vast evidence from in vitro and in vivo studies highlights their multifaceted benefits, ranging from neuroprotection and antidiabetic effects to cardiovascular health and cosmetic applications. The diverse biological activities of these natural compounds make them attractive candidates for developing novel therapeutic and preventive strategies with minimal or negligible side effects. Different mushroom derivatives have reported anticancer, antiviral, antioxidant, anti-inflammatory, antimetastatic, antimicrobial, antidiabetic, neuroprotective, and wound-healing activities in different cell lines, which are explained in detail in Table 1. Future research should focus on the development of more sophisticated in vitro models that better mimic the complex interactions within human tissues, which can have immense potential. For instance, 3D cell culture and organ-on-a-chip technologies could provide more accurate insight into how the different bioactives of mushrooms can affect cellular pathways relevant to aging- and lifestyle-related diseases and cancer.
Analyzing the effects of mushrooms in in vivo models is essential, as they can mimic the activities of the whole organism. C. elegans, being the smallest in vivo invertebrate model, highlighted the lifespan extending efficacies of different mushroom derivatives during normal as well as stress conditions. Interestingly, the molecular mechanism could be studied efficiently in this model. Drosophila is another model organism that can provide a better understanding of the effects and regulation of different genes and pathways, as it is a better known model for studying genetics. The zebrafish model, which is a vertebrate and slightly higher than the other models, allows researchers to gain a better idea of the impact on different organs during disease conditions as well as treatment stages. In the case of higher mammalian models, such as mice and rats, the changes in behavior patterns, neurological changes, the impact on aging and age-associated diseases, and the functioning of different internal organs in the presence of mushroom derivatives can be understood. These models have already provided valuable insights into the activities of different mushrooms; however, incorporating more model organisms could aid in uncovering new mechanisms of action and potential therapeutic targets.
Mushrooms can synthesize important biomolecules that are vital to the synthesis of nanoparticles with bioaccumulation and high stability, which is linked to protein capping and amide linkages [425]. Mushroom biomolecules aid in the process of stabilizing and reducing metal ions in nanoparticles, and their negative charges serve as adhesive and electrostatic forces during the formation of nanoparticles [426]. Interestingly, the majority of mushrooms incorporated in nanobiotechnology are edible and highly medicinal, thus serving as biofactories for the production of safe and medically important nanoparticles of iron, silver, selenium, gold, and others [427]. Among all oyster mushroom-mediated nanoparticles, 66% are silver nanoparticles, while 25% are gold nanoparticles and zinc oxide [428]. The biological synthesis of mushroom nanoparticles is stable, environmentally friendly, and non toxic [429].
Mushrooms contain riboflavin, which has light sensitive and water solubility properties that are essential for nanoparticle synthesis. Several biomolecules in mushrooms can reduce and stabilize metal ions in nanoparticles, most especially the biomolecules involved in the transfer of electrons in the complex pathways of NADPH/NADH to NAD+/NAD+ [430,431,432]. Different factors, including temperature, concentration of the raw materials, pressure, pH of the solution, time, magnitude of the particle, size of the pore, the environment, and accumulation of the mushroom extract can affect the biosynthesis of nanoparticles [433]. The mushroom-sourced biosynthesis of nanoparticles is considered to be safer, biocompatible, ecologically friendly, cost effective, and widely acceptable [429]. For example, resveratrol, a major polyphenol and functional food with poor solubility and bioavailability, was efficiently transported into the host using mushroom-derived nanoparticles [434,435]. The future might lead to a broad range of uses of mushrooms through nanotechnology, especially in the area of biomolecule delivery and tissue biomimetics [429,436].
The integration of omics technologies, such as genomics, proteomics, and metabolomics, into these studies will enhance our understanding of the systemic effects of mushroom bioactives and identify biomarkers for potential activity. Future research should pave the way in that direction, which will be beneficial to mankind. Also, it is important to note that several effects, such as antioxidant, neuroprotective, lifespan extension, and anticancer, were observed in almost every model. This implies that these effects could be conserved in different models and could also be present in humans as well. Even though mushrooms are a part of the human diet in different countries, high-quality human studies have to be designed and performed to confirm the optimum dosage and efficacy of these compounds in diverse populations. Regulatory frameworks must also evolve to accommodate the unique properties of natural products, ensuring that they can be effectively and safely integrated into mainstream healthcare. Future research must therefore focus on integrating innovative models and technologies, conduct comprehensive clinical trials, and thereby explore personalized approaches to therapy. This will allow researchers to better understand the mechanisms underlying their beneficial effects and translate these findings into effective interventions that improve health and quality of life.

Author Contributions

Conceptualization, R.S., T.T. and S.C.; validation, R.S., K.M., P.R., S.N. and S.C.; writing—original draft preparation, R.S., K.M., P.R., M.I.P., S.N., P.P., T.T. and S.C.; writing—review and editing, R.S., K.M., P.R., M.I.P., S.N., P.P., T.T. and S.C.; visualization, R.S., K.M., P.R., S.N. and S.C.; project administration and funding acquisition, S.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Chulalongkorn University (ReinUni_65_03_37_11).

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Rahi, D.K.; Malik, D. Diversity of mushrooms and their metabolites of nutraceutical and therapeutic significance. J. Mycol. 2016, 2016, 1–18. [Google Scholar] [CrossRef]
  2. Cheung, P.C. The nutritional and health benefits of mushrooms. Nutr. Bull. 2010, 35, 292–299. [Google Scholar] [CrossRef]
  3. Motta, F.; Gershwin, M.E.; Selmi, C. Mushrooms and immunity. J. Autoimmun. 2021, 117, 102576. [Google Scholar] [CrossRef] [PubMed]
  4. Dudekula, U.T.; Doriya, K.; Devarai, S.K. A critical review on submerged production of mushroom and their bioactive metabolites. 3 Biotech. 2020, 10, 337. [Google Scholar] [CrossRef] [PubMed]
  5. Qin, D.W.; Han, C. Medicinal and edible fungi as an alternative medicine for treating age-related disease. Evid. Based Complement. Alternat Med. 2014, 2014, 638561. [Google Scholar] [CrossRef] [PubMed]
  6. Sillapachaiyaporn, C.; Nilkhet, S.; Ung, A.T.; Chuchawankul, S. Anti-HIV-1 protease activity of the crude extracts and isolated compounds from Auricularia polytricha. BMC Complement. Altern. Med. 2019, 19, 315. [Google Scholar] [CrossRef] [PubMed]
  7. Dasgupta, A.; Acharya, K. Mushrooms: An emerging resource for therapeutic terpenoids. 3 Biotech. 2019, 9, 369. [Google Scholar] [CrossRef] [PubMed]
  8. Venturella, G.; Ferraro, V.; Cirlincione, F.; Gargano, M.L. Medicinal mushrooms: Bioactive compounds, use, and clinical trials. Int. J. Mol. Sci. 2021, 22, 634. [Google Scholar] [CrossRef] [PubMed]
  9. Nowakowski, P.; Markiewicz-Żukowska, R.; Bielecka, J.; Mielcarek, K.; Grabia, M.; Socha, K. Treasures from the forest: Evaluation of mushroom extracts as anti-cancer agents. Biomed. Pharmacother. 2021, 143, 112106. [Google Scholar] [CrossRef]
  10. Sillapachaiyaporn, C.; Rangsinth, P.; Nilkhet, S.; Ung, A.T.; Chuchawankul, S.; Tencomnao, T. Neuroprotective effects against Glutamate-Induced HT-22 hippocampal cell damage and Caenorhabditis elegans lifespan/healthspan enhancing activity of Auricularia polytricha mushroom extracts. Pharmaceuticals 2021, 14, 1001. [Google Scholar] [CrossRef]
  11. Kumar, K.; Mehra, R.; Guiné, R.P.; Lima, M.J.; Kumar, N.; Kaushik, R.; Ahmed, N.; Yadav, A.N.; Kumar, H. Edible Mushrooms: A comprehensive review on bioactive compounds with health benefits and processing aspects. Foods 2021, 10, 2996. [Google Scholar] [CrossRef] [PubMed]
  12. Anusiya, G.; Gowthama Prabu, U.; Yamini, N.V.; Sivarajasekar, N.; Rambabu, K.; Bharath, G.; Banat, F. A review of the therapeutic and biological effects of edible and wild mushrooms. Bioengineered 2021, 12, 11239–11268. [Google Scholar] [CrossRef] [PubMed]
  13. Landi, N.; Clemente, A.; Pedone, P.V.; Ragucci, S.; Di Maro, A. An updated review of bioactive peptides from mushrooms in a well-defined molecular weight range. Toxins 2022, 14, 84. [Google Scholar] [CrossRef] [PubMed]
  14. Usman, M.; Murtaza, G.; Ditta, A. Nutritional, medicinal, and cosmetic value of bioactive compounds in button mushroom (Agaricus bisporus): A review. Appl. Sci. 2021, 11, 5943. [Google Scholar] [CrossRef]
  15. Graudejus, O.; Ponce Wong, R.D.; Varghese, N.; Wagner, S.; Morrison, B. Bridging the gap between in vivo and in vitro research: Reproducing in vitro the mechanical and electrical environment of cells in vivo. Front. Cell. Neurosci. 2018, 12, 00069. [Google Scholar] [CrossRef]
  16. Mukherjee, P.; Roy, S.; Ghosh, D.; Nandi, S.K. Role of animal models in biomedical research: A review. Lab. Anim. Res. 2022, 38, 18. [Google Scholar] [CrossRef] [PubMed]
  17. Sorimachi, K.; Akimoto, K.; Ikehara, Y.; Inafuku, K.; Okubo, A.; Yamazaki, S. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct. Funct. 2001, 26, 103–108. [Google Scholar] [CrossRef] [PubMed]
  18. Bruggemann, R.; Matsuo Orlandi, J.; Benati, F.J.; Faccin, L.C.; Mantovani, M.S.; Nozawa, C.; Linhares, R.E. Antiviral activity of Agaricus blazei Murrill ss. Heinem extract against human and bovine herpesviruses in cell culture. Braz. J. Microbiol. 2006, 37, 561–565. [Google Scholar] [CrossRef]
  19. Faccin, L.C.; Benati, F.; Rincão, V.P.; Mantovani, M.S.; Soares, S.A.; Gonzaga, M.L.; Nozawa, C.; Carvalho Linhares, R.E. Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1. Lett. Appl. Microbiol. 2007, 45, 24–28. [Google Scholar] [CrossRef] [PubMed]
  20. Endo, M.; Beppu, H.; Akiyama, H.; Wakamatsu, K.; Ito, S.; Kawamoto, Y.; Shimpo, K.; Sumiya, T.; Koike, T.; Matsui, T. Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochim. Et Biophys. Acta (BBA)-Gen. Subj. 2010, 1800, 669–673. [Google Scholar] [CrossRef]
  21. de Sousa Cardozo, F.T.; Camelini, C.M.; Mascarello, A.; Rossi, M.J.; Nunes, R.J.; Barardi, C.R.; de Mendonça, M.M.; Simões, C.M. Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia. Antivir. Res. 2011, 92, 108–114. [Google Scholar] [CrossRef] [PubMed]
  22. Misgiati, M.; Widyawaruyanti, A.; Raharjo, S.J.; Sukardiman, S. Ergosterol isolated from Agaricus blazei Murill n-hexane extracts as potential anticancer MCF-7 activity. Pharmacogn. J. 2021, 13, 418–426. [Google Scholar] [CrossRef]
  23. Adams, L.S.; Chen, S.; Phung, S.; Wu, X.; Ki, L. White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice. Nutr. Cancer 2008, 60, 744–756. [Google Scholar] [CrossRef]
  24. Jeong, S.C.; Koyyalamudi, S.R.; Jeong, Y.T.; Song, C.H.; Pang, G. Macrophage immunomodulating and antitumor activities of polysaccharides isolated from Agaricus bisporus white button mushrooms. J. Med. Food 2012, 15, 58–65. [Google Scholar] [CrossRef] [PubMed]
  25. Muszynska, B.; Grzywacz, A.; Kala, K.; Gdula-Argasinska, J. Anti-inflammatory potential of in vitro cultures of the white button mushroom, Agaricus bisporus (Agaricomycetes), in Caco-2 cells. Int. J. Med. Mushrooms 2018, 20, 129–139. [Google Scholar] [CrossRef] [PubMed]
  26. Smiderle, F.R.; Ruthes, A.C.; van Arkel, J.; Chanput, W.; Iacomini, M.; Wichers, H.J.; Van Griensven, L.J. Polysaccharides from Agaricus bisporus and Agaricus brasiliensis show similarities in their structures and their immunomodulatory effects on human monocytic THP-1 cells. BMC Complement. Altern. Med. 2011, 11, 58. [Google Scholar] [CrossRef] [PubMed]
  27. Liu, Z.; Li, L.; Xue, B.; Zhao, D.; Zhang, Y.; Yan, X. A new lectin from Auricularia auricula inhibited the proliferation of lung cancer cells and improved pulmonary Flora. BioMed Res. Int. 2021, 2021, 1–15. [Google Scholar] [CrossRef]
  28. Hikam, A.R.; Ekowati, N.; Hernayanti, H. The Cytotoxic and Apoptosis Effects of Chloroform Extracts of Auricularia auricula on Cervical Cancer Cells. Biosaintifika J. Biol. Biol. Educ. 2019, 11, 32–38. [Google Scholar] [CrossRef]
  29. Kang, M.A.; Jeon, Y.K.; Nam, M.J. Auricularia auricula increases an apoptosis in human hepatocellular carcinoma cells via a regulation of the peroxiredoxin1. J. Food Biochem. 2020, 44, e13373. [Google Scholar] [CrossRef]
  30. Shahar, O.; Pereman, I.; Khamisie, H.; Ezov, N.; Danay, O.; Khattib, A.; Khatib, S.; Mahajna, J. Compounds originating from the edible mushroom Auricularia auricula-judae inhibit tropomyosin receptor kinase B activity. Heliyon 2023, 9, e13756. [Google Scholar] [CrossRef]
  31. Qian, L.; Liu, H.; Li, T.; Liu, Y.; Zhang, Z.; Zhang, Y. Purification, characterization and in vitro antioxidant activity of a polysaccharide AAP-3-1 from Auricularia auricula. Int. J. Biol. Macromol. 2020, 162, 1453–1464. [Google Scholar] [CrossRef] [PubMed]
  32. Yu, J.; Sun, R.; Zhao, Z.; Wang, Y. Auricularia polytricha polysaccharides induce cell cycle arrest and apoptosis in human lung cancer A549 cells. Int. J. Biol. Macromol. 2014, 68, 67–71. [Google Scholar] [CrossRef] [PubMed]
  33. Sillapachaiyaporn, C.; Chuchawankul, S.; Nilkhet, S.; Moungkote, N.; Sarachana, T.; Ung, A.T.; Baek, S.J.; Tencomnao, T. Ergosterol isolated from cloud ear mushroom (Auricularia polytricha) attenuates bisphenol A-induced BV2 microglial cell inflammation. Food Res. Int. 2022, 157, 111433. [Google Scholar] [CrossRef] [PubMed]
  34. Sillapachaiyaporn, C.; Mongkolpobsin, K.; Chuchawankul, S.; Tencomnao, T.; Baek, S.J. Neuroprotective effects of ergosterol against TNF-α-induced HT-22 hippocampal cell injury. Biomed. Pharmacother. 2022, 154, 113596. [Google Scholar] [CrossRef] [PubMed]
  35. Yang, H.L.; Chen, C.S.; Chang, W.H.; Lu, F.J.; Lai, Y.C.; Chen, C.C.; Hseu, T.H.; Kuo, C.T.; Hseu, Y.C. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett. 2006, 231, 215–227. [Google Scholar] [CrossRef] [PubMed]
  36. Yang, H.L.; Kuo, Y.H.; Tsai, C.T.; Huang, Y.T.; Chen, S.C.; Chang, H.W.; Lin, E.; Lin, W.H.; Hseu, Y.C. Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food Chem. Toxicol. 2011, 49, 290–298. [Google Scholar] [CrossRef] [PubMed]
  37. Hseu, Y.C.; Wu, F.Y.; Wu, J.J.; Chen, J.Y.; Chang, W.H.; Lu, F.J.; Lai, Y.C.; Yang, H.L. Anti-inflammatory potential of Antrodia camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway. Int. Immunopharmacol. 2005, 5, 1914–1925. [Google Scholar] [CrossRef]
  38. Yeh, C.T.; Rao, Y.K.; Yao, C.J.; Yeh, C.F.; Li, C.H.; Chuang, S.E.; Luong, J.H.; Lai, G.M.; Tzeng, Y.M. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett. 2009, 285, 73–79. [Google Scholar] [CrossRef]
  39. Huang, Y.; Lin, X.; Qiao, X.; Ji, S.; Liu, K.; Yeh, C.T.; Tzeng, Y.M.; Guo, D.; Ye, M. Antcamphins A–L, ergostanoids from Antrodia camphorata. J. Nat. Prod. 2014, 77, 118–124. [Google Scholar] [CrossRef]
  40. Rao, Y.K.; Wu, A.T.; Geethangili, M.; Huang, M.T.; Chao, W.J.; Wu, C.H.; Deng, W.P.; Yeh, C.T.; Tzeng, Y.M. Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells. Chem. Res. Toxicol. 2011, 24, 238–245. [Google Scholar] [CrossRef]
  41. Yeh, C.T.; Huang, W.C.; Rao, Y.K.; Ye, M.; Lee, W.H.; Wang, L.S.; Tzeng, D.T.; Wu, C.H.; Shieh, Y.S.; Huang, C.Y.; et al. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells. Carcinogenesis 2013, 34, 2918–2928. [Google Scholar] [CrossRef] [PubMed]
  42. Peng, C.C.; Chen, K.C.; Peng, R.Y.; Su, C.H.; Hsieh-Li, H.M. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts. Cancer Lett. 2006, 243, 109–119. [Google Scholar] [CrossRef] [PubMed]
  43. Hsieh, Y.H.; Chu, F.H.; Wang, Y.S.; Chien, S.C.; Chang, S.T.; Shaw, J.F.; Chen, C.Y.; Hsiao, W.W.; Kuo, Y.H.; Wang, S.Y. Antrocamphin A, an anti-inflammatory principal from the fruiting body of Taiwanofungus camphoratus, and its mechanisms. J. Agric. Food Chem. 2010, 58, 3153–3158. [Google Scholar] [CrossRef] [PubMed]
  44. Chen, C.C.; Shiao, Y.J.; Lin, R.D.; Shao, Y.Y.; Lai, M.N.; Lin, C.C.; Ng, L.T.; Kuo, Y.H. Neuroprotective Diterpenes from the Fruiting Body of Antrodiac amphorata. J. Nat. Prod. 2006, 69, 689–691. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, S.C.; Lee, T.H.; Hsu, C.H.; Chang, Y.J.; Chang, M.S.; Wang, Y.C.; Ho, Y.S.; Wen, W.C.; Lin, R.K. Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential. J. Agric. Food Chem. 2014, 62, 5625–5635. [Google Scholar] [CrossRef]
  46. Hseu, Y.C.; Chang, W.C.; Hseu, Y.T.; Lee, C.Y.; Yech, Y.J.; Chen, P.C.; Chen, J.Y.; Yang, H.L. Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes. Life Sci. 2002, 71, 469–482. [Google Scholar] [CrossRef] [PubMed]
  47. Lien, H.M.; Lin, H.W.; Wang, Y.J.; Chen, L.C.; Yang, D.Y.; Lai, Y.Y.; Ho, Y.S. Inhibition of anchorage-independent proliferation and G0/G1 cell-cycle regulation in human colorectal carcinoma cells by 4, 7-dimethoxy-5-methyl-l, 3-benzodioxole isolated from the fruiting body of Antrodia camphorate. Evid.-Based Complement. Altern. Med. 2011, 2011, 984027. [Google Scholar] [CrossRef]
  48. Zou, X.G.; Xu, M.T.; Dong, X.L.; Ying, Y.M.; Guan, R.F.; Wu, W.C.; Yang, K.; Sun, P.L. Solid-state-cultured mycelium of Antrodia camphorata exerts potential neuroprotective activities against 6-hydroxydopamine-induced toxicity in PC12 cells. J. Food Biochem. 2022, 46, e14208. [Google Scholar] [CrossRef] [PubMed]
  49. Lemieszek, M.K.; Cardoso, C.; Nunes, F.H.; Marques, G.; Pożarowski, P.; Rzeski, W. Boletus edulis biologically active biopolymers induce cell cycle arrest in human colon adenocarcinoma cells. Food Funct. 2013, 4, 575–585. [Google Scholar] [CrossRef] [PubMed]
  50. Lemieszek, M.K.; Ribeiro, M.; Alves, H.G.; Marques, G.; Nunes, F.M.; Rzeski, W. Boletus edulis ribonucleic acid–a potent apoptosis inducer in human colon adenocarcinoma cells. Food Funct. 2016, 7, 3163–3175. [Google Scholar] [CrossRef] [PubMed]
  51. Meng, T.; Yu, S.S.; Ji, H.Y.; Xu, X.M.; Liu, A.J. A novel acid polysaccharide from Boletus edulis: Extraction, characteristics and antitumor activities in vitro. Glycoconj. J. 2021, 38, 13–24. [Google Scholar] [CrossRef] [PubMed]
  52. Feng, T.; Li, Z.H.; Dong, Z.J.; Su, J.; Li, Y.; Liu, J.K. Non-isoprenoid botryane sesquiterpenoids from basidiomycete Boletus edulis and their cytotoxic activity. Nat. Prod. Bioprospecting 2011, 1, 29–32. [Google Scholar] [CrossRef]
  53. Bovi, M.; Cenci, L.; Perduca, M.; Capaldi, S.; Carrizo, M.E.; Civiero, L.; Chiarelli, L.R.; Galliano, M.; Monaco, H.L. BEL β-trefoil: A novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms. Glycobiology 2013, 23, 578–592. [Google Scholar] [CrossRef] [PubMed]
  54. Liang, Q.L. Isolation, structure identification and cytotoxicity evaluation of three steroids from Boletus edulis. Appl. Mech. Mater. 2014, 675, 1670–1673. [Google Scholar] [CrossRef]
  55. Kaplan, Ö.; Tosun, N.G.; Özgür, A.; Tayhan, S.E.; Bilgin, S.; Türkekul, İ.; Gökce, İ. Microwave-assisted green synthesis of silver nanoparticles using crude extracts of Boletus edulis and Coriolus versicolor: Characterization, anticancer, antimicrobial and wound healing activities. J. Drug Deliv. Sci. Technol. 2021, 64, 102641. [Google Scholar] [CrossRef]
  56. Yu, S.; Ma, R.; Dong, X.; Ji, H.; Liu, A. A novel polysaccharide from Boletus edulis: Extraction, purification, characterization and immunologic activity. Ind. Crops Prod. 2022, 186, 115206. [Google Scholar] [CrossRef]
  57. Chang, Y.C.; Hsiao, Y.M.; Wu, M.F.; Ou, C.C.; Lin, Y.W.; Lue, K.H.; Ko, J.L. Interruption of lung cancer cell migration and proliferation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes. J. Agric. Food Chem. 2013, 61, 12044–12052. [Google Scholar] [CrossRef] [PubMed]
  58. Mitra, S.; Bhartiya, P.; Kaushik, N.; Nhat Nguyen, L.; Wahab, R.; Bekeschus, S.; Choi, E.H.; Kaushik, N.K. Plasma-treated Flammulina velutipes-derived extract showed anticancer potential in human breast cancer cells. Appl. Sci. 2020, 10, 8395. [Google Scholar] [CrossRef]
  59. Yang, W.; Pei, F.; Shi, Y.; Zhao, L.; Fang, Y.; Hu, Q. Purification, characterization and anti-proliferation activity of polysaccharides from Flammulina velutipes. Carbohydr. Polym. 2012, 88, 474–480. [Google Scholar] [CrossRef]
  60. Ukaegbu, C.I.; Shah, S.R.; Hamid, H.A.; Alara, O.R.; Sarker, M.Z. Phenolic compounds of aqueous and methanol extracts of Hypsizygus tessellatus (brown and white var.) and Flammulina velutipes caps: Antioxidant and antiproliferative activities. Pharm. Chem. J. 2020, 54, 170–183. [Google Scholar] [CrossRef]
  61. Chen, G.T.; Fu, Y.X.; Yang, W.J.; Hu, Q.H.; Zhao, L.Y. Effects of polysaccharides from the base of Flammulina velutipes stipe on growth of murine RAW264. 7, B16F10 and L929 cells. Int. J. Biol. Macromol. 2018, 107, 2150–2156. [Google Scholar] [CrossRef] [PubMed]
  62. Yi, C.; Zhong, H.; Tong, S.; Cao, X.; Firempong, C.K.; Liu, H.; Fu, M.; Yang, Y.; Feng, Y.; Zhang, H.; et al. Enhanced oral bioavailability of a sterol-loaded microemulsion formulation of Flammulina velutipes, a potential antitumor drug. Int. J. Nanomed. 2012, 7, 5067–5078. [Google Scholar]
  63. Stajic, M. Se effect on biological activity of Flammulina velutipes. Ital. J. Food Sci. 2015, 27, 57–63. [Google Scholar]
  64. Tabuchi, A.; Fukushima-Sakuno, E.; Osaki-Oka, K.; Futamura, Y.; Motoyama, T.; Osada, H.; Ishikawa, N.K.; Nagasawa, E.; Tokimoto, K. Productivity and bioactivity of enokipodins A–D of Flammulina rossica and Flammulina velutipes. Biosci. Biotechnol. Biochem. 2020, 84, 876–886. [Google Scholar] [CrossRef] [PubMed]
  65. Hu, Y.N.; Sung, T.J.; Chou, C.H.; Liu, K.L.; Hsieh, L.P.; Hsieh, C.W. Characterization and antioxidant activities of yellow strain Flammulina velutipes (Jinhua mushroom) polysaccharides and their effects on ROS content in L929 cell. Antioxidants 2019, 8, 298. [Google Scholar] [CrossRef] [PubMed]
  66. Ding, M.; Lv, K.; Zhang, D.; Fan, W.; Tsopmejio, I.S.; Jin, Z.; Song, H. Effect of Flammulina velutipes polysaccharides on endoplasmic reticulum stress-mediated apoptosis by activating PLC–IP3 pathway in HepG2 cells. J. Food Sci. 2023, 88, 523–536. [Google Scholar] [CrossRef] [PubMed]
  67. Jia, W.; Feng, J.; Zhang, J.; Lin, C.C.; Wang, W.; Chen, H.G. Structural characteristics of the novel polysaccharide FVPA1 from winter culinary-medicinal mushroom, Flammulina velutipes (Agaricomycetes), capable of enhancing natural killer cell activity against K562 tumor cells. Int. J. Med. Mushrooms 2017, 19, 535–546. [Google Scholar] [CrossRef] [PubMed]
  68. Hu, Q.; Yu, J.; Yang, W.; Kimatu, B.M.; Fang, Y.; Ma, N.; Pei, F. Identification of flavonoids from Flammulina velutipes and its neuroprotective effect on pheochromocytoma-12 cells. Food Chem. 2016, 204, 274–282. [Google Scholar] [CrossRef] [PubMed]
  69. Sliva, D.; Labarrere, C.; Slivova, V.; Sedlak, M.; Lloyd, F.P., Jr.; Ho, N.W. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem. Biophys. Res. Commun. 2002, 298, 603–612. [Google Scholar] [CrossRef] [PubMed]
  70. Zhao, S.; Ye, G.; Fu, G.; Cheng, J.; Yang, B.B.; Peng, C. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int. J. Oncol. 2011, 38, 1319–1327. [Google Scholar]
  71. Hu, H.; Ahn, N.S.; Yang, X.; Lee, Y.S.; Kang, K.S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int. J. Cancer 2002, 102, 250–253. [Google Scholar] [CrossRef] [PubMed]
  72. Xie, J.T.; Wang, C.Z.; Wicks, S.; Yin, J.J.; Kong, J.; Li, J.; Li, Y.C.; Yuan, C.S. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp. Oncol. 2006, 28, 25–29. [Google Scholar] [PubMed]
  73. Yuen, J.W.; Gohel, M.D.; Au, D.W. Telomerase-associated apoptotic events by mushroom ganoderma lucidum on premalignant human urothelial cells. Nutr. Cancer 2007, 60, 109–119. [Google Scholar] [CrossRef] [PubMed]
  74. Tang, W.; Liu, J.W.; Zhao, W.M.; Wei, D.Z.; Zhong, J.J. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006, 80, 205–211. [Google Scholar] [CrossRef] [PubMed]
  75. Dudhgaonkar, S.; Thyagarajan, A.; Sliva, D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int. Immunopharmacol. 2009, 9, 1272–1280. [Google Scholar] [CrossRef] [PubMed]
  76. Hilliard, A.; Mendonca, P.; Soliman, K.F. Involvement of NFƙB and MAPK signaling pathways in the preventive effects of Ganoderma lucidum on the inflammation of BV-2 microglial cells induced by LPS. J. Neuroimmunol. 2020, 345, 577269. [Google Scholar] [CrossRef] [PubMed]
  77. Liu, C.; Dunkin, D.; Lai, J.; Song, Y.; Ceballos, C.; Benkov, K.; Li, X.M. Anti-inflammatory effects of Ganoderma lucidum triterpenoid in human crohn’s disease associated with downregulation of NF-κB signaling. Inflamm. Bowel Dis. 2015, 21, 1918–1925. [Google Scholar] [CrossRef] [PubMed]
  78. Lu, S.Y.; Peng, X.R.; Dong, J.R.; Yan, H.; Kong, Q.H.; Shi, Q.Q.; Li, D.S.; Zhou, L.; Li, Z.R.; Qiu, M.H. Aromatic constituents from Ganoderma lucidum and their neuroprotective and anti-inflammatory activities. Fitoterapia 2019, 134, 58–64. [Google Scholar] [CrossRef] [PubMed]
  79. Choi, S.; Tae, N.; Lee, S.; Ryoo, S.; Min, B.S.; Lee, J.H. Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW264. 7 cells. Toxicol. Appl. Pharmacol. 2014, 280, 434–442. [Google Scholar] [CrossRef]
  80. Shi, Q.; Huang, Y.; Su, H.; Gao, Y.; Peng, X.; Zhou, L.; Li, X.; Qiu, M. C28 steroids from the fruiting bodies of Ganoderma resinaceum with potential anti-inflammatory activity. Phytochemistry 2019, 168, 112109. [Google Scholar] [CrossRef]
  81. Cho, J.Y.; Sadiq, N.B.; Kim, J.C.; Lee, B.; Hamayun, M.; Lee, T.S.; Kim, H.S.; Park, S.H.; Nho, C.W.; Kim, H.Y. Optimization of antioxidant, anti-diabetic, and anti-inflammatory activities and ganoderic acid content of differentially dried Ganoderma lucidum using response surface methodology. Food Chem. 2021, 335, 127645. [Google Scholar]
  82. Kou, R.W.; Xia, B.; Wang, Z.J.; Li, J.N.; Yang, J.R.; Gao, Y.Q.; Yin, X.; Gao, J.M. Triterpenoids and meroterpenoids from the edible Ganoderma resinaceum and their potential anti-inflammatory, antioxidant and anti-apoptosis activities. Bioorganic Chem. 2022, 121, 105689. [Google Scholar] [CrossRef] [PubMed]
  83. Liu, J.Q.; Lian, C.L.; Hu, T.Y.; Wang, C.F.; Xu, Y.; Xiao, L.; Liu, Z.Q.; Qiu, S.Q.; Cheng, B.H. Two new farnesyl phenolic compounds with anti-inflammatory activities from Ganoderma duripora. Food Chem. 2018, 263, 155–162. [Google Scholar] [CrossRef] [PubMed]
  84. Mei, R.Q.; Zuo, F.J.; Duan, X.Y.; Wang, Y.N.; Li, J.R.; Qian, C.Z.; Xiao, J.P. Ergosterols from Ganoderma sinense and their anti-inflammatory activities by inhibiting NO production. Phytochem. Lett. 2019, 32, 177–180. [Google Scholar] [CrossRef]
  85. Sangtitanu, T.; Sangtanoo, P.; Srimongkol, P.; Saisavoey, T.; Reamtong, O.; Karnchanatat, A. Peptides obtained from edible mushrooms: Hericium erinaceus offers the ability to scavenge free radicals and induce apoptosis in lung cancer cells in humans. Food Funct. 2020, 11, 4927–4939. [Google Scholar] [CrossRef] [PubMed]
  86. Liu, J.Y.; Hou, X.X.; Li, Z.Y.; Shan, S.H.; Chang, M.C.; Feng, C.P.; Wei, Y. Isolation and structural characterization of a novel polysaccharide from Hericium erinaceus fruiting bodies and its arrest of cell cycle at S-phage in colon cancer cells. Int. J. Biol. Macromol. 2020, 157, 288–295. [Google Scholar] [CrossRef] [PubMed]
  87. Ren, Z.; Qin, T.; Qiu, F.; Song, Y.; Lin, D.; Ma, Y.; Li, J.; Huang, Y. Immunomodulatory effects of hydroxyethylated Hericium erinaceus polysaccharide on macrophages RAW264. 7. Int. J. Biol. Macromol. 2017, 105, 879–885. [Google Scholar] [CrossRef] [PubMed]
  88. Cheng, J.H.; Tsai, C.L.; Lien, Y.Y.; Lee, M.S.; Sheu, S.C. High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity. BMC Complement. Altern. Med. 2016, 16, 170. [Google Scholar] [CrossRef] [PubMed]
  89. Liao, B.; Zhou, C.; Liu, T.; Dai, Y.; Huang, H. A novel Hericium erinaceus polysaccharide: Structural characterization and prevention of H2O2-induced oxidative damage in GES-1 cells. Int. J. Biol. Macromol. 2020, 154, 1460–1470. [Google Scholar] [CrossRef]
  90. Atay, S.; Ak, H.; Kalmis, E.; Kayalar, H.; Aydin, H.H. Transcriptome-Wide Analysis Reveals the Molecular Mechanism of Tumoricidal Effects of Lion’s Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), on MCF-7 Breast Cancer Cells. Int. J. Med. Mushrooms 2021, 23, 91–106. [Google Scholar] [CrossRef]
  91. Wang, M.; Zhang, Y.; Xiao, X.; Xu, D.; Gao, Y.; Gao, Q. A polysaccharide isolated from mycelia of the lion’s mane medicinal mushroom Hericium erinaceus (Agaricomycetes) induced apoptosis in precancerous human gastric cells. Int. J. Med. Mushrooms 2017, 19, 1053–1060. [Google Scholar] [CrossRef] [PubMed]
  92. Zan, X.; Cui, F.; Li, Y.; Yang, Y.; Wu, D.; Sun, W.; Ping, L. Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis. Int. J. Biol. Macromol. 2015, 76, 242–253. [Google Scholar] [CrossRef] [PubMed]
  93. Chang, H.C.; Yang, H.L.; Pan, J.H.; Korivi, M.; Pan, J.Y.; Hsieh, M.C.; Chao, P.M.; Huang, P.J.; Tsai, C.T.; Hseu, Y.C. Hericium erinaceus inhibits TNF-α-induced angiogenesis and ROS generation through suppression of MMP-9/NF-κB signaling and activation of Nrf2-mediated antioxidant genes in human EA. hy926 endothelial cells. Oxidative Med. Cell. Longevit 2016, 2016, 8257238. [Google Scholar] [CrossRef] [PubMed]
  94. Kim, S.P.; Kang, M.Y.; Choi, Y.H.; Kim, J.H.; Nam, S.H.; Friedman, M. Mechanism of Hericium erinaceus (Yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells. Food Funct. 2011, 2, 348–356. [Google Scholar] [CrossRef] [PubMed]
  95. Zhang, Z.; Liu, R.N.; Tang, Q.J.; Zhang, J.S.; Yang, Y.; Shang, X.D. A new diterpene from the fungal mycelia of Hericium erinaceus. Phytochem. Lett. 2015, 11, 151–156. [Google Scholar] [CrossRef]
  96. Zhang, F.; Lv, H.; Zhang, X. Erinacerins, Novel Glioma Inhibitors from Hericium erinaceus, Induce Apoptosis of U87 Cells through Bax/Capase-2 Pathway. Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem.-Anti-Cancer Agents) 2020, 20, 2082–2088. [Google Scholar] [CrossRef] [PubMed]
  97. Ashour, A.; Amen, Y.; Allam, A.E.; Kudo, T.; Nagata, M.; Ohnuki, K.; Shimizu, K. New isoindolinones from the fruiting bodies of the fungus Hericium erinaceus. Phytochem. Lett. 2019, 32, 10–14. [Google Scholar] [CrossRef]
  98. Youn, M.J.; Kim, J.K.; Park, S.Y.; Kim, Y.; Park, C.; Kim, E.S.; Park, K.I.; So, H.S.; Park, R. Potential anticancer properties of the water extract of Inontus obliquus by induction of apoptosis in melanoma B16-F10 cells. J. Ethnopharmacol. 2009, 121, 221–228. [Google Scholar] [CrossRef]
  99. Arata, S.; Watanabe, J.; Maeda, M.; Yamamoto, M.; Matsuhashi, H.; Mochizuki, M.; Kagami, N.; Honda, K.; Inagaki, M. Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice. Heliyon 2016, 2, E00111. [Google Scholar] [CrossRef]
  100. Lee, S.H.; Hwang, H.S.; Yun, J.W. Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother. Res. 2009, 23, 1784–1789. [Google Scholar] [CrossRef]
  101. Baek, J.; Roh, H.S.; Baek, K.H.; Lee, S.; Lee, S.; Song, S.S.; Kim, K.H. Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells. J. Ethnopharmacol. 2018, 224, 63–75. [Google Scholar] [CrossRef] [PubMed]
  102. Ma, L.; Chen, H.; Dong, P.; Lu, X. Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus. Food Chem. 2013, 139, 503–508. [Google Scholar] [CrossRef] [PubMed]
  103. Sim, Y.C.; Lee, J.S.; Lee, S.; Son, Y.K.; Park, J.E.; Song, J.E.; Ha, S.J.; Hong, E.K. Effects of polysaccharides isolated from Inonotus obliquus against hydrogen peroxide-induced oxidative damage in RINm5F pancreatic β-cells. Mol. Med. Rep. 2016, 14, 4263–4270. [Google Scholar] [CrossRef] [PubMed]
  104. Xue, J.; Tong, S.; Wang, Z.; Liu, P. Chemical characterization and hypoglycaemic activities in vitro of two polysaccharides from Inonotus obliquus by submerged culture. Molecules 2018, 23, 3261. [Google Scholar] [CrossRef] [PubMed]
  105. Song, Y.; Hui, J.; Kou, W.; Xin, R.; Jia, F.; Wang, N.; Hu, F.; Zhang, H.; Liu, H. Identification of Inonotus obliquus and analysis of antioxidation and antitumor activities of polysaccharides. Curr. Microbiol. 2008, 57, 454–462. [Google Scholar] [CrossRef] [PubMed]
  106. Chen, Y.; Huang, Y.; Cui, Z.; Liu, J. Purification, characterization and biological activity of a novel polysaccharide from Inonotus obliquus. Int. J. Biol. Macromol. 2015, 79, 587–594. [Google Scholar] [CrossRef] [PubMed]
  107. Lo, H.C.; Hsu, T.H.; Lee, C.H. Extracellular polysaccharopeptides from fermented Turkey Tail medicinal mushroom, Trametes versicolor (Agaricomycetes), mitigate oxidative stress, hyperglycemia, and hyperlipidemia in rats with type 2 diabetes mellitus. Int. J. Med. Mushrooms 2020, 22, 417–429. [Google Scholar] [CrossRef] [PubMed]
  108. Yap, H.Y.; Kong, B.H.; Yap, C.S.; Ong, K.C.; Zain, R.B.; Tan, S.H.; Zaini, Z.M.; Ng, S.T.; Tan, C.S.; Fung, S.Y. Immunomodulatory Effect and an Intervention of TNF Signalling Leading to Apoptotic and Cell Cycle Arrest on ORL-204 Oral Cancer Cells by Tiger Milk Mushroom, Lignosus rhinocerus. Food Technol. Biotechnol. 2022, 60, 80–88. [Google Scholar] [CrossRef]
  109. Lee, M.L.; Tan, N.H.; Fung, S.Y.; Tan, C.S.; Ng, S.T. The antiproliferative activity of sclerotia of Lignosus rhinocerus (Tiger Milk Mushroom). Evid.-Based Complement. Altern. Med. 2012, 2012. [Google Scholar] [CrossRef]
  110. Yap, H.Y.; Tan, N.H.; Ng, S.T.; Tan, C.S.; Fung, S.Y. Molecular attributes and apoptosis-inducing activities of a putative serine protease isolated from Tiger Milk mushroom (Lignosus rhinocerus) sclerotium against breast cancer cells in vitro. PeerJ 2018, 6, e4940. [Google Scholar] [CrossRef]
  111. Xiong, C.; Zhu, Y.; Luo, Q.; Phan, C.W.; Huo, Y.; Li, P.; Li, Q.; Jin, X.; Huang, W. Neuroprotective effects of a novel peptide from Lignosus rhinocerotis against 6-hydroxydopamine-induced apoptosis in PC12 cells by inhibiting NF-κB activation. Food Sci. Nutr. 2023, 11, 2152–2165. [Google Scholar] [CrossRef] [PubMed]
  112. Tan, Y.H.; Lim, C.S.; Wong, K.H.; Sabaratnam, V. Cytoprotective Effects of the Tiger’s Milk Mushroom Lignosus rhinocerotis (Agaricomycetes) Sclerotia against Oxidative Stress in PC12 Cells. Int. J. Med. Mushrooms 2022, 24, 1–17. [Google Scholar] [CrossRef] [PubMed]
  113. Seow, S.L.; Eik, L.F.; Naidu, M.; David, P.; Wong, K.H.; Sabaratnam, V. Lignosus rhinocerotis (Cooke) Ryvarden mimics the neuritogenic activity of nerve growth factor via MEK/ERK1/2 signaling pathway in PC-12 cells. Sci. Rep. 2015, 5, 16349. [Google Scholar] [CrossRef] [PubMed]
  114. Kittimongkolsuk, P.; Roxo, M.; Li, H.; Chuchawankul, S.; Wink, M.; Tencomnao, T. Extracts of the Tiger Milk Mushroom (Lignosus rhinocerus) Enhance Stress Resistance and Extend Lifespan in Caenorhabditis elegans via the DAF-16/FoxO Signaling Pathway. Pharmaceuticals 2021, 14, 93. [Google Scholar] [CrossRef] [PubMed]
  115. Yeo, Y.; Tan, J.B.L.; Lim, L.W.; Tan, K.O.; Heng, B.C.; Lim, W.L. Human embryonic stem cell-derived neural lineages as in vitro models for screening the neuroprotective properties of Lignosus rhinocerus (Cooke) Ryvarden. BioMed Res. Int. 2019, 2019, 1–19. [Google Scholar] [CrossRef] [PubMed]
  116. Phan, C.W.; David, P.; Naidu, M.; Wong, K.H.; Sabaratnam, V. Neurite outgrowth stimulatory effects of culinary-medicinal mushrooms and their toxicity assessment using differentiating Neuro-2a and embryonic fibroblast BALB/3T3. BMC Complement. Altern. Med. 2013, 13, 261. [Google Scholar] [CrossRef] [PubMed]
  117. Eik, L.F.; Naidu, M.; David, P.; Wong, K.H.; Tan, Y.S.; Sabaratnam, V. Lignosus rhinocerus (Cooke) Ryvarden: A medicinal mushroom that stimulates neurite outgrowth in PC-12 cells. Evid.-Based Complement. Altern. Med. 2012, 2012, 320308. [Google Scholar] [CrossRef] [PubMed]
  118. Faris Taufeq, F.Y.; Habideen, N.H.; Rao, L.N.; Podder, P.K.; Katas, H. Potential Hemostatic and Wound Healing Effects of Thermoresponsive Wound Dressing Gel Loaded with Lignosus rhinocerotis and Punica granatum Extracts. Gels 2023, 9, 48. [Google Scholar] [CrossRef] [PubMed]
  119. Yamashita, S.; Seino, T.; Inobe, M.; Jutanom, M.; Matsumoto, S.; Kinoshita, M. Polar lipid fraction from golden oyster mushrooms (Pleurotus citrinopileatus) suppresses colon injuries from inflammatory stresses in vivo and in vitro. J. Oleo Sci. 2020, 69, 751–757. [Google Scholar] [CrossRef]
  120. Younis, A.M.; Abdel-Aziz, M.M.; Yosri, M. Evaluation of some biological applications of Pleurotus citrinopileatus and Boletus edulis fruiting bodies. Curr. Pharm. Biotechnol. 2019, 20, 1309–1320. [Google Scholar] [CrossRef]
  121. Huang, Y.; Gao, Y.; Pi, X.; Zhao, S.; Liu, W. In vitro hepatoprotective and human gut microbiota modulation of polysaccharide-peptides in Pleurotus citrinopileatus. Front. Cell. Infect. Microbiol. 2022, 553. [Google Scholar] [CrossRef] [PubMed]
  122. Chen, J.N.; Ma, C.Y.; Tsai, P.F.; Wang, Y.T.; Wu, J.S. In vitro antitumor and immunomodulatory effects of the protein PCP-3A from mushroom Pleurotus citrinopileatus. J. Agric. Food Chem. 2010, 58, 12117–12122. [Google Scholar] [CrossRef] [PubMed]
  123. Tao, Q.Q.; Ma, K.; Bao, L.; Wang, K.; Han, J.J.; Wang, W.Z.; Zhang, J.X.; Huang, C.Y.; Liu, H.W. Sesquiterpenoids with PTP1B inhibitory activity and cytotoxicity from the edible mushroom Pleurotus citrinopileatus. Planta Medica 2016, 82, 639–644. [Google Scholar] [CrossRef] [PubMed]
  124. Sun, Y.; Li, W. Activity-guided isolation and structural identification of immunomodulating substances from Pleurotus eryngii byproducts. Int. Immunopharmacol. 2017, 51, 82–90. [Google Scholar] [CrossRef] [PubMed]
  125. Bae, J.S.; Park, J.W.; Park, S.H.; Park, J.B.; Rho, Y.H.; Ryu, Y.B.; Lee, K.S.; Park, K.H.; Bae, Y.S. Apoptotic cell death of human leukaemia U937 cells by ubiquinone-9 purified from Pleurotus eryngii. Nat. Prod. Res. 2009, 23, 1112–1119. [Google Scholar] [CrossRef] [PubMed]
  126. Kang, M.J.; Kim, K.K.; Son, B.Y.; Nam, S.W.; Shin, P.G.; Kim, G.D. The Anti-Adipogenic Activity of a New Cultivar, Pleurotus eryngii var. ferulae’Beesan No. 2’, through Down-Regulation of PPAR γ and C/EBP α in 3T3-L1 Cells. J. Microbiol. Biotechnol. 2016, 26, 1836–1844. [Google Scholar] [CrossRef] [PubMed]
  127. Han, E.H.; Hwang, Y.P.; Kim, H.G.; Choi, J.H.; Im, J.H.; Yang, J.H.; Lee, H.U.; Chun, S.S.; Chung, Y.C.; Jeong, H.G. Inhibitory effect of Pleurotus eryngii extracts on the activities of allergic mediators in antigen-stimulated mast cells. Food Chem. Toxicol. 2011, 49, 1416–1425. [Google Scholar] [CrossRef] [PubMed]
  128. Vlassopoulou, M.; Paschalidis, N.; Savvides, A.L.; Saxami, G.; Mitsou, E.K.; Kerezoudi, E.N.; Koutrotsios, G.; Zervakis, G.I.; Georgiadis, P.; Kyriacou, A.; et al. Immunomodulating activity of Pleurotus eryngii mushrooms following their in vitro fermentation by human fecal microbiota. J. Fungi 2022, 8, 329. [Google Scholar] [CrossRef] [PubMed]
  129. Xu, D.; Wang, H.; Zheng, W.; Gao, Y.; Wang, M.; Zhang, Y.; Gao, Q. Charaterization and immunomodulatory activities of polysaccharide isolated from Pleurotus eryngii. Int. J. Biol. Macromol. 2016, 92, 30–36. [Google Scholar] [CrossRef]
  130. Ma, G.; Yang, W.; Mariga, A.M.; Fang, Y.; Ma, N.; Pei, F.; Hu, Q. Purification, characterization and antitumor activity of polysaccharides from Pleurotus eryngii residue. Carbohydr. Polym. 2014, 114, 297–305. [Google Scholar] [CrossRef]
  131. Gong, P.; Long, H.; Guo, Y.; Wang, S.; Chen, F.; Chen, X. Isolation, Structural Characterization, and Hypoglycemic Activities In vitro of Polysaccharides from Pleurotus eryngii. Molecules 2022, 27, 7140. [Google Scholar] [CrossRef] [PubMed]
  132. Ellefsen, C.F.; Wold, C.W.; Wilkins, A.L.; Rise, F.; Samuelsen, A.B. Water-soluble polysaccharides from Pleurotus eryngii fruiting bodies, their activity and affinity for Toll-like receptor 2 and dectin-1. Carbohydr. Polym. 2021, 264, 117991. [Google Scholar] [CrossRef] [PubMed]
  133. Mariga, A.M.; Yang, W.J.; Mugambi, D.K.; Pei, F.; Zhao, L.Y.; Shao, Y.N.; Hu, Q. Antiproliferative and immunostimulatory activity of a protein from Pleurotus eryngii. J. Sci. Food Agric. 2014, 94, 3152–3162. [Google Scholar] [CrossRef] [PubMed]
  134. Yehia, R.S.; Al-Sheikh, H. Biosynthesis and characterization of silver nanoparticles produced by Pleurotus ostreatus and their anticandidal and anticancer activities. World J. Microbiol. Biotechnol. 2014, 30, 2797–2803. [Google Scholar] [CrossRef] [PubMed]
  135. Jedinak, A.; Sliva, D. Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. Int. J. Oncol. 2008, 33, 1307–1313. [Google Scholar] [PubMed]
  136. Wang, L.; Li, K.; Cui, Y.; Peng, H.; Hu, Y.; Zhu, Z. Preparation, structural characterization and neuroprotective effects to against H2O2-induced oxidative damage in PC12 cells of polysaccharides from Pleurotus ostreatus. Food Res. Int. 2023, 163, 112146. [Google Scholar] [CrossRef] [PubMed]
  137. Hamad, D.; El-Sayed, H.; Ahmed, W.; Sonbol, H.; Ramadan, M.A. GC-MS analysis of potentially volatile compounds of Pleurotus ostreatus polar extract: In vitro antimicrobial, cytotoxic, immunomodulatory, and antioxidant activities. Front. Microbiol. 2022, 13, 834525. [Google Scholar] [CrossRef] [PubMed]
  138. Gunawardena, D.; Bennett, L.; Shanmugam, K.; King, K.; Williams, R.; Zabaras, D.; Head, R.; Ooi, L.; Gyengesi, E.; Münch, G. Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages. Food Chem. 2014, 148, 92–96. [Google Scholar] [CrossRef] [PubMed]
  139. Jedinak, A.; Dudhgaonkar, S.; Wu, Q.L.; Simon, J.; Sliva, D. Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling. Nutr. J. 2011, 10, 52. [Google Scholar] [CrossRef]
  140. Wang, D.; Wang, J.; Liu, H.; Liu, M.; Yang, Y.; Zhong, S. The Main Structural Unit Elucidation and Immunomodulatory Activity In vitro of a Selenium-Enriched Polysaccharide Produced by Pleurotus ostreatus. Molecules 2022, 27, 2591. [Google Scholar] [CrossRef]
  141. Zhang, Y.; Zhang, Z.; Liu, H.; Wang, D.; Wang, J.; Liu, M.; Yang, Y.; Zhong, S. A natural selenium polysaccharide from Pleurotus ostreatus: Structural elucidation, anti-gastric cancer and anti-colon cancer activity in vitro. Int. J. Biol. Macromol. 2022, 201, 630–640. [Google Scholar] [CrossRef] [PubMed]
  142. Wu, J.Y.; Chen, C.H.; Chang, W.H.; Chung, K.T.; Liu, Y.W.; Lu, F.J.; Chen, C.H. Anti-cancer effects of protein extracts from Calvatia lilacina, Pleurotus ostreatus and Volvariella volvacea. Evid.-Based Complement. Altern. Med. 2011, 2011, 982368. [Google Scholar] [CrossRef] [PubMed]
  143. Xu, W.; Huang, J.J.; Cheung, P.C. Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway. PLoS ONE 2012, 7, e34406. [Google Scholar] [CrossRef] [PubMed]
  144. Jiménez-Medina, E.; Berruguilla, E.; Romero, I.; Algarra, I.; Collado, A.; Garrido, F.; Garcia-Lora, A. The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer 2008, 8, 78. [Google Scholar] [CrossRef] [PubMed]
  145. Ünyayar, A.; Demirbilek, M.; Turkoglu, M.; Celik, A.; Mazmanci, M.A.; Erkurt, E.A.; Ünyayar, S.; Cekic, Ö.; Atacag, H. Evaluation of cytotoxic and mutagenic effects of Coriolus versicolor and Funalia trogii extracts on mammalian cells. Drug Chem. Toxicol. 2006, 29, 69–83. [Google Scholar] [CrossRef] [PubMed]
  146. Luo, K.W.; Yue, G.G.; Ko, C.H.; Lee, J.K.; Gao, S.; Li, L.F.; Li, G.; Fung, K.P.; Leung, P.C.; Bik-San Lau, C. In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine 2014, 21, 1078–1087. [Google Scholar] [CrossRef] [PubMed]
  147. Lee, C.L.; Yang, X.; Wan, J.M. The culture duration affects the immunomodulatory and anticancer effect of polysaccharopeptide derived from Coriolus versicolor. Enzym. Microb. Technol. 2006, 38, 14–21. [Google Scholar] [CrossRef]
  148. Sekhon, B.K.; Sze, D.M.; Chan, W.K.; Fan, K.; Li, G.Q.; Moore, D.E.; Roubin, R.H. PSP activates monocytes in resting human peripheral blood mononuclear cells: Immunomodulatory implications for cancer treatment. Food Chem. 2013, 138, 2201–2209. [Google Scholar] [CrossRef] [PubMed]
  149. Hsieh, T.C.; Wu, J.M. Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells. Int. J. Oncol. 2001, 18, 81–89. [Google Scholar] [CrossRef]
  150. Hickman, D.L.; Johnson, J.; Vemulapalli, T.H.; Crisler, J.R.; Shepherd, R. Commonly used animal models. Princ. Anim. Res. Grad. Undergrad. Stud. 2017, 117–175. [Google Scholar] [CrossRef]
  151. Ohno, N.; Furukawa, M.; Miura, N.N.; Adachi, Y.; Motoi, M.; Yadomae, T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol. Pharm. Bull. 2001, 24, 820–828. [Google Scholar] [CrossRef] [PubMed]
  152. Kimura, Y.; Kido, T.; Takaku, T.; Sumiyoshi, M.; Baba, K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: Its antitumor and antimetastatic actions. Cancer Sci. 2004, 95, 758–764. [Google Scholar] [CrossRef] [PubMed]
  153. da Silva Pinto, A.V.; Martins, P.R.; Romagnoli, G.G.; Campanelli, A.P.; Terezan, A.P.; Rodrigues Filho, E.; da Eira, A.F.; Kaneno, R. Polysaccharide fraction of Agaricus brasiliensis avoids tumor-induced IL-10 production and changes the microenvironment of subcutaneous Ehrlich adenocarcinoma. Cell. Immunol. 2009, 256, 27–38. [Google Scholar] [CrossRef] [PubMed]
  154. Liu, Y.; Fukuwatari, Y.; Okumura, K.; Takeda, K.; Ishibashi, K.I.; Furukawa, M.; Ohno, N.; Mori, K.; Gao, M.; Motoi, M. Immunomodulating activity of Agaricus brasiliensis KA21 in mice and in human volunteers. Evid.-Based Complement. Altern. Med. 2008, 5, 205–219. [Google Scholar] [CrossRef] [PubMed]
  155. Ellertsen, L.K.; Hetland, G. An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy. Clin. Mol. Allergy 2009, 7, 6. [Google Scholar] [CrossRef] [PubMed]
  156. Komura, D.L.; Carbonero, E.R.; Gracher, A.H.; Baggio, C.H.; Freitas, C.S.; Marcon, R.; Santos, A.R.; Gorin, P.A.; Iacomini, M. Structure of Agaricus spp. fucogalactans and their anti-inflammatory and antinociceptive properties. Bioresour. Technol. 2010, 101, 6192–6199. [Google Scholar] [CrossRef] [PubMed]
  157. Shimizu, T.; Kawai, J.; Ouchi, K.; Kikuchi, H.; Osima, Y.; Hidemi, R. Agarol, an ergosterol derivative from Agaricus blazei, induces caspase-independent apoptosis in human cancer cells. Int. J. Oncol. 2016, 48, 1670–1678. [Google Scholar] [CrossRef] [PubMed]
  158. Wang, X.; Ha, D.; Mori, H.; Chen, S. White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft. J. Nutr. Biochem. 2021, 89, 108580. [Google Scholar] [CrossRef] [PubMed]
  159. Qiu, J.; Zhang, H.; Wang, Z. Auricularia auriculajudae polysaccharide-cisplatin complexes conjugated with folic acid as new tumor targeting agents. Int. J. Biol. Macromol. 2018, 120, 966–974. [Google Scholar] [CrossRef]
  160. Ma, Z.; Wang, J.; Zhang, L.; Zhang, Y.; Ding, K. Evaluation of water soluble β-D-glucan from Auricularia auricular-judae as potential anti-tumor agent. Carbohydr. Polym. 2010, 80, 977–983. [Google Scholar] [CrossRef]
  161. Liu, Q.; An, X.; Chen, Y.; Deng, Y.; Niu, H.; Ma, R.; Zhao, H.; Cao, W.; Wang, X.; Wang, M. Effects of Auricularia auricula polysaccharides on gut microbiota and metabolic phenotype in mice. Foods 2022, 11, 2700. [Google Scholar] [CrossRef] [PubMed]
  162. Hou, R.; Liu, X.; Wu, X.; Zheng, M.; Fu, J. Therapeutic effect of natural melanin from edible fungus Auricularia auricula on alcohol-induced liver damage in vitro and in vivo. Food Sci. Hum. Wellness 2021, 10, 514–522. [Google Scholar] [CrossRef]
  163. Chen, G.; Luo, Y.C.; Ji, B.P.; Li, B.; Guo, Y.; Li, Y.; Su, W.; Xiao, Z.L. Effect of polysaccharide from Auricularia auricula on blood lipid metabolism and lipoprotein lipase activity of ICR mice fed a cholesterol-enriched diet. J. Food Sci. 2008, 73, H103–H108. [Google Scholar] [CrossRef] [PubMed]
  164. Mapoung, S.; Umsumarng, S.; Semmarath, W.; Arjsri, P.; Thippraphan, P.; Yodkeeree, S.; Limtrakul, P. Skin wound-healing potential of polysaccharides from medicinal mushroom Auricularia auricula-judae (Bull.). J. Fungi 2021, 7, 247. [Google Scholar] [CrossRef] [PubMed]
  165. Wang, X.; Lan, Y.; Zhu, Y.; Li, S.; Liu, M.; Song, X.; Zhao, H.; Liu, W.; Zhang, J.; Wang, S.; et al. Hepatoprotective effects of Auricularia cornea var. Li. polysaccharides against the alcoholic liver diseases through different metabolic pathways. Sci. Rep. 2018, 8, 7574. [Google Scholar] [CrossRef] [PubMed]
  166. Yu, M.; Xu, X.; Qing, Y.; Luo, X.; Yang, Z.; Zheng, L. Isolation of an anti-tumor polysaccharide from Auricularia polytricha (jew’s ear) and its effects on macrophage activation. Eur. Food Res. Technol. 2009, 228, 477–485. [Google Scholar] [CrossRef]
  167. Song, X.; Pang, H.; Cui, W.; Zhang, J.; Li, J.; Jia, L. Renoprotective effects of enzyme-hydrolyzed polysaccharides from Auricularia polytricha on adenine-induced chronic kidney diseases in mice. Biomed. Pharmacother. 2021, 135, 111004. [Google Scholar] [CrossRef] [PubMed]
  168. Tsopmejio, I.S.; Yuan, J.; Diao, Z.; Fan, W.; Wei, J.; Zhao, C.; Li, Y.; Song, H. Auricularia polytricha and Flammulina velutipes reduce liver injury in DSS-induced Inflammatory Bowel Disease by improving inflammation, oxidative stress, and apoptosis through the regulation of TLR4/NF-κB signaling pathways. J. Nutr. Biochem. 2023, 111, 109190. [Google Scholar] [CrossRef] [PubMed]
  169. Hseu, Y.C.; Chen, S.C.; Chen, H.C.; Liao, J.W.; Yang, H.L. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo. Food Chem. Toxicol. 2008, 46, 2680–2688. [Google Scholar] [CrossRef]
  170. Hsiao, G.; Shen, M.Y.; Lin, K.H.; Lan, M.H.; Wu, L.Y.; Chou, D.S.; Lin, C.H.; Su, C.H.; Sheu, J.R. Antioxidative and hepatoprotective effects of Antrodia camphorata extract. J. Agric. Food Chem. 2003, 51, 3302–3308. [Google Scholar] [CrossRef]
  171. Tu, S.H.; Wu, C.H.; Chen, L.C.; Huang, C.S.; Chang, H.W.; Chang, C.H.; Lien, H.M.; Ho, Y.S. In vivo antitumor effects of 4, 7-dimethoxy-5-methyl-1, 3-benzodioxole isolated from the fruiting body of Antrodia camphorata through activation of the p53-mediated p27/Kip1 signaling pathway. J. Agric. Food Chem. 2012, 60, 3612–3618. [Google Scholar] [CrossRef] [PubMed]
  172. Wang, Y.H.; Chern, C.M.; Liou, K.T.; Kuo, Y.H.; Shen, Y.C. Ergostatrien-7, 9 (11), 22-trien-3β-ol from Antrodia camphorata ameliorates ischemic stroke brain injury via downregulation of p65NF-κ-B and caspase 3, and activation of Akt/GSK3/catenin-associated neurogenesis. Food Funct. 2019, 10, 4725–4738. [Google Scholar] [CrossRef] [PubMed]
  173. Wang, D.; Sun, S.Q.; Wu, W.Z.; Yang, S.L.; Tan, J.M. Characterization of a water-soluble polysaccharide from Boletus edulis and its antitumor and immunomodulatory activities on renal cancer in mice. Carbohydr. Polym. 2014, 105, 127–134. [Google Scholar] [CrossRef] [PubMed]
  174. Wu, S.; Wang, G.; Yang, R.; Cui, Y. Anti-inflammatory effects of Boletus edulis polysaccharide on asthma pathology. Am. J. Transl. Res. 2016, 8, 4478. [Google Scholar] [PubMed]
  175. Zhang, Y.; Zhou, R.; Liu, F.; Ng, T.B. Purification and characterization of a novel protein with activity against non-small-cell lung cancer in vitro and in vivo from the edible mushroom Boletus edulis. Int. J. Biol. Macromol. 2021, 174, 77–88. [Google Scholar] [CrossRef] [PubMed]
  176. Zhang, W.; Tian, G.; Feng, S.; Wong, J.H.; Zhao, Y.; Chen, X.; Wang, H.; Ng, T.B. Boletus edulis nitrite reductase reduces nitrite content of pickles and mitigates intoxication in nitrite-intoxicated mice. Sci. Rep. 2015, 5, 14907. [Google Scholar] [CrossRef] [PubMed]
  177. Luo, A.; Luo, A.; Huang, J.; Fan, Y. Purification, characterization and antioxidant activities in vitro and in vivo of the polysaccharides from Boletus edulis bull. Molecules 2012, 17, 8079–8090. [Google Scholar] [CrossRef] [PubMed]
  178. Zhao, R.; Ji, Y.; Chen, X.; Hu, Q.; Zhao, L. Polysaccharide from Flammulina velutipes attenuates markers of metabolic syndrome by modulating the gut microbiota and lipid metabolism in high fat diet-fed mice. Food Funct. 2021, 12, 6964–6980. [Google Scholar] [CrossRef] [PubMed]
  179. Zhao, R.; Hu, Q.; Ma, G.; Su, A.; Xie, M.; Li, X.; Chen, G.; Zhao, L. Effects of Flammulina velutipes polysaccharide on immune response and intestinal microbiota in mice. J. Funct. Foods 2019, 56, 255–264. [Google Scholar] [CrossRef]
  180. Liang, Q.; Zhao, Q.; Hao, X.; Wang, J.; Ma, C.; Xi, X.; Kang, W. The effect of Flammulina velutipes polysaccharide on immunization analyzed by intestinal flora and proteomics. Front. Nutr. 2022, 9, 35. [Google Scholar] [CrossRef]
  181. Yuan, F.; Gao, Z.; Liu, W.; Li, H.; Zhang, Y.; Feng, Y.; Song, X.; Wang, W.; Zhang, J.; Huang, C.; et al. Characterization, antioxidant, anti-aging and organ protective effects of sulfated polysaccharides from Flammulina velutipes. Molecules 2019, 24, 3517. [Google Scholar] [CrossRef] [PubMed]
  182. Liu, Y.; Li, H.; Ren, P.; Che, Y.; Zhou, J.; Wang, W.; Yang, Y.; Guan, L. Polysaccharide from Flammulina velutipes residues protects mice from Pb poisoning by activating Akt/GSK3β/Nrf-2/HO-1 signaling pathway and modulating gut microbiota. Int. J. Biol. Macromol. 2023, 230, 123154. [Google Scholar] [CrossRef] [PubMed]
  183. Song, X.; Fu, H.; Chen, W. Effects of Flammulina velutipes polysaccharides on quality improvement of fermented milk and antihyperlipidemic on streptozotocin-induced mice. J. Funct. Foods 2021, 87, 104834. [Google Scholar] [CrossRef]
  184. Xu, Y.; Zhang, Z.; Wang, B.; He, X.; Tang, J.; Peng, W.; Zhou, J.; Wang, Y. Flammulina velutipes Polysaccharides Modulate Gut Microbiota and Alleviate Carbon Tetrachloride-Induced Hepatic Oxidative Injury in Mice. Front. Microbiol. 2022, 13, 941. [Google Scholar]
  185. Chang, H.H.; Hsieh, K.Y.; Yeh, C.H.; Tu, Y.P.; Sheu, F. Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma. Int. Immunopharmacol. 2010, 10, 239–246. [Google Scholar] [CrossRef] [PubMed]
  186. Ma, J.Q.; Liu, C.M.; Qin, Z.H.; Jiang, J.H.; Sun, Y.Z. Ganoderma applanatum terpenes protect mouse liver against benzo (α) pyren-induced oxidative stress and inflammation. Environ. Toxicol. Pharmacol. 2011, 31, 460–468. [Google Scholar] [CrossRef] [PubMed]
  187. Qin, F.Y.; Zhang, H.X.; Di, Q.Q.; Wang, Y.; Yan, Y.M.; Chen, W.L.; Cheng, Y.X. Ganoderma cochlear metabolites as probes to identify a COX-2 active site and as in vitro and in vivo anti-inflammatory agents. Org. Lett. 2020, 22, 2574–2578. [Google Scholar] [CrossRef] [PubMed]
  188. Lin, J.Y.; Chen, M.L.; Chiang, B.L.; Lin, B.F. Ganoderma tsugae supplementation alleviates bronchoalveolar inflammation in an airway sensitization and challenge mouse model. Int. Immunopharmacol. 2006, 6, 241–251. [Google Scholar] [CrossRef]
  189. Suarez-Arroyo, I.J.; Rosario-Acevedo, R.; Aguilar-Perez, A.; Clemente, P.L.; Cubano, L.A.; Serrano, J.; Schneider, R.J.; Martínez-Montemayor, M.M. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PLoS ONE 2013, 8, e57431. [Google Scholar] [CrossRef]
  190. Na, K.; Li, K.; Sang, T.; Wu, K.; Wang, Y.; Wang, X. Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo. Int. J. Oncol. 2017, 50, 1541–1554. [Google Scholar] [CrossRef]
  191. Jedinak, A.; Thyagarajan-Sahu, A.; Jiang, J.; Sliva, D. Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ss-catenin signaling. Int. J. Oncol. 2011, 38, 761–767. [Google Scholar] [PubMed]
  192. Akihisa, T.; Nakamura, Y.; Tagata, M.; Tokuda, H.; Yasukawa, K.; Uchiyama, E.; Suzuki, T.; Kimura, Y. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem. Biodivers. 2007, 4, 224–231. [Google Scholar] [CrossRef] [PubMed]
  193. Wu, Y.S.; Ho, S.Y.; Nan, F.H.; Chen, S.N. Ganoderma lucidum beta 1, 3/1, 6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet. BMC Complement. Altern. Med. 2016, 16, 500. [Google Scholar] [CrossRef] [PubMed]
  194. Lakshmi, B.; Ajith, T.A.; Sheena, N.; Gunapalan, N.; Janardhanan, K.K. Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India. Teratog. Carcinog. Mutagen. 2003, 23 (Suppl. S1), 85–97. [Google Scholar] [CrossRef] [PubMed]
  195. Ren, Z.L.; Wang, C.D.; Wang, T.; Ding, H.; Zhou, M.; Yang, N.; Liu, Y.Y.; Chan, P. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacol. Sin. 2019, 40, 441–450. [Google Scholar] [CrossRef] [PubMed]
  196. Li, G.; Yu, K.; Li, F.; Xu, K.; Li, J.; He, S.; Cao, S.; Tan, G. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers. J. Ethnopharmacol. 2014, 153, 521–530. [Google Scholar] [CrossRef]
  197. Kim, S.P.; Nam, S.H.; Friedman, M. Hericium erinaceus (Lion’s Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-tansplanted mice. J. Agric. Food Chem. 2013, 61, 4898–4904. [Google Scholar] [CrossRef] [PubMed]
  198. Ren, Y.; Geng, Y.; Du, Y.; Li, W.; Lu, Z.M.; Xu, H.Y.; Xu, G.H.; Shi, J.S.; Xu, Z.H. Polysaccharide of Hericium erinaceus attenuates colitis in C57BL/6 mice via regulation of oxidative stress, inflammation-related signaling pathways and modulating the composition of the gut microbiota. J. Nutr. Biochem. 2018, 57, 67–76. [Google Scholar] [CrossRef] [PubMed]
  199. Lu, C.C.; Huang, W.S.; Lee, K.F.; Lee, K.C.; Hsieh, M.C.; Huang, C.Y.; Lee, L.Y.; Lee, B.O.; Teng, C.C.; Shen, C.H.; et al. Inhibitory effect of Erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21. J. Funct. Foods 2016, 21, 474–484. [Google Scholar] [CrossRef]
  200. Qin, T.; Ren, Z.; Huang, Y.; Song, Y.; Lin, D.; Li, J.; Ma, Y.; Wu, X.; Qiu, F.; Xiao, Q. Selenizing Hericium erinaceus polysaccharides induces dendritic cells maturation through MAPK and NF-κB signaling pathways. Int. J. Biol. Macromol. 2017, 97, 287–298. [Google Scholar] [CrossRef]
  201. Jang, H.J.; Kim, J.E.; Jeong, K.H.; Lim, S.C.; Kim, S.Y.; Cho, K.O. The neuroprotective effect of Hericium erinaceus extracts in mouse hippocampus after pilocarpine-induced status epilepticus. Int. J. Mol. Sci. 2019, 20, 859. [Google Scholar] [CrossRef] [PubMed]
  202. Chou, Y.J.; Kan, W.C.; Chang, C.M.; Peng, Y.J.; Wang, H.Y.; Yu, W.C.; Cheng, Y.H.; Jhang, Y.R.; Liu, H.W.; Chuu, J.J. Renal protective effects of low molecular weight of Inonotus obliquus polysaccharide (LIOP) on HFD/STZ-induced nephropathy in mice. Int. J. Mol. Sci. 2016, 17, 1535. [Google Scholar] [CrossRef] [PubMed]
  203. Su, L.; Xin, C.; Yang, J.; Dong, L.; Mei, H.; Dai, X.; Wang, Q. A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus. Int. J. Biol. Macromol. 2022, 214, 312–323. [Google Scholar] [CrossRef] [PubMed]
  204. Xu, L.; Sang, R.; Yu, Y.; Li, J.; Ge, B.; Zhang, X. The polysaccharide from Inonotus obliquus protects mice from Toxoplasma gondii-induced liver injury. Int. J. Biol. Macromol. 2019, 125, 1–8. [Google Scholar] [CrossRef] [PubMed]
  205. Xu, T.; Li, G.; Wang, X.; Lv, C.; Tian, Y. Inonotus obliquus polysaccharide ameliorates serum profiling in STZ-induced diabetic mice model. BMC Chem. 2021, 15, 64. [Google Scholar] [CrossRef] [PubMed]
  206. Wang, Y.; Ouyang, F.; Teng, C.; Qu, J. Optimization for the extraction of polyphenols from Inonotus obliquus and its antioxidation activity. Prep. Biochem. Biotechnol. 2021, 51, 852–859. [Google Scholar] [CrossRef]
  207. Chen, Y.F.; Zheng, J.J.; Qu, C.; Xiao, Y.; Li, F.F.; Jin, Q.X.; Li, H.H.; Meng, F.P.; Jin, G.H.; Jin, D. Inonotus obliquus polysaccharide ameliorates dextran sulphate sodium induced colitis involving modulation of Th1/Th2 and Th17/Treg balance. Artif. Cells Nanomed. Biotechnol. 2019, 47, 757–766. [Google Scholar] [CrossRef] [PubMed]
  208. Hyun, K.W.; Jeong, S.C.; Lee, D.H.; Park, J.S.; Lee, J.S. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides 2006, 27, 1173–1178. [Google Scholar] [CrossRef] [PubMed]
  209. Lee, S.; Cho, H. Anti-tumor effect of Inonotus obliquus in xenograft animals with EBV+ human gastric carcinoma. Korean J. Microbiol. 2016, 52, 482–486. [Google Scholar] [CrossRef]
  210. Tanaka, K.; Matsui, Y.; Ishikawa, S.; Kawanishi, T.; Harada, M. Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum. Oncol. Rep. 2012, 27, 325–332. [Google Scholar]
  211. Tanaka, K.; Ishikawa, S.; Matsui, Y.; Tamesada, M.; Harashima, N.; Harada, M. Oral ingestion of Lentinula edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell-mediated immunosuppression. Cancer Sci. 2011, 102, 516–521. [Google Scholar] [CrossRef] [PubMed]
  212. Johnathan, M.; Muhamad, S.A.; Gan, S.H.; Stanslas, J.; Mohd Fuad, W.E.; Hussain, F.A.; Wan Ahmad, W.A.; Nurul, A.A. Lignosus rhinocerotis Cooke Ryvarden ameliorates airway inflammation, mucus hypersecretion and airway hyperresponsiveness in a murine model of asthma. PLoS ONE 2021, 16, e0249091. [Google Scholar] [CrossRef] [PubMed]
  213. Muhamad, S.A.; Muhammad, N.S.; Ismail, N.D.; Mohamud, R.; Safuan, S.; Nurul, A.A. Intranasal administration of Lignosus rhinocerotis (Cooke) Ryvarden (Tiger Milk mushroom) extract attenuates airway inflammation in murine model of allergic asthma. Exp. Ther. Med. 2019, 17, 3867–3876. [Google Scholar] [CrossRef] [PubMed]
  214. Ng, M.J.; Kong, B.H.; Teoh, K.H.; Yap, Y.H.; Ng, S.T.; Tan, C.S.; Razif, M.F.; Fung, S.Y. In vivo anti-tumor activity of Lignosus rhinocerus TM02® using a MCF7-xenograft NCr nude mice model. J. Ethnopharmacol. 2023, 304, 115957. [Google Scholar] [CrossRef]
  215. Hu, T.; Huang, Q.; Wong, K.; Yang, H. Structure, molecular conformation, and immunomodulatory activity of four polysaccharide fractions from Lignosus rhinocerotis sclerotia. Int. J. Biol. Macromol. 2017, 94, 423–430. [Google Scholar] [CrossRef] [PubMed]
  216. Zhang, J.; Wang, G.; Li, H.; Zhuang, C.; Mizuno, T.; Ito, H.; Suzuki, C.; Okamoto, H.; Li, J. Antitumor polysaccharides from a Chinese mushroom,“yuhuangmo” the fruiting body of Pleurotus citrinopileatus. Biosci. Biotechnol. Biochem. 1994, 58, 1195–1201. [Google Scholar] [CrossRef]
  217. Meng, M.; Sun, Y.; Bai, Y.; Xu, J.; Sun, J.; Han, L.; Sun, H.; Han, R. A polysaccharide from Pleurotus citrinopileatus mycelia enhances the immune response in cyclophosphamide-induced immunosuppressed mice via p62/Keap1/Nrf2 signal transduction pathway. Int. J. Biol. Macromol. 2023, 228, 165–177. [Google Scholar] [CrossRef] [PubMed]
  218. Wang, Q.; Niu, L.L.; Liu, H.P.; Wu, Y.R.; Li, M.Y.; Jia, Q. Structural characterization of a novel polysaccharide from Pleurotus citrinopileatus and its antitumor activity on H22 tumor-bearing mice. Int. J. Biol. Macromol. 2021, 168, 251–260. [Google Scholar] [CrossRef] [PubMed]
  219. Sheng, Y.; Zhao, C.; Zheng, S.; Mei, X.; Huang, K.; Wang, G.; He, X. Anti-obesity and hypolipidemic effect of water extract from Pleurotus citrinopileatus in C57BL/6J mice. Food Sci. Nutr. 2019, 7, 1295–1301. [Google Scholar] [CrossRef]
  220. Li, Y.R.; Liu, Q.H.; Wang, H.X.; Ng, T.B. A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus. Biochim. Et Biophys. Acta (BBA)-Gen. Subj. 2008, 1780, 51–57. [Google Scholar] [CrossRef]
  221. Li, X.; Jin, Q.; Zhang, Y.; Wu, Y.L.; Jin, C.M.; Cui, B.W.; Li, Y.; Jin, M.J.; Shang, Y.; Jiang, M.; et al. Inhibition of P2X7R–NLRP3 Inflammasome Activation by Pleurotus citrinopileatus: A Possible Protective Role in Alcoholic Hepatosteatosis. J. Agric. Food Chem. 2018, 66, 13183–13190. [Google Scholar] [CrossRef] [PubMed]
  222. Kim, D.H.; Park, Y.H.; Lee, J.S.; Jeong, H.I.; Lee, K.W.; Kang, T.H. Anti-obesity effect of DKB-117 through the inhibition of pancreatic lipase and α-amylase activity. Nutrients 2020, 12, 3053. [Google Scholar] [CrossRef] [PubMed]
  223. Song, X.; Xu, X.; Chen, W. Antioxidant and Immunostimulatory Activities of Fermented Sour Soybean Milk Added With Polypeptides From Pleurotus eryngii. Front. Microbiol. 2022, 13, 750039. [Google Scholar] [CrossRef] [PubMed]
  224. Yang, Z.; Xu, J.; Fu, Q.; Fu, X.; Shu, T.; Bi, Y.; Song, B. Antitumor activity of a polysaccharide from Pleurotus eryngii on mice bearing renal cancer. Carbohydr. Polym. 2013, 95, 615–620. [Google Scholar] [CrossRef] [PubMed]
  225. Ma, G.; Hu, Q.; Han, Y.; Du, H.; Yang, W.; Pan, C.; Cao, X.; Kimatu, B.M.; Pei, F.; Xiao, H. Inhibitory effects of β-type glycosidic polysaccharide from Pleurotus eryngii on dextran sodium sulfate-induced colitis in mice. Food Funct. 2021, 12, 3831–3841. [Google Scholar] [CrossRef]
  226. Boulaka, A.; Mantellou, P.; Stanc, G.-M.; Souka, E.; Valavanis, C.; Saxami, G.; Mitsou, E.; Koutrotsios, G.; Zervakis, G.I.; Kyriacou, A.; et al. Genoprotective activity of the Pleurotus eryngii mushrooms following their in vitro and in vivo fermentation by fecal microbiota. Front. Nutr. 2022, 9, 988517. [Google Scholar] [CrossRef] [PubMed]
  227. Jo, K.-J.; Ghim, J.; Kim, J.; Lee, H.; Lee, T.G.; Kim, J.-I.; Kim, Y.; Byun, J.W.; Min, B.S.; Son, J.S.; et al. Water extract of Pleurotus eryngii var. ferulae prevents high-fat diet-induced obesity by inhibiting pancreatic Lipase. J. Med. Food 2019, 22, 178–185. [Google Scholar] [CrossRef] [PubMed]
  228. Chen, L.; Ren, A.; Wang, Y.; Qu, Y.; Gong, H.; Mayo, K.H.; Zhou, Y.; Cheng, H. Heterogalactan WPEP-Nb from Pleurotus eryngii enhances immunity in immunocompromised mice. Int. J. Biol. Macromol. 2023, 225, 1010–1020. [Google Scholar] [CrossRef] [PubMed]
  229. Devi, K.S.P.; Roy, B.; Patra, P.; Sahoo, B.; Islam, S.S.; Maiti, T.K. Characterization and lectin microarray of an immunomodulatory heteroglucan from Pleurotus ostreatus mycelia. Carbohydr. Polym. 2013, 94, 857–865. [Google Scholar] [CrossRef] [PubMed]
  230. Kurashige, S.; Akuzawa, Y.; Endo, F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol. Immunotoxicol. 1997, 19, 175–183. [Google Scholar] [CrossRef]
  231. Hu, Y.; Xu, J.; Sheng, Y.; Liu, J.; Li, H.; Guo, M.; Xu, W.; Luo, Y.; Huang, K.; He, X. Pleurotus ostreatus Ameliorates Obesity by Modulating the Gut Microbiota in Obese Mice Induced by High-Fat Diet. Nutrients 2022, 14, 1868. [Google Scholar] [CrossRef]
  232. Ravi, B.; Renitta, R.E.; Prabha, M.L.; Issac, R.; Naidu, S. Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice. Immunopharmacol. Immunotoxicol. 2013, 35, 101–109. [Google Scholar] [CrossRef] [PubMed]
  233. Jedinak, A.; Dudhgaonkar, S.; Jiang, J.; Sandusky, G.; Sliva, D. Pleurotus ostreatus inhibits colitis-related colon carcinogenesis in mice. Int. J. Mol. Med. 2010, 26, 643–650. [Google Scholar] [PubMed]
  234. Sarangi, I.; Ghosh, D.; Bhutia, S.K.; Mallick, S.K.; Maiti, T.K. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int. Immunopharmacol. 2006, 6, 1287–1297. [Google Scholar] [CrossRef] [PubMed]
  235. Llauradó, G.; Morris, H.J.; Lebeque, Y.; Venet, G.; Fong, O.; Marcos, J.; Fontaine, R.; Cos, P.; Bermúdez, R.C. Oral administration of an aqueous extract from the oyster mushroom Pleurotus ostreatus enhances the immunonutritional recovery of malnourished mice. Biomed. Pharmacother. 2016, 83, 1456–1463. [Google Scholar] [CrossRef] [PubMed]
  236. Yatsuzuka, R.; Nakano, Y.; Jiang, S.; Ueda, Y.; Kishi, Y.; Suzuki, Y.; Yokota, E.; Rahman, A.; Ono, R.; Kohno, I.; et al. Effect of usuhiratake (Pleurotus pulmonarius) on sneezing and nasal rubbing in BALB/c mice. Biol. Pharm. Bull. 2007, 30, 1557–1560. [Google Scholar] [CrossRef] [PubMed]
  237. Ahmad Tarmizi, N.A.; Kushairi, N.; Phan, C.W.; Sabaratnam, V.; Naidu, M.; David, P. β-Glucan-Rich Extract of Gray Oyster Mushroom, Pleurotus pulmonarius, Improves Object Recognition Memory and Hippocampus Morphology in Mice Fed a High-Fat Diet. J. Med. Food 2022, 25, 230–238. [Google Scholar] [CrossRef] [PubMed]
  238. Lavi, I.; Levinson, D.; Peri, I.; Tekoah, Y.; Hadar, Y.; Schwartz, B. Chemical characterization, antiproliferative and antiadhesive properties of polysaccharides extracted from Pleurotus pulmonarius mycelium and fruiting bodies. Appl. Microbiol. Biotechnol. 2010, 85, 1977–1990. [Google Scholar] [CrossRef]
  239. Lavi, I.; Nimri, L.; Levinson, D.; Peri, I.; Hadar, Y.; Schwartz, B. Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice. J. Gastroenterol. 2012, 47, 504–518. [Google Scholar] [CrossRef]
  240. Mao, X.W.; Archambeau, J.O.; Gridley, D.S. Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor. Cancer Biother. Radiopharm. 1996, 11, 393–403. [Google Scholar] [CrossRef]
  241. Yang, S.F.; Zhuang, T.F.; Si, Y.M.; Qi, K.Y.; Zhao, J. Coriolus versicolor mushroom polysaccharides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways. Mol. Immunol. 2015, 64, 144–151. [Google Scholar] [CrossRef] [PubMed]
  242. Ko, C.H.; Yue, G.G.; Gao, S.; Luo, K.W.; Siu, W.S.; Shum, W.T.; Shiu, H.T.; Lee, J.K.; Li, G.; Leung, P.C.; et al. Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model. J. Ethnopharmacol. 2017, 204, 77–85. [Google Scholar] [CrossRef] [PubMed]
  243. Yeung, J.H.; Or, P.M. Effects of polysaccharide peptides from COV-1 strain of Coriolus versicolor on glutathione and glutathione-related enzymes in the mouse. Food Chem. Toxicol. 2007, 45, 953–961. [Google Scholar] [CrossRef] [PubMed]
  244. Jumes, F.M.; Lugarini, D.; Pereira, A.L.; de Oliveira, A.; Christoff, A.D.; Linde, G.A.; do Valle, J.S.; Colauto, N.B.; Acco, A. Effects of Agaricus brasiliensis mushroom in Walker-256 tumor-bearing rats. Can. J. Physiol. Pharmacol. 2010, 88, 21–27. [Google Scholar] [CrossRef] [PubMed]
  245. Kim, S.K.; Hong, U.P.; Kim, J.S.; Kim, C.H.; Lee, K.W.; Choi, S.E.; Park, K.H.; Lee, M.W. Antidiabetic effect of Auricularia auricula mycelia in streptozotocin-induced diabetic rats. Nat. Prod. Sci. 2007, 13, 390–393. [Google Scholar]
  246. Kyakulaga, A.H.; Ogwang, P.E.; Obua, C.; Nakabonge, G.; Mwavu, E.N. Immunomodulatory effects of aqueous extracts of auricularia sp and pleurotus sp mushrooms in cyclophosphamide-immunosuppressed wistar rats. Br. J. Pharm. Res. 2013, 3, 662–670. [Google Scholar] [CrossRef]
  247. Li, Z.; Yao, X.; Liu, B.; Reheman, H.N.; Yang, G.; Zhan, S.; Qi, M.A. Auricularia auricular-judae polysaccharide attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and inflammation. Biomed. Rep. 2015, 3, 478–482. [Google Scholar] [CrossRef] [PubMed]
  248. KChellappan, D.; Ganasen, S.; Batumalai, S.; Candasamy, M.; Krishnappa, P.; Dua, K.; Chellian, J.; Gupta, G. The protective action of the aqueous extract of Auricularia polytricha in paracetamol induced hepatotoxicity in rats. Recent Pat. Drug Deliv. Formul. 2016, 10, 72–76. [Google Scholar] [CrossRef] [PubMed]
  249. Budinastiti, R.; Sunoko, H.R.; Widiastiti, N.S. The effect of cloud ear fungus (Auricularia polytricha) on serum total cholesterol, LDL and HDL levels on Wistar rats induced by reused cooking oil. In E3S Web of Conferences 2018; EDP Sciences: Les Ulis, France, 2018; Volume 31, p. 06006. [Google Scholar]
  250. Zhao, S.; Rong, C.; Liu, Y.; Xu, F.; Wang, S.; Duan, C.; Chen, J.; Wu, X. Extraction of a soluble polysaccharide from Auricularia polytricha and evaluation of its anti-hypercholesterolemic effect in rats. Carbohydr. Polym. 2015, 122, 39–45. [Google Scholar] [CrossRef]
  251. Sheu, J.R.; Geraldine, P.; Yen, M.H. Bioactives and traditional herbal medicine for the treatment of cardiovascular/cerebrovascular diseases 2015. Evid.-Based Complement. Altern. Med. 2015, 2015, 320545. [Google Scholar] [CrossRef]
  252. Wang, L.C.; Wang, S.E.; Wang, J.J.; Tsai, T.Y.; Lin, C.H.; Pan, T.M.; Lee, C.L. In vitro and in vivo comparisons of the effects of the fruiting body and mycelium of Antrodia camphorata against amyloid β-protein-induced neurotoxicity and memory impairment. Appl. Microbiol. Biotechnol. 2012, 94, 1505–1519. [Google Scholar] [CrossRef] [PubMed]
  253. Chen, H.Y.; Cheng, K.C.; Wang, H.T.; Hsieh, C.W.; Lai, Y.J. Extracts of Antrodia cinnamomea mycelium as a highly potent tyrosinase inhibitor. J. Cosmet. Dermatol. 2021, 20, 2341–2349. [Google Scholar] [CrossRef] [PubMed]
  254. Fukushima, M.; Ohashi, T.; Fujiwara, Y.; Sonoyama, K.; Nakano, M. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp. Biol. Med. 2001, 226, 758–765. [Google Scholar] [CrossRef] [PubMed]
  255. Jiang, G.; Lei, A.; Chen, Y.; Yu, Q.; Xie, J.; Yang, Y.; Yuan, T.; Su, D. The protective effects of the Ganoderma atrum polysaccharide against acrylamide-induced inflammation and oxidative damage in rats. Food Funct. 2021, 12, 397–407. [Google Scholar] [CrossRef] [PubMed]
  256. Chao, M.W.; Liao, C.W.; Lin, C.H.; Tseng, C.Y. Immunomodulatory protein from ganoderma microsporum protects against oxidative damages and cognitive impairments after traumatic brain injury. Mol. Cell. Neurosci. 2022, 120, 103735. [Google Scholar] [CrossRef] [PubMed]
  257. Zhou, Z.Y.; Tang, Y.P.; Xiang, J.; Wua, P.; Jin, H.M.; Wang, Z.; Mori, M.; Cai, D.F. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J. Ethnopharmacol. 2010, 131, 154–164. [Google Scholar] [CrossRef] [PubMed]
  258. Lee, M.K.; Li, X.; Yap, A.C.; Cheung, P.C.; Tan, C.S.; Ng, S.T.; Roberts, R.; Ting, K.N.; Fung, S.Y. Airway relaxation effects of water-soluble sclerotial extract from Lignosus rhinocerotis. Front. Pharmacol. 2018, 9, 461. [Google Scholar] [CrossRef] [PubMed]
  259. Lee, M.K.; Lim, K.H.; Millns, P.; Mohankumar, S.K.; Ng, S.T.; Tan, C.S.; Then, S.M.; Mbaki, Y.; Ting, K.N. Bronchodilator effects of Lignosus rhinocerotis extract on rat isolated airways is linked to the blockage of calcium entry. Phytomedicine 2018, 42, 172–179. [Google Scholar] [CrossRef] [PubMed]
  260. Seow, S.L.; Naidu, M.; Sabaratnam, V.; Vidyadaran, S.; Wong, K.H. Tiger’s milk medicinal mushroom, Lignosus rhinocerotis (Agaricomycetes) sclerotium inhibits nitric oxide production in LPS-stimulated BV2 microglia. Int. J. Med. Mushrooms 2017, 19, 405–418. [Google Scholar] [CrossRef]
  261. Lee, S.S.; Tan, N.H.; Fung, S.Y.; Sim, S.M.; Tan, C.S.; Ng, S.T. Anti-inflammatory effect of the sclerotium of Lignosus rhinocerotis (Cooke) Ryvarden, the Tiger Milk mushroom. BMC Complement. Altern. Med. 2014, 14, 359. [Google Scholar] [CrossRef]
  262. Hu, S.H.; Liang, Z.C.; Chia, Y.C.; Lien, J.L.; Chen, K.S.; Lee, M.Y.; Wang, J.C. Antihyperlipidemic and antioxidant effects of extracts from Pleurotus citrinopileatus. J. Agric. Food Chem. 2006, 54, 2103–2110. [Google Scholar] [CrossRef] [PubMed]
  263. Shimizu, K.; Yamanaka, M.; Gyokusen, M.; Kaneko, S.; Tsutsui, M.; Sato, J.; Sato, I.; Sato, M.; Kondo, R. Estrogen-like activity and prevention effect of bone loss in calcium deficient ovariectomized rats by the extract of Pleurotus eryngii. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2006, 20, 659–664. [Google Scholar] [CrossRef] [PubMed]
  264. Huang, J.F.; Zhan, T.; Yu, X.L.; He, Q.A.; Huang, W.J.; Lin, L.Z.; Du, Y.T.; Pan, Y.T. Therapeutic effect of Pleurotus eryngii cellulose on experimental fatty liver in rats. Genet. Mol. Res. 2016, 15, 15017805. [Google Scholar] [CrossRef] [PubMed]
  265. Huang, J.; Wu, Q.; Lin, Z.; Liu, S.; Su, Q.; Pan, Y. Therapeutic effects of chitin from Pleurotus eryngii on high-fat diet induced obesity in rats. Acta Sci. Polonorum. Technol. Alimentaria. 2020, 19, 279–289. [Google Scholar]
  266. Yang, Q.; Huang, B.; Li, H.; Zhang, C.; Zhang, R.; Huang, Y.; Wang, J. Gastroprotective activities of a polysaccharide from the fruiting bodies of Pleurotus ostreatus in rats. Int. J. Biol. Macromol. 2012, 50, 1224–1228. [Google Scholar] [CrossRef] [PubMed]
  267. Olufemi, A.E.; Terry, A.O.; Kola, O.J. Anti-leukemic and immunomodulatory effects of fungal metabolites of Pleurotus pulmonarius and Pleurotus ostreatus on benzene-induced leukemia in Wister rats. Korean J. Hematol. 2012, 47, 67–73. [Google Scholar] [CrossRef] [PubMed]
  268. Balaji, P.; Madhanraj, R.; Rameshkumar, K.; Veeramanikandan, V.; Eyini, M.; Arun, A.; Thulasinathan, B.; Al Farraj, D.A.; Elshikh, M.S.; Alokda, A.M.; et al. Evaluation of antidiabetic activity of Pleurotus pulmonarius against streptozotocin-nicotinamide induced diabetic wistar albino rats. Saudi J. Biol. Sci. 2020, 27, 913–924. [Google Scholar] [CrossRef]
  269. Chahardehi, A.M.; Arsad, H.; Lim, V. Zebrafish as a Successful Animal Model for Screening Toxicity of Medicinal Plants. Plants 2020, 9, 1345. [Google Scholar] [CrossRef]
  270. Safari, R.; Hoseinifar, S.H.; Dadar, M.; Khalili, M. Powder of the white bottom mushroom, Agaricus bisporus (Agaricomycetes), improved immunomodulatory and health-promoting effects of Lactobacillus casei in zebrafish (Danio rerio). Int. J. Med. Mushrooms 2018, 20, 695–704. [Google Scholar] [CrossRef]
  271. Li, X.; Xue, Y.; Pang, L.; Len, B.; Lin, Z.; Huang, J.; ShangGuan, Z.; Pan, Y. Agaricus bisporus-derived β-glucan prevents obesity through PPAR γ downregulation and autophagy induction in zebrafish fed by chicken egg yolk. Int. J. Biol. Macromol. 2019, 125, 820–828. [Google Scholar] [CrossRef]
  272. Zakariaee, H.; Sudagar, M.; Hosseini, S.S.; Paknejad, H.; Baruah, K. In vitro Selection of Synbiotics and in vivo Investigation of Growth Indices, Reproduction Performance, Survival, and Ovarian Cyp19α Gene Expression in Zebrafish Danio rerio. Front. Microbiol. 2021, 12, 758758. [Google Scholar] [CrossRef] [PubMed]
  273. Peng, W.; Zhang, W.; Wu, Q.; Cai, S.; Jia, T.; Sun, J.; Lin, Z.; Alitongbieke, G.; Chen, Y.; Su, Y.; et al. Agaricus bisporus-derived glucosamine hydrochloride facilitates skeletal injury repair through Bmp signaling in zebrafish osteoporosis model. J. Nat. Prod. 2021, 84, 1294–1305. [Google Scholar] [CrossRef] [PubMed]
  274. Pavic, A.; Ilic-Tomic, T.; Glamočlija, J. Unravelling anti-melanogenic potency of edible mushrooms laetiporus sulphureus and agaricus silvaticus in vivo using the zebrafish model. J. Fungi 2021, 7, 834. [Google Scholar] [CrossRef]
  275. Sheng, F.; Zhang, L.; Wang, S.; Yang, L.; Li, P. Deacetyl Ganoderic Acid F Inhibits LPS-Induced Neural Inflammation via NF-κB Pathway Both In vitro and In vivo. Nutrients 2019, 12, 85. [Google Scholar] [CrossRef] [PubMed]
  276. Huang, Q.; Wang, L.; Zhang, L.; Hu, B.; Wang, Q.; Liang, L. Antioxidant Properties of Triterpenoids Isolated from Bagasse-Cultivated Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), at Different Developmental Stages. Int. J. Med. Mushrooms 2022, 24, 41–51. [Google Scholar] [CrossRef] [PubMed]
  277. Wan-Mohtar, W.A.A.Q.I.; Ilham, Z.; Jamaludin, A.A.; Rowan, N. Use of Zebrafish Embryo Assay to Evaluate Toxicity and Safety of Bioreactor-Grown Exopolysaccharides and Endopolysaccharides from European Ganoderma applanatum Mycelium for Future Aquaculture Applications. Int. J. Mol. Sci. 2021, 22, 1675. [Google Scholar] [CrossRef] [PubMed]
  278. Valu, M.V.; Soare, L.C.; Ducu, C.; Moga, S.; Negrea, D.; Vamanu, E.; Balseanu, T.A.; Carradori, S.; Hritcu, L.; Boiangiu, R.S. Hericium erinaceus (Bull.) Pers. Ethanolic Extract with Antioxidant Properties on Scopolamine-Induced Memory Deficits in a Zebrafish Model of Cognitive Impairment. J. Fungi 2021, 7, 477. [Google Scholar] [CrossRef] [PubMed]
  279. Eid, J.I.; Das, B. Molecular insights and cell cycle assessment upon exposure to Chaga (Inonotus obliquus) mushroom polysaccharides in zebrafish (Danio rerio). Sci. Rep. 2020, 10, 7406. [Google Scholar] [CrossRef] [PubMed]
  280. Eid, J.I.; Al-Tuwaijri, M.M.; Mohanty, S.; Das, B. Chaga mushroom (Inonotus obliquus) polysaccharides exhibit genoprotective effects in UVB-exposed embryonic zebrafish (Danio rerio) through coordinated expression of DNA repair genes. Heliyon 2021, 7, e06003. [Google Scholar] [CrossRef]
  281. Lee, H.; Lee, K.; Lee, S.; Lee, J.; Jeong, W.T.; Lim, H.B.; Hyun, T.K.; Yi, S.J.; Kim, K. Ethyl acetate fraction of aqueous extract of lentinula edodes inhibits osteoclastogenesis by suppressing nfatc1 expression. Int. J. Mol. Sci. 2020, 21, 1347. [Google Scholar] [CrossRef]
  282. Mahmood, I.; Azfaralariff, A.; Mohamad, A.; Airianah, O.B.; Law, D.; Dyari, H.R.; Lim, Y.C.; Fazry, S. Mutated Shiitake extracts inhibit melanin-producing neural crest-derived cells in zebrafish embryo. Comp. Biochem. Physiol. Part. C Toxicol. Pharmacol. 2021, 245, 109033. [Google Scholar] [CrossRef] [PubMed]
  283. Dey, D.K.; Chang, S.N.; Gu, J.Y.; Kim, K.M.; Lee, J.J.; Kim, T.H.; Kang, S.C. Ultraviolet B-irradiated mushroom supplementation increased the Ca++ uptake and ameliorated the LPS-induced inflammatory responses in zebrafish larvae. J. Food Biochem. 2021, 45, e13742. [Google Scholar] [CrossRef] [PubMed]
  284. Lin, S.; Lai, T.C.; Chen, L.; Kwok, H.F.; Lau, C.B.; Cheung, P.C. Antioxidant and antiangiogenic properties of phenolic extract from Pleurotus tuber-regium. J. Agric. Food Chem. 2014, 62, 9488–9498. [Google Scholar] [CrossRef] [PubMed]
  285. Wang, C.; Liu, Y.; Lan, Y.; Yuan, J. Extraction of a Triterpene Solution and Evaluation of the Hypolipidemic Efficacy of the Pleurotus tuber-regium (Fr.) Sing Sclerotium. Foods 2022, 11, 2881. [Google Scholar] [CrossRef]
  286. Panchal, K.; Tiwari, A.K. Drosophila melanogaster “a potential model organism” for identification of pharmacological properties of plants/plant-derived components. Biomed. Pharmacother. 2017, 89, 1331–1345. [Google Scholar] [CrossRef] [PubMed]
  287. Pratomo, A.R.; Salim, E.; Hori, A.; Kuraishi, T. Drosophila as an Animal Model for Testing Plant-Based Immunomodulators. Int. J. Mol. Sci. 2022, 23, 14801. [Google Scholar] [CrossRef] [PubMed]
  288. Liu, H.P.; Kuo, Y.H.; Cheng, J.; Chang, L.Z.; Chang, M.S.; Su, L.W.; Chuang, T.N.; Lin, W.Y. Ergosta-7,9,22-trien-3β-ol Rescues AD Deficits by Modulating Microglia Activation but Not Oxidative Stress. Molecules 2021, 26, 5338. [Google Scholar] [CrossRef]
  289. Ma, W.W.; Tao, Y.; Wang, Y.Y.; Peng, I.F. Effects of Gardenia jasminoides extracts on cognition and innate immune response in an adult Drosophila model of Alzheimer’s disease. Chin. J. Nat. Med. 2017, 15, 899–904. [Google Scholar] [CrossRef]
  290. Li, I.C.; Lee, L.Y.; Chen, Y.J.; Chou, M.Y.; Wang, M.F.; Chen, W.P.; Chen, Y.P.; Chen, C.C. Erinacine A-enriched Hericium erinaceus mycelia promotes longevity in Drosophila melanogaster and aged mice. PLoS ONE 2019, 14, e0217226. [Google Scholar] [CrossRef]
  291. Wu, Y.L.; Chen, S.C.; Chang, J.C.; Lin, W.Y.; Chen, C.C.; Li, C.C.; Hsieh, M.; Chen, H.W.; Chang, T.Y.; Liu, C.S.; et al. The protective effect of erinacine A-enriched Hericium erinaceus mycelium ethanol extract on oxidative Stress-Induced neurotoxicity in cell and Drosophila models of spinocerebellar ataxia type 3. Free Radic. Biol. Med. 2023, 195, 1–12. [Google Scholar] [CrossRef]
  292. Matjuskova, N.; Azena, E.; Serstnova, K.; Muiznieks, I. The influence of the hot water extract from shiitake medicinal mushroom, Lentinus edodes (higher Basidiomycetes) on the food intake, life span, and age-related locomotor activity of Drosophila melanogaster. Int. J. Med. Mushrooms 2014, 16, 605–6015. [Google Scholar] [CrossRef] [PubMed]
  293. Agunloye, O.M.; Oboh, G.; Falade, A.O. Pleurotus ostreatus and Lentinus subnudus supplemented diets restore altered acetylcholinesterase and butyrylcholinesterase activities and improve antioxidant status in transgenic Drosophila melanogaster model. J. Diet. Suppl. 2021, 18, 372–386. [Google Scholar] [CrossRef] [PubMed]
  294. Kylyc, A.; Yesilada, E. Preliminary results on antigenotoxic effects of dried mycelia of two medicinal mushrooms in Drosophila melanogaster somatic mutation and recombination test. Int. J. Med. Mushrooms 2013, 15, 415–421. [Google Scholar] [CrossRef] [PubMed]
  295. Ayuda-Durán, B.; González-Manzano, S.; Miranda-Vizuete, A.; Sánchez-Hernández, E.; Romero, M.R.; Dueñas, M.; Santos-Buelga, C.; González-Paramás, A.M. Exploring target genes involved in the effect of quercetin on the response to oxidative stress in Caenorhabditis elegans. Antioxidants 2019, 8, 585. [Google Scholar] [CrossRef] [PubMed]
  296. Shen, M.; Fang, Z.; Chen, Y.; Chen, Y.; Xiao, B.; Guo, L.; Xu, Y.; Wang, G.; Wang, W.; Zhang, Y. Hypoglycemic Effect of the Degraded Polysaccharides from the Wood Ear Medicinal Mushroom Auricularia auricula-judae (Agaricomycetes). Int. J. Med. Mushrooms 2019, 21, 1033–1042. [Google Scholar] [CrossRef] [PubMed]
  297. Huang, Q.; Xiao, B.; Chen, S.; Zeng, J.; Yao, J.; Tan, J.; Wang, G.; Wang, W.; Zhang, Y. Effect of Enzyme-Assisted Extraction on the Chemical Properties and Antioxidant Activities of Polysaccharides Obtained from the Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). Int. J. Med. Mushrooms 2022, 24, 49–62. [Google Scholar] [CrossRef] [PubMed]
  298. Chen, Y.; Xu, M.; Wang, X.; Shan, X.; Ji, L.; Zhang, Y. Preparation of Wood Ear Medicinal Mushroom, Auricularia auricula-judae (Agaricomycetes), Melanin and Its Antioxidant Properties: Evaluation In vitro and In vivo. Int. J. Med. Mushrooms 2021, 23, 89–100. [Google Scholar] [CrossRef] [PubMed]
  299. Xu, S.; Zhang, Y.; Jiang, K. Antioxidant activity in vitro and in vivo of the polysaccharides from different varieties of Auricularia auricula. Food Funct. 2016, 7, 3868–3879. [Google Scholar] [CrossRef] [PubMed]
  300. Gu, J.; Li, Q.; Liu, J.; Ye, Z.; Feng, T.; Wang, G.; Wang, W.; Zhang, Y. Ultrasonic-assisted extraction of polysaccharides from Auricularia auricula and effects of its acid hydrolysate on the biological function of Caenorhabditis elegans. Int. J. Biol. Macromol. 2021, 167, 423–433. [Google Scholar] [CrossRef]
  301. Xiao, B.; Chen, S.; Huang, Q.; Tan, J.; Zeng, J.; Yao, J.; Feng, T.; Wang, G.; Zhang, Y. The lipid lowering and antioxidative stress potential of polysaccharide from Auricularia auricula prepared by enzymatic method. Int. J. Biol. Macromol. 2021, 187, 651–663. [Google Scholar] [CrossRef] [PubMed]
  302. Fang, Z.; Chen, Y.; Wang, G.; Feng, T.; Shen, M.; Xiao, B.; Gu, J.; Wang, W.; Li, J.; Zhang, Y. Evaluation of the antioxidant effects of acid hydrolysates from Auricularia auricular polysaccharides using a Caenorhabditis elegans model. Food Funct. 2019, 10, 5531–5543. [Google Scholar] [CrossRef] [PubMed]
  303. Li, Z.; Zhang, Y.; Lin, L.; Cui, H.; Wang, T.; Chen, M.; Wang, C. Cellulase-assisted extraction and anti-ultraviolet activity of polysaccharides from the root of Flammulina velutipes on Caenorhabditis elegans. Pak. J. Pharm. Sci. 2018, 31, 2487–2495. [Google Scholar] [PubMed]
  304. Chuang, M.H.; Chiou, S.H.; Huang, C.H.; Yang, W.B.; Wong, C.H. The lifespan-promoting effect of acetic acid and Reishi polysaccharide. Bioorg Med. Chem. 2009, 17, 7831–7840. [Google Scholar] [CrossRef] [PubMed]
  305. Cuong, V.T.; Chen, W.; Shi, J.; Zhang, M.; Yang, H.; Wang, N.; Yang, S.; Li, J.; Yang, P.; Fei, J. The anti-oxidation and anti-aging effects of Ganoderma lucidum in Caenorhabditis elegans. Exp. Gerontol. 2019, 117, 99–105. [Google Scholar] [CrossRef] [PubMed]
  306. Peng, H.H.; Wu, C.Y.; Hsiao, Y.C.; Martel, J.; Ke, P.Y.; Chiu, C.Y.; Liau, J.C.; Chang, I.T.; Su, Y.H.; Ko, Y.F.; et al. Ganoderma lucidum stimulates autophagy-dependent longevity pathways in Caenorhabditis elegans and human cells. Aging 2021, 13, 13474–13495. [Google Scholar] [CrossRef]
  307. Wu, F.; Jia, X.; Yin, L.; Cheng, Y.; Miao, Y.; Zhang, X. The Effect of Hemicellulose and Lignin on Properties of Polysaccharides in Lentinus edodes and Their Antioxidant Evaluation. Molecules 2019, 24, 1834. [Google Scholar] [CrossRef] [PubMed]
  308. Kittimongkolsuk, P.; Pattarachotanant, N.; Chuchawankul, S.; Wink, M.; Tencomnao, T. Neuroprotective Effects of Extracts from Tiger Milk Mushroom Lignosus rhinocerus Against Glutamate-Induced Toxicity in HT22 Hippocampal Neuronal Cells and Neurodegenerative Diseases in Caenorhabditis elegans. Biology 2021, 10, 30. [Google Scholar] [CrossRef] [PubMed]
  309. Twardowski, P.; Kanaya, N.; Frankel, P.; Synold, T.; Ruel, C.; Pal, S.K.; Junqueira, M.; Prajapati, M.; Moore, T.; Tryon, P.; et al. A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses. Cancer 2015, 121, 2942–2950. [Google Scholar] [CrossRef] [PubMed]
  310. Grinde, B.; Hedand, G.; Johnson, E. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. Int. Immunopharmacol. 2006, 6, 1311–1314. [Google Scholar] [CrossRef]
  311. Ahn, W.S.; Kim, D.J.; Chae, G.T.; Lee, J.M.; Bae, S.M.; Sin, J.I.; Kim, Y.W.; Namkoong, S.E.; Lee, I.P. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int. J. Gynecol. Cancer 2004, 14, 589–594. [Google Scholar] [CrossRef]
  312. Tangen, J.M.; Tierens, A.; Caers, J.; Binsfeld, M.; Olstad, O.K.; Troseid, A.M.S.; Wang, J.B.; Tjonnfjord, G.E.; Hetland, G. Immunomodulatory Effects of the Agaricus blazei Murrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study. Biomed. Res. Int. 2015, 2015, 718539. [Google Scholar] [CrossRef] [PubMed]
  313. Valadares, F.; Garbi Novaes, M.R.; Canete, R. Effect of Agaricus sylvaticus supplementation on nutritional status and adverse events of chemotherapy of breast cancer: A randomized, placebo-controlled, double-blind clinical trial. Indian J. Pharmacol. 2013, 45, 217–222. [Google Scholar]
  314. Fortes, R.C.; Recova, V.L.; Melo, A.L.; Novaes, M.R.C.G. Effects of dietary supplementation with medicinal fungus in fasting glycemia levels of patients with colorectal cancer: A randomized, double-blind, placebo-controlled clinical study. Nutr. Hosp. 2008, 23, 591–598. [Google Scholar] [PubMed]
  315. Tsai, M.Y.; Hung, Y.C.; Chen, Y.H.; Chen, Y.H.; Huang, Y.C.; Kao, C.W.; Su, Y.L.; Chiu, H.H.; Rau, K.M. A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer. BMC Complement. Altern. Med. 2016, 16, 322. [Google Scholar] [CrossRef]
  316. Torkelson, C.J.; Sweet, E.; Martzen, M.R.; Sasagawa, M.; Wenner, C.A.; Gay, J.; Putiri, A.; Standish, L.J. Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. ISRN Oncol. 2012, 2012, 251632. [Google Scholar] [CrossRef]
  317. Chay, W.Y.; Tham, C.K.; Toh, H.C.; Lim, H.Y.; Tan, C.K.; Lim, C.; Wang, W.W.; Choo, S.P. Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy. J. Altern. Complement. Med. 2017, 23, 648–652. [Google Scholar] [CrossRef]
  318. Zhao, H.; Zhang, Q.; Zhao, L.; Huang, X.; Wang, J.; Kang, X. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid. Based Complement. Alternat. Med. 2012, 2012, 809614. [Google Scholar] [CrossRef] [PubMed]
  319. Grammatikopoulou, M.G.; Gkiouras, K.; Papageorgiou, S.T.; Myrogiannis, I.; Mykoniatis, I.; Papamitsou, T.; Bogdanos, D.P.; Goulis, D.G. Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials. Nutrients 2020, 12, 2985. [Google Scholar] [CrossRef]
  320. Deng, G.; Lin, H.; Seidman, A.; Fornier, M.; D’Andrea, G.; Wesa, K.; Yeung, S.; Cunningham-Rundles, S.; Vickers, A.J.; Cassileth, B. Aphase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: Immunological effects. J. Cancer Res. Clin. 2009, 135, 1215–1221. [Google Scholar] [CrossRef]
  321. Wesa, K.M.; Cunningham-Rundles, S.; Klimek, V.M.; Vertosick, E.; Coleton, M.I.; Yeung, K.S.; Lin, H.; Nimer, S.; Cassileth, B.R. Maitake mushroom extract in myelodysplastic syndromes (MDS): A phase II study. Cancer Immunol. Immun. 2015, 64, 237–247. [Google Scholar] [CrossRef]
  322. Griessmayr, P.C.; Gauthier, M.; Barber, L.G.; Cotter, S.M. Mushroom-derived Maitake PET fraction as single agent for the treatment of lymphoma in dogs. J. Vet. Intern. Med. 2007, 21, 1409–1412. [Google Scholar] [PubMed]
  323. Docherty, S.; Doughty, F.L.; Smith, E.F. The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients 2023, 15, 4842. [Google Scholar] [CrossRef] [PubMed]
  324. Yamaguchi, Y.; Miyahara, E.; Hihara, J. Efficacy and Safety of Orally Administered Lentinula edodes Mycelia Extract for Patients Undergoing Cancer Chemotherapy: A Pilot Study. Am. J. Chin. Med. 2011, 39, 451–459. [Google Scholar] [CrossRef] [PubMed]
  325. White, R.W.D.; Hackman, R.M.; Soares, S.E.; Beckett, L.A.; Sun, B.X. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002, 60, 640–644. [Google Scholar] [CrossRef] [PubMed]
  326. Sumiyoshi, Y.; Hashine, K.; Kakehi, Y.; Yoshimura, K.; Satou, T.; Kuruma, H.; Namiki, S.; Shinohara, N. Dietary Administration of Mushroom Mycelium Extracts in Patients with Early-Stage Prostate Cancers Managed Expectantly: A Phase II Study. Jpn. J. Clin. Oncol. 2010, 40, 967–972. [Google Scholar] [CrossRef] [PubMed]
  327. Ito, T.; Urushima, H.; Sakaue, M.; Yukawa, S.; Honda, H.; Hirai, K.; Igura, T.; Hayashi, N.; Maeda, K.; Kitagawa, T.; et al. Reduction of Adverse Effects by a Mushroom Product, Active Hexose Correlated Compound (AHCC) in Patients with Advanced Cancer During Chemotherapy-The Significance of the Levels of HHV-6 DNA in Saliva as a Surrogate Biomarker during Chemotherapy. Nutr. Cancer 2014, 66, 377–382. [Google Scholar] [CrossRef] [PubMed]
  328. Meera, C.R.; Janardhanan, K.K. Antitumor Activity of a Polysaccharide-Protein Complex Isolated from a Wood-Rotting Polypore Macro Fungus Phellinus rimosus (Berk) Pilat. J. Environ. Pathol. Tox. 2012, 31, 223–232. [Google Scholar] [CrossRef] [PubMed]
  329. Dicks, L.; Ellinger, S. Effect of the Intake of Oyster Mushrooms (Pleurotus ostreatus) on Cardiometabolic Parameters-A Systematic Review of Clinical Trials. Nutrients 2020, 12, 1134. [Google Scholar] [CrossRef] [PubMed]
  330. Lee, H.; Cha, H.J. Poria cocos Wolf extracts represses pigmentation in vitro and in vivo. Cell Mol. Biol. 2018, 64, 80–84. [Google Scholar] [CrossRef]
  331. Sivanesan, I.; Muthu, M.; Gopal, J.; Oh, J.W. Mushroom Polysaccharide-Assisted Anticarcinogenic Mycotherapy: Reviewing Its Clinical Trials. Molecules 2022, 27, 4090. [Google Scholar] [CrossRef]
  332. Zhang, Y.R.; Zhang, M.; Jiang, Y.F.; Li, X.L.; He, Y.L.; Zeng, P.J.; Guo, Z.H.; Chang, Y.J.; Luo, H.; Liu, Y.; et al. Lentinan as an immunotherapeutic for treating lung cancer: A review of 12 years clinical studies in China. J. Cancer Res. Clin. 2018, 144, 2177–2186. [Google Scholar] [CrossRef] [PubMed]
  333. Sakamoto, J.; Morita, S.; Oba, K.; Matsui, T.; Kobayashi, M.; Nakazato, H.; Ohashi, Y. Meta-Analysis Group of the Japanese Society for Cancer of the Colon, R. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol. Immunother. 2006, 55, 404–411. [Google Scholar] [PubMed]
  334. Taguchi, T.; Furue, H.; Kimura, T.; Kondo, T.; Hattori, T.; Itoh, T.; Osawa, N. End point result of a randomized controlled study of the treatment of gastrointestinal cancer with a combination of lentinan and chemotherapeutic agents. Excerpta Med. 1985, 40, 151–165. [Google Scholar]
  335. Taguchi, T.; Furue, H.; Kimura, T.; Kondo, T.; Hattori, T.; Itoh, T.; Osawa, N. End point results of phase III study of lentinan. Jpn. J. Cancer Chemother. 1985, 12, 366–380. [Google Scholar]
  336. Furue, H.; Kitoh, I. Phase 111-study on Lentinan. Jpn. J. Cancer Chemother. 1981, 8, 944–960. [Google Scholar]
  337. Daba, A.S.; Ezeronye, Q.U. Anti-cancer effect of polysaccharides isolated from higher basidiomycetes mushrooms. Afr. J. Biotechnol. 2003, 2, 672–678. [Google Scholar]
  338. Kimura, Y.; Mizuno, H.; Satake, K.; Tahara, H.; Tsukuda, M. Clinical evaluation of Sizofiran an assistant immunotherapy in treatment of head and neck cancer. Acta Oto-Laryngol. 1994, 511, 192–195. [Google Scholar] [CrossRef] [PubMed]
  339. Okamura, K.; Suzuki, M.; Chihara, T.; Fujiwara, A.; Fukuda, T.; Goto, S.; Ichinohe, K.; Jimi, S.; Kasamatsu, T.; Kawai, N.; et al. Clinical-Evaluation of Schizophyllan Combined with Irradiation in Patients with Cervical-Cancer—A Randomized Controlled Study. Cancer 1986, 58, 865–872. [Google Scholar] [CrossRef] [PubMed]
  340. Okamura, K.; Kinukawa, T.; Tsumura, Y.; Otani, T.; Itoh, T.; Kobayashi, H.; Matsuura, O.; Kobayashi, M.; Fukutsu, T.; Ohshima, S. Adjuvant immunochemotherapy: Two randomized controlled studies of patients with cervical cancer. Biomed. Pharmacother. 1989, 43, 177–181. [Google Scholar] [CrossRef] [PubMed]
  341. Miyazaki, K.; Mizutani, H.; Katabuchi, H.; Fukuma, K.; Fujisaki, S.; Okamura, H. Activated (Hla-Dr+) T-Lymphocyte Subsets in Cervical-Carcinoma and Effects of Radiotherapy and Immunotherapy with Sizofiran on Cell-Mediated-Immunity and Survival. Gynecol. Oncol. 1995, 56, 412–420. [Google Scholar] [CrossRef] [PubMed]
  342. Chen, C.C.; Li, I.C.; Lin, T.W.; Chang, H.L.; Lin, W.H.; Shen, Y.C. Efficacy and safety of oral Antrodia cinnamomea mycelium in mildly hypertensive adults: A randomized controlled pilot clinical study. Eur. J. Integr. Med. 2016, 8, 654–660. [Google Scholar] [CrossRef]
  343. Yen, Y.T.; Park, J.H.; Kang, S.W.; Su, T.; Cheng, H.; Wen, W.C.; Lin, S.Y.; Tai, Y.; Chen, P.N.; Tsai, S.C. Clinical benefits of golden-Antrodia camphorata containing antroquinonol in liver protection and liver fat reduction after alcoholic hepatitis. Front. Pharmacol. 2022, 13, 757494. [Google Scholar] [CrossRef] [PubMed]
  344. Dosychev, E.A.; Bystrova, V.N. Treatment of psoriasis using “Chaga” fungus preparations. Vestnik Dermatologii i Venerologii 1973, 47, 79–83. [Google Scholar] [PubMed]
  345. Kim, Y.R. Immunomodulatory activity of the water extract from medici nal mushroom Inonotus obliquus. Mycobiology 2005, 33, 158–162. [Google Scholar] [CrossRef]
  346. Fedotov, A.A.; Yu, I.R. Effect of Befungin on the central nervous system in patients with peptic ulcers. Klin. Meditsina 1981, 59, 22–25. [Google Scholar]
  347. Ku, Y.H.; Kang, J.H. Efficacy of Phellinus linteus extract on immunity enhancement: A CONSORT-randomized, double-blind, placebo controlled pilot trial. Medicine 2022, 101, 30829. [Google Scholar] [CrossRef] [PubMed]
  348. Ryu, H.Y.; Lee, H.; Kang, J.H. A pilot clinical study of the efficacy and safety of Phellinus Linteus (Sanghuang) extract treatment for knee osteoar thritis. J. Acupuncture Res. 2022, 39, 115–121. [Google Scholar] [CrossRef]
  349. Sung, H.L.; Ho, K.H.; Chang, M.K.; Woo, J.L. Potential impact of Phellinus linteus on adherence to adjuvant treatment after curative resection of pancreatic ductal adenocarcinoma: Outcomes of a propensity score matched analysis. Integr. Cancer Ther. 2018, 18, 1534735418816825. [Google Scholar]
  350. Tee, P.Y.E.; Krishnan, T.; Cheong, X.T.; Maniam, S.A.P.; Looi, C.Y.; Ooi, Y.Y.; Chua, C.L.L.; Fung, S.Y.; Chia, A.Y.Y. A review on the cultivation, bioactive compounds, health-promoting factors and clinical trials of medicinal mushrooms Taiwanofungus camphoratus, Inonotus obliquus and Tropicoporus linteus. Fungal Biol. Biotechnol. 2024, 11, 7. [Google Scholar] [CrossRef]
  351. Muddapu, V.R.; Dharshini, S.; Chakravarthy, V.S.; Gromiha, M.M. Neurodegenerative diseases–is metabolic deficiency the root cause? Front. Neurosci. 2020, 14, 213. [Google Scholar] [CrossRef]
  352. Thongbai, B.; Rapior, S.; Hyde, K.D.; Wittstein, K.; Stadler, M. Hericium erinaceus, an amazing medicinal mushroom. Mycol. Prog. 2015, 14, 91. [Google Scholar] [CrossRef]
  353. Obara, Y.; Nakahata, N. The signaling pathway of neurotrophic factor biosynthesis. Drug News Perspect. 2002, 15, 290–298. [Google Scholar] [CrossRef] [PubMed]
  354. Kolotushkina, E.V.; Moldavan, M.G.; Voronin, K.Y.; Skibo, G.G. The influence of Hericium erinaceus extract on myelination process in vitro. Fiziol Zh 2003, 49, 38–45. [Google Scholar]
  355. Lai, P.L.; Naidu, M.; Sabaratnam, V.; Wong, K.H.; David, R.P.; Kuppusamy, U.R.; Abdullah, N.; Malek, S.N.A. Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. Int. J. Med. Mushrooms 2013, 15, 539–554. [Google Scholar] [CrossRef] [PubMed]
  356. Zhang, J.; An, S.; Hu, W.; Teng, M.; Wang, X.; Qu, Y.; Liu, Y.; Yuan, Y.; Wang, D. The neuroprotective properties of Hericium erinaceus in glutamate-damaged differentiated PC12 cells and an Alzheimer’s disease mouse model. Int. J. Mol. Sci. 2016, 17, 1810. [Google Scholar] [CrossRef] [PubMed]
  357. Wang, X.Y.; Zhang, D.D.; Yin, J.Y.; Nie, S.P.; Xie, M.Y. Recent developments in Hericium erinaceus polysaccharides: Extraction, purification, structural characteristics and biological activities. Crit. Rev. Food Sci. Nutr. 2019, 59 (Suppl. S1), S96–S115. [Google Scholar] [CrossRef] [PubMed]
  358. Wong, K.H.; Kanagasabapathy, G.; Bakar, R.; Phan, C.W.; Sabaratnam, V. Restoration of sensory dysfunction following peripheral nerve injury by the polysaccharide from culinary and medicinal mushroom, Hericium erinaceus (Bull.: Fr.) Pers. through its neuroregenerative action. Food Sci. Technol. 2015, 35, 712–721. [Google Scholar] [CrossRef]
  359. Mori, K.; Obara, Y.; Moriya, T.; Inatomi, S.; Nakahata, N. Effects of Hericium erinaceus on amyloid β (25–35) peptide-induced learning and memory deficits in mice. Biomed. Res. 2011, 32, 67–72. [Google Scholar] [CrossRef] [PubMed]
  360. Aysun, E.; Hüseyin, O.; Emre, B.B.; Cenap, E.; Senay, D.; Engin, D. Neuroprotective Effects of Ganoderma lucidum on Spinal Cord Injury. Int. J. Morphol. 2018, 36, 175–179. [Google Scholar]
  361. Divanlıoğlu, D.; Salihoğlu, E.M.; Korkmaz, M.; Seçen, A.E.; Öcal, Ö.; Günerhan, G.; Belen, D.; Dalgıç, A. Biochemical analysis for neuroprotective effects of ganoderma lucidum in experimental rat spinal cord trauma model. J. Turk. Spinal Surg. 2021, 32, 116–122. [Google Scholar] [CrossRef]
  362. Zhou, Y.; Qu, Z.Q.; Zeng, Y.S.; Lin, Y.K.; Li, Y.; Chung, P.; Wong, R.; Hägg, U. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp. Toxicol. Pathol. 2012, 64, 673–680. [Google Scholar] [CrossRef] [PubMed]
  363. Sun, X.Z.; Liao, Y.; Li, W.; Guo, L.M. Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis. Neural Regen. Res. 2017, 12, 953. [Google Scholar]
  364. Sharma, P.; Tulsawani, R. Ganoderma lucidum aqueous extract prevents hypobaric hypoxia induced memory deficit by modulating neurotransmission, neuroplasticity and maintaining redox homeostasis. Sci. Rep. 2020, 10, 8944. [Google Scholar] [CrossRef] [PubMed]
  365. Wang, C.; Liu, X.; Lian, C.; Ke, J.; Liu, J. Triterpenes and aromatic meroterpenoids with antioxidant activity and neuroprotective effects from Ganoderma lucidum. Molecules 2019, 24, 4353. [Google Scholar] [CrossRef]
  366. Wang, S.Q.; Li, X.J.; Zhou, S.; Sun, D.X.; Wang, H.; Cheng, P.F.; Ma, X.R.; Liu, L.; Liu, J.X.; Wang, F.F.; et al. Intervention effects of ganoderma lucidum spores on epileptiform discharge hippocampal neurons and expression of neurotrophin-4 and N-cadherin. PLoS ONE 2013, 8, e61687. [Google Scholar] [CrossRef] [PubMed]
  367. Wang, S.Q.; Li, X.J.; Qiu, H.B.; Jiang, Z.M.; Simon, M.; Ma, X.R.; Liu, L.; Liu, J.X.; Wang, F.F.; Liang, Y.F.; et al. Anti-epileptic effect of Ganoderma lucidum polysaccharides by inhibition of intracellular calcium accumulation and stimulation of expression of CaMKII α in epileptic hippocampal neurons. PLoS ONE 2014, 9, e102161. [Google Scholar] [CrossRef] [PubMed]
  368. Liu, W.; Ge, T.; Pan, Z.; Leng, Y.; Lv, J.; Li, B. The effects of herbal medicine on epilepsy. Oncotarget 2017, 8, 48385. [Google Scholar] [CrossRef]
  369. Pan, W.; Jiang, P.; Zhao, J.; Shi, H.; Zhang, P.; Yang, X.; Biazik, J.; Hu, M.; Hua, H.; Ge, X.; et al. β-Glucan from Lentinula edodes prevents cognitive impairments in high-fat diet-induced obese mice: Involvement of colon-brain axis. J. Transl. Med. 2021, 19, 54. [Google Scholar] [CrossRef] [PubMed]
  370. Seo, D.S.; Lee, E.N.; Seo, G.S.; Lee, J.S. Screening and optimal extraction of a new antidementia β-secretase inhibitor-containing mushroom. Mycobiology 2008, 36, 195–197. [Google Scholar] [CrossRef]
  371. Han, Y.; Nan, S.; Fan, J.; Chen, Q.; Zhang, Y. Inonotus obliquus polysaccharides protect against Alzheimer’s disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects. Int. J. Biol. Macromol. 2019, 131, 769–778. [Google Scholar] [CrossRef]
  372. Gunjima, K.; Tomiyama, R.; Takakura, K.; Yamada, T.; Hashida, K.; Nakamura, Y.; Konishi, T.; Matsugo, S.; Hori, O. 3, 4-dihydroxybenzalacetone protects against Parkinson’s disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway. J. Cell. Biochem. 2014, 115, 151–160. [Google Scholar] [CrossRef] [PubMed]
  373. Zou, C.X.; Wang, X.B.; Lv, T.M.; Hou, Z.L.; Lin, B.; Huang, X.X.; Song, S.J. Flavan derivative enantiomers and drimane sesquiterpene lactones from the Inonotus obliquus with neuroprotective effects. Bioorganic Chem. 2020, 96, 103588. [Google Scholar] [CrossRef] [PubMed]
  374. Janjušević, L.; Karaman, M.; Šibul, F.; Tommonaro, G.; Iodice, C.; Jakovljević, D.; Pejin, B. The lignicolous fungus Trametes versicolor (L.) Lloyd (1920): A promising natural source of antiradical and AChE inhibitory agents. J. Enzym. Inhib. Med. Chem. 2017, 32, 355–362. [Google Scholar] [CrossRef] [PubMed]
  375. Jeong, J.W.; Jin, C.Y.; Kim, G.Y.; Lee, J.D.; Park, C.; Kim, G.D.; Kim, W.J.; Jung, W.K.; Seo, S.K.; Choi, I.W.; et al. Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells. Int. Immunopharmacol. 2010, 10, 1580–1586. [Google Scholar] [CrossRef] [PubMed]
  376. Yuan, J.; Wang, A.; He, Y.; Si, Z.; Xu, S.; Zhang, S.; Wang, K.; Wang, D.; Liu, Y. Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats. Brain Res. Bull. 2016, 127, 171–176. [Google Scholar] [CrossRef] [PubMed]
  377. Wei, P.; Wang, K.; Luo, C.; Huang, Y.; Misilimu, D.; Wen, H.; Jin, P.; Li, C.; Gong, Y.; Gao, Y. Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury. J. Neuroinflammation 2021, 18, 137. [Google Scholar] [CrossRef] [PubMed]
  378. Wang, J.; Liu, Y.M.; Cao, W.; Yao, K.W.; Liu, Z.Q.; Guo, J.Y. Anti-inflammation and antioxidant effect of Cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Metab. Brain Dis. 2012, 27, 159–165. [Google Scholar] [CrossRef]
  379. Marcotullio, M.C.; Pagiotti, R.; Maltese, F.; Mwankie GN, O.M.; Hoshino, T.; Obara, Y.; Nakahata, N. Cyathane diterpenes from Sarcodon cyrneus and evaluation of their activities of neuritegenesis and nerve growth factor production. Bioorganic Med. Chem. 2007, 15, 2878–2882. [Google Scholar] [CrossRef] [PubMed]
  380. Obara, Y.; Hoshino, T.; Marcotullio, M.C.; Pagiotti, R.; Nakahata, N. A novel cyathane diterpene, cyrneine A, induces neurite outgrowth in a Rac1-dependent mechanism in PC12 cells. Life Sci. 2007, 80, 1669–1677. [Google Scholar] [CrossRef]
  381. Shi, X.W.; Liu, L.; Gao, J.M.; Zhang, A.L. Cyathane diterpenes from Chinese mushroom Sarcodon scabrosus and their neurite outgrowth-promoting activity. Eur. J. Med. Chem. 2011, 46, 3112–3117. [Google Scholar] [CrossRef]
  382. Cao, C.Y.; Zhang, C.C.; Shi, X.W.; Li, D.; Cao, W.; Yin, X.; Gao, J.M. Sarcodonin G derivatives exhibit distinctive effects on neurite outgrowth by modulating NGF signaling in PC12 cells. ACS Chem. Neurosci. 2018, 9, 1607–1615. [Google Scholar] [CrossRef] [PubMed]
  383. Liu, L.; Shi, X.W.; Zong, S.C.; Tang, J.J.; Gao, J.M. Scabronine M, a novel inhibitor of NGF-induced neurite outgrowth from PC12 cells from the fungus Sarcodon scabrosus. Bioorganic Med. Chem. Lett. 2012, 22, 2401–2406. [Google Scholar] [CrossRef] [PubMed]
  384. Yadav, S.K.; Ir, R.; Jeewon, R.; Doble, M.; Hyde, K.D.; Kaliappan, I.; Jeyaraman, R.; Reddi, R.N.; Krishnan, J.; Li, M.; et al. A mechanistic review on medicinal mushrooms-derived bioactive compounds: Potential mycotherapy candidates for alleviating neurological disorders. Planta Medica 2020, 86, 1161–1175. [Google Scholar] [CrossRef] [PubMed]
  385. Phan, C.W.; Wong, W.L.; David, P.; Naidu, M.; Sabaratnam, V. Pleurotus giganteus (Berk.) Karunarathna & KD Hyde: Nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells. BMC Complement. Altern. Med. 2012, 12, 102. [Google Scholar]
  386. Phan, C.W.; David, P.; Wong, K.H.; Naidu, M.; Sabaratnam, V. Uridine from Pleurotus giganteus and its neurite outgrowth stimulatory effects with underlying mechanism. PLoS ONE 2015, 10, e0143004. [Google Scholar] [CrossRef] [PubMed]
  387. Najjar, S.; Pearlman, D.M.; Alper, K.; Najjar, A.; Devinsky, O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10, 816. [Google Scholar] [CrossRef] [PubMed]
  388. Troncoso-Escudero, P.; Parra, A.; Nassif, M.; Vidal, R.L. Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson’s Disease. Front. Neurol. 2018, 9, 860. [Google Scholar] [CrossRef] [PubMed]
  389. Leng, F.; Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat. Rev. Neurol. 2021, 17, 157–172. [Google Scholar] [CrossRef]
  390. Aramabašić Jovanović, J.; Mihailović, M.; Uskoković, A.; Grdović, N.; Dinić, S.; Vidaković, M. The effects of major mushroom bioactive compounds on mechanisms that control blood glucose level. J. Fungi 2021, 7, 58. [Google Scholar] [CrossRef]
  391. Jugran, A.K.; Rawat, S.; Devkota, H.P.; Bhatt, I.D.; Rawal, R.S. Diabetes and plant-derived natural products: From ethnopharmacological approaches to their potential for modern drug discovery and development. Phytother. Res. 2021, 35, 223–245. [Google Scholar] [CrossRef]
  392. Gray, A.M.; Flatt, P.R. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J. Endocrinol. 1998, 157, 259–266. [Google Scholar] [CrossRef] [PubMed]
  393. Wang, Y.; Liu, Y.; Wang, H.; Li, C.; Qi, P.; Bao, J. Agaricus bisporus lectins mediates islet β-cell proliferation through regulation of cell cycle proteins. Exp. Biol. Med. 2012, 237, 287–296. [Google Scholar] [CrossRef] [PubMed]
  394. Wei, Q.; Zhan, Y.; Chen, B.; Xie, B.; Fang, T.; Ravishankar, S.; Jiang, Y. Assessment of antioxidant and antidiabetic properties of Agaricus blazei Murill extracts. Food Sci. Nutr. 2020, 8, 332–339. [Google Scholar] [CrossRef] [PubMed]
  395. Jeong, G.H.; Cho, J.H.; Park, K.I.; Kim, K.; Kim, T.H. Enzymatic transformation of esculetin as a potent class of α-glucosidase inhibitors. Bioorganic Med. Chem. Lett. 2023, 88, 129302. [Google Scholar]
  396. Lee, S.K.; Ryu, S.H.; Turk, A.; Yeon, S.W.; Jo, Y.H.; Han, Y.K.; Hwang, B.Y.; Lee, K.Y.; Lee, M.K. Characterization of α-glucosidase inhibitory constituents of the fruiting body of lion’s mane mushroom (Hericium erinaceus). J. Ethnopharmacol. 2020, 262, 113197. [Google Scholar] [CrossRef] [PubMed]
  397. Vincent, M.; Philippe, E.; Everard, A.; Kassis, N.; Rouch, C.; Denom, J.; Takeda, Y.; Uchiyama, S.; Delzenne, N.M.; Cani, P.D.; et al. Dietary supplementation with Agaricus blazei Murill extract prevents diet-induced obesity and insulin resistance in rats. Obesity 2013, 21, 553–561. [Google Scholar] [CrossRef] [PubMed]
  398. Kim, Y.W.; Kim, K.H.; Choi, H.J.; Lee, D.S. Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol. Lett. 2005, 27, 483–487. [Google Scholar] [CrossRef] [PubMed]
  399. Hu, X.; Liu, C.; Wang, X.; Jia, D.; Lu, W.; Sun, X.; Liu, Y.; Yuan, L. Hpyerglycemic and anti-diabetic nephritis activities of polysaccharides separated from Auricularia auricular in diet-streptozotocin-induced diabetic rats. Exp. Ther. Med. 2017, 13, 352–358. [Google Scholar] [CrossRef] [PubMed]
  400. Chen, Z.; Wang, J.; Fan, Z.; Qiu, J.; Rumbani, M.; Yang, X.; Zhang, H.; Wang, Z. Effects of polysaccharide from the fruiting bodies of Auricularia auricular on glucose metabolism in 60Co-γ-radiated mice. Int. J. Biol. Macromol. 2019, 135, 887–897. [Google Scholar] [CrossRef]
  401. Wu, N.J.; Chiou, F.J.; Weng, Y.M.; Yu, Z.R.; Wang, B.J. In vitro hypoglycemic effects of hot water extract from Auricularia polytricha (wood ear mushroom). Int. J. Food Sci. Nutr. 2014, 65, 502–506. [Google Scholar] [CrossRef]
  402. Kuang, Y.; Chai, Y.; Su, H.; Lo, J.Y.; Qiao, X.; Ye, M. A network pharmacology-based strategy to explore the pharmacological mechanisms of Antrodia camphorata and antcin K for treating type II diabetes mellitus. Phytomedicine 2022, 96, 153851. [Google Scholar] [CrossRef]
  403. Senthil, K.K.; Gokila, V.M.; Wang, S.Y. Activation of Nrf2-mediated anti-oxidant genes by antrodin C prevents hyperglycemia-induced senescence and apoptosis in human endothelial cells. Oncotarget 2017, 8, 96568. [Google Scholar] [CrossRef] [PubMed]
  404. Lin, L.; Cui, F.; Zhang, J.; Gao, X.; Zhou, M.; Xu, N.; Zhao, H.; Liu, M.; Zhang, C.; Jia, L.E. Antioxidative and renoprotective effects of residue polysaccharides from Flammulina velutipes. Carbohydr. Polym. 2016, 146, 388–395. [Google Scholar] [CrossRef] [PubMed]
  405. Chiang, K.H.; Chiu, Y.C.; Yar, N.; Chen, Y.C.; Cheng, C.H.; Liu, Y.C.; Chang, C.Y.; Chuu, J.J. Renoprotective Impacts of Inonotus obliquus Ethanol-Ethyl Acetate Extract on Combined Streptozotocin and Unilateral Nephrectomy-Induced Diabetic Nephropathy in Mice. Int. J. Mol. Sci. 2023, 24, 4443. [Google Scholar] [CrossRef] [PubMed]
  406. Liu, Q.; Tie, L. Preventive and therapeutic effect of Ganoderma (Lingzhi) on diabetes. Ganoderma Health Pharmacol. Clin. Appl. 2019, 1182, 201–215. [Google Scholar]
  407. Yi, Z.; Shao-Long, Y.; Ai-Hong, W.; Zhi-Chun, S.; Ya-Fen, Z.; Ye-Ting, X.; Yu-Ling, H. Protective effect of ethanol extracts of Hericium erinaceus on alloxan-induced diabetic neuropathic pain in rats. Evid.-Based Complement. Altern. Med. 2015, 2015, 595480. [Google Scholar] [CrossRef] [PubMed]
  408. Zhang, C.; Li, J.; Hu, C.; Wang, J.; Zhang, J.; Ren, Z.; Song, X.; Jia, L. Antihyperglycaemic and organic protective effects on pancreas, liver and kidney by polysaccharides from Hericium erinaceus SG-02 in streptozotocin-induced diabetic mice. Sci. Rep. 2017, 7, 10847. [Google Scholar] [CrossRef]
  409. Miletić, D.; Turło, J.; Podsadni, P.; Sknepnek, A.; Szczepańska, A.; Lević, S.; Nedović, V.; Nikšić, M. Turkey tail medicinal mushroom, Trametes versicolor (Agaricomycetes), crude exopolysaccharides with antioxidative activity. Int. J. Med. Mushrooms 2020, 22, 885–895. [Google Scholar] [CrossRef] [PubMed]
  410. Chen, C.H.; Kang, L.; Lo, H.C.; Hsu, T.H.; Lin, F.Y.; Lin, Y.S.; Wang, Z.J.; Chen, S.T.; Shen, C.L. Polysaccharides of Trametes versicolor improve bone properties in diabetic rats. J. Agric. Food Chem. 2015, 63, 9232–9238. [Google Scholar] [CrossRef] [PubMed]
  411. Nabel, E.G. Cardiovascular disease. N. Engl. J. Med. 2003, 349, 60–72. [Google Scholar] [CrossRef] [PubMed]
  412. Sima, P.; Vannucci, L.; Vetvicka, V. β-glucans and cholesterol. Int. J. Mol. Med. 2018, 41, 1799–1808. [Google Scholar] [PubMed]
  413. Guillamón, E.; García-Lafuente, A.; Lozano, M.; Rostagno, M.A.; Villares, A.; Martínez, J.A. Edible mushrooms: Role in the prevention of cardiovascular diseases. Fitoterapia 2010, 81, 715–723. [Google Scholar] [CrossRef] [PubMed]
  414. Uffelman, C.N.; Chan, N.I.; Davis, E.M.; Wang, Y.; McGowan, B.S.; Campbell, W.W. An assessment of mushroom consumption on cardiometabolic disease risk factors and morbidities in humans: A systematic review. Nutrients 2023, 15, 1079. [Google Scholar] [CrossRef] [PubMed]
  415. Mago, P.; Sharma, R.; Hafeez, I.; Nawaz, I.; Joshi, M.; Mehrotra, R. Mushroom based Cosmeceuticals: An Upcoming Biotechnology Sector. Biosci. Biotechnol. Res. Asia 2023, 20, 381–394. [Google Scholar] [CrossRef]
  416. Wu, Y.; Choi, M.H.; Li, J.; Yang, H.; Shin, H.J. Mushroom cosmetics: The present and future. Cosmetics 2016, 3, 22. [Google Scholar] [CrossRef]
  417. Srivastava, A.; Attri, B.L.; Sharma, V.P. Status report on mushroom based cosmetic products in market. Mushroom Res. 2020, 29. [Google Scholar] [CrossRef]
  418. Wennig, R.; Eyer, F.; Schaper, A.; Zilker, T.; Streichert, H.A. Mushroom Poisoning. Dtsch. Arztebl. Int. 2020, 117, 701–708. [Google Scholar] [CrossRef] [PubMed]
  419. Nieminen, P.; Mustonen, A.M. Toxic Potential of Traditionally Consumed Mushroom Species-A Controversial Continuum with Many Unanswered Questions. Toxins 2020, 12, 639. [Google Scholar] [CrossRef] [PubMed]
  420. Gwenzi, W.; Tagwireyi, C.; Musiyiwa, K.; Chipurura, B.; Nyamangara, J.; Sanganyado, E.; Chaukura, N. Occurrence, behavior, and human exposure and health risks of potentially toxic elements in edible mushrooms with focus on Africa. Env. Monit. Assess. 2021, 193, 302. [Google Scholar] [CrossRef]
  421. Parulska, D.S.; Falandysz, J. A Review of the Occurrence of Alpha-Emitting Radionuclides in Wild Mushrooms. Int. J. Env. Res. Public. Health 2020, 17, 8220. [Google Scholar] [CrossRef]
  422. Amobonye, A.; Lalung, J.; Awasthi, M.K.; Pillai, S. Fungal mycelium as leather alternative: A sustainable biogenic material for the fashion industry. Sustain. Mater. Technol. 2023, 38, e00724. [Google Scholar] [CrossRef]
  423. Vaksmaa, A.; Guerrero-Cruz, S.; Ghosh, P.; Zeghal, E.; Hernando-Morales, V.; Niemann, H. Role of fungi in bioremediation of emerging pollutants. Front. Mar. Sci. 2023, 10, 1070905. [Google Scholar] [CrossRef]
  424. Alemu, D.; Tafesse, M.; Mondal, A.K. Mycelium-Based Composite: The Future Sustainable Biomaterial. Int. J. Biomater. 2022, 2022, 8401528. [Google Scholar] [CrossRef] [PubMed]
  425. Anthony, K.J.; Murugan, M.; Jeyaraj, M.; Rathinam, N.K.; Sangiliyandi, G. Synthesis of silver nanoparticles using pine mushroom extract: A potential antimicrobial agent against E. coli & B. subtilis. J. Ind. Eng. Chem. 2013, 5, 2325–2331. [Google Scholar]
  426. Afshar, P.; Sedaghat, S. Bio-synthesis of silver nanoparticles using water extracts of Satureja hortensis L and evaluation of the antibacterial properties. Curr. Nanosci. 2016, 12, 90–93. [Google Scholar] [CrossRef]
  427. Owaid, M.N.; Barish, A.; Shariati, M.A. Cultivation of Agaricus bisporus (button mushroom) and its usages in the biosynthesis of nanoparticles. Open Agric. 2017, 2, 537–543. [Google Scholar] [CrossRef]
  428. Paul, S.; Sasikumari, C.S.; Singh, A.R. Fabrication of silver nanoparticles synthesized from Ganodermalucidum intothecottonfabric and its antimicrobial property. Int. J. Pharm. Pharm. Sci. 2015, 7, 53–56. [Google Scholar]
  429. Adebayo, E.A.; Azeez, M.A.; Alao, M.B.; Oke, M.A.; Aina, D.A. Mushroom Nanobiotechnology: Concepts, Developments and Potentials. In Materials Horizons: From Nature to Nanomaterials; Springer: Berlin/Heidelberg, Germany, 2021; pp. 257–285. [Google Scholar] [CrossRef]
  430. Gudikandula, K.; Vadapally, P.; Charya, M.A.S. Biogenic synthesis of silver nanoparticles from white rot fungi: Their characterization and antibacterial studies. Open Nano 2017, 2, 64–78. [Google Scholar] [CrossRef]
  431. Baymiller, M.; Huang, F.; Rogelj, S. Rapid one-step synthesis of gold nanoparticles using the ubiquitous coenzyme, NADH. Matters 2017, 3, e201705000007. [Google Scholar] [CrossRef]
  432. Hietzschold, S.; Walter, A.; Davis, C.; Taylor, A.A.; Sepunaru, L. Does nitrate reductase play a role in silver nanoparticle synthesis? Evidence for NADPH as the sole reducing agent. ACS Sustain. Chem. Eng. 2019, 7, 8070–8076. [Google Scholar] [CrossRef]
  433. Baker, S.; Rakshith, D.; Kavitha, K.S.; Santosh, P.; Kavitha, H.U.; Rao, Y.; Satish, S. Plants: Emerging as nanofactories towards facile route in the synthesis of nanoparticles. Bio Impacts 2013, 3, 111–117. [Google Scholar]
  434. Liu, K.; Liu, Y.; Lu, J.; Liu, X.; Hao, L.; Yi, J. Nanoparticles prepared by polysaccharides extracted from Biyang floral mushroom loaded with resveratrol: Characterization, bioactivity and release behavior under in vitro digestion. Food Chem. 2023, 426, 136612. [Google Scholar] [CrossRef] [PubMed]
  435. Zhang, Z.; Ge, M.; Wu, D.; Li, W.; Chen, W.; Liu, P.; Zhang, H.; Yang, Y. Resveratrol-loaded sulfated Hericium erinaceus β-glucan-chitosan nanoparticles: Preparation, characterization and synergistic anti-inflammatory effects. Carbohydr Polym. 2024, 332, 121916. [Google Scholar] [CrossRef] [PubMed]
  436. Ansari, M.A. Nanotechnology in Food and Plant Science: Challenges and Future Prospects. Plants 2023, 12, 2565. [Google Scholar] [CrossRef]
Nutrients 16 02682 g001
Figure 1. Overview of the different health-enhancing benefits exhibited by edible mushrooms reported in different in vitro and in vivo models.
Figure 1. Overview of the different health-enhancing benefits exhibited by edible mushrooms reported in different in vitro and in vivo models.
Nutrients 16 02682 g001
Nutrients 16 02682 g002
Figure 2. Schematic representation of C. elegans as a model to study the overall mechanisms of action of biomolecules isolated from mushrooms. The different biomolecules from mushrooms can modulate different transcription factors, including DAF-16 and SKN-1, regulate stress resistance, and improve anti-aging and neuroprotective potential.
Figure 2. Schematic representation of C. elegans as a model to study the overall mechanisms of action of biomolecules isolated from mushrooms. The different biomolecules from mushrooms can modulate different transcription factors, including DAF-16 and SKN-1, regulate stress resistance, and improve anti-aging and neuroprotective potential.
Nutrients 16 02682 g002
Nutrients 16 02682 g003
Figure 3. Schematic representation of the impact of dietary inclusion of mushrooms and their protective effects against neurodegenerative, neuropsychiatric, and neuronal inflammation-mediated disorders. Mushroom bioactives are able to improve NRF levels and thereby reduce the levels of ROS and improve neuronal outgrowth.
Figure 3. Schematic representation of the impact of dietary inclusion of mushrooms and their protective effects against neurodegenerative, neuropsychiatric, and neuronal inflammation-mediated disorders. Mushroom bioactives are able to improve NRF levels and thereby reduce the levels of ROS and improve neuronal outgrowth.
Nutrients 16 02682 g003
Table 1. The beneficial activities of various mushroom-derived compounds are summarized based on the various in vitro models used and the mechanisms of action.
Table 1. The beneficial activities of various mushroom-derived compounds are summarized based on the various in vitro models used and the mechanisms of action.
Mushroom NameCell Line UsedExtract/
Compound		Protective EffectsMechanismReferences
Agaricus blazei Murillprimary macrophage from rat bone marrowAqueous extract-Induced macrophage activity via promoting cytokine and NO secretion[17]
HEP-2 cellsAntiviral activity against herpes simplex type 1 (HSV-1) and bovine herpes type 1 (BoHV-1)-[18]
Isolated polysaccharideAntiviral activity against poliovirus infection, Poliovirus type 1-induced infection-[19]
U937, MOLT4, HL60 and K562Agaritine, β-N-(γ-l(+)-glutamyl)-4-(hydroxymethyl) phenylhydrazineAntitumor
activity		Inhibited tumor cell proliferation [20]
Vero cellsSulfated polysaccharidesAntiviral activity against Herpes simplex virus, HSV-1 KOS and 29 R, and HSV-2 333-induced infection-[21]
MCF-7ErgosterolAnticancer
activity		Induced cancer cell apoptosis and inhibit cell growth[22]
Agaricus bisporusLNCaP, PC3, and DU145 cell linesConjugated linoleic acidAnticancer
activity		Inhibited prostate cancer cell proliferation[23]
Murine J774A.1 macrophages, murine Sarcoma 180 cells, and human cancer cell lines (MCF-7, HT29, DU145 and CRL-1739)PolysaccharidesAnticancer
activity		Induced macrophage activation and inhibit cancer cell growth[24]
Caco-2 cellsAnti-inflammatory and antioxidant activity, LPS- and TNF-α-induced inflammation-[25]
THP-1 cells Immunomodulatory effectActivation of pro-inflammatory cytokine production[26]
Auricularia auricula-judaeA549 cellsLectin
(Ammonium-sulfate fractionation)		AntitumorModulation of JUN, TLR4, and MYD88 expression[27]
HeLa cellsChloroform extract Anticancer activity-[28]
HCT-15, huh-7, SK-MEL-5, SNU-213, and SNU-484 PolysaccharideAnticancer activityAnticancer cell proliferation and anti-oxidative enzyme. Inhibition of the peroxiredoxin 1 pathway[29]
Ba/F3 TPR-Met and Ba/F3 TPR-TrkB cell linesEthyl acetate extractAnticancer activityInhibition of cancer cell growth via suppressing tropomyosin receptor kinase B activity. Obstruction of auto-phosphorylation of TrkB[30]
HepG2 cellsAuricularia auricula polysaccharide-3-1Antioxidant activityReduction of reactive oxygen species production, malondialdehyde, and increased activities of superoxide dismutase, glutathione peroxidase, and catalase[31]
Auricularia polytrichaA549 and 3T3-L1 cellsPolysaccharides
(Ethanol extraction)		Anticancer activityInhibition of cancer cell proliferation and induced cell apoptosis. Increased p53 and p21 levels and decreased cyclin A, cyclin D, and CDK2 expression[32]
BV2 and HT-22 cellsErgosterol
(Hexane and ethanol extraction)		Anti-inflammatory and antioxidant activities Increased SOD-1 expression and modulation of the NF-κB signaling pathway in BPA-induced inflammation[33,34]
Antrodia camphorateMCF-7 and HBL100 cellsFermented culture brothAnticancer activityInhibition of cell viability, chromatin condensation, inter-nucleosomal DNA fragmentation, and sub-G1 phase accumulation[35]
MDA-MB-231 cellsAntimetastatic activitiesInhibition of MMP-9, MMP-2, uPA, uPA receptor (uPAR), and vascular endothelial growth factor (VEGF) and suppression of phosphorylation of ERK1/2, p38, and JNK1/2[36]
HER-2/Neu-overexpressing SKOV-3 cells and human ovarian surface epithelial (IOSE) cellsAnticancer activityInhibition of HER-2/Neu activity, tyrosine phosphorylation, activation of PI3K/Akt and their downstream effector β-catenin[37]
RAW 264 cells (LPS induced)Anti-inflammatory activityReduced tumor necrosis factor (TNF-α) and interleukin (IL)-1β levels and decreased cytokine, iNOS, and COX-2 expression by blocking NF-κB activation[37]
HT-29 cellsFive lanostanes (2, 3, 4, 6, and 8) and three ergostane types (1, 5, and 7) triterpenes. (Chloroform extraction)Anticancer activityInduced cytotoxicity and sub-G1 cell cycle arrest[38]
MDA-MB-23, A549, and HS68 cellsTwelve ergostanoids, named antcamphins A–L (1–12), together with 20 known triterpenoids. (95% ethanol extraction).Anticancer activityInduction of cytotoxicity[39]
MCF-7, MDA-MB-231, MCF10A, and HS-68 cellsAntrocinAnticancer activity Induction of cleavage of caspase-3 and poly (ADP-ribose) polymerase, reduced Bcl-2 and Bcl-xL, and suppressed phosphorylation of Akt and the activities of its downstream effectors mTOR, GSK-3β, and NF-κB [40]
CL1-0, CL1-5, A549, H1975, H441, PC9, and BEAS-2B cellsAnticancer activityIncreased expression of caspase-3, increased Bax/Bcl2 ratio, and downregulated the JAK/STAT signaling pathway[41]
HTB-4 cell linePhosphate-buffered saline (PBS) at the ratio of 1:25 (w/v)Anticancer and anti-metastatic activitiesInhibited MMP-9 and induced phase G2M arrest[42]
Huh7, HepG2, and Hep3B cell linesAntcin A, antcin C, and methyl antcinate A Anticancer activityInduced sub-G1 population, DNA fragmentation, TUNEL-positive cells, and caspase activation[43]
LNCaP, PC-3, and MEF cell linesEthanol extractionAnticancer activityInduced G1/S phase arrest, inhibited cyclin D1 activity, and prevented pRb phosphorylation[44]
MCF7, T47D, MDA-MB-231, MCF10A, and IMR-90 cell linesAntroquinonol DAnticancer activityInhibited DNMT1 methyltransferase activity[45]
Human erythrocytesAqueous extractionAntioxidant activity Increased glutathione (GSH) and ATP levels in peroxyl radical [2,2′-Azobis(2-amidinopropane) dihydrochloride, AAPH]-induced oxidation[46]
COLO 205 cell line5-Substituted 4,7-dimethoxy-1,3-benzodioxoles (compounds 1–9) (Ethyl acetate extraction)Anticancer activity Induced G0/G1 cell cycle arrest and increased p53, p21, and p27 levels[47]
PC12 cell line (6-hydroxydopamine-induced)95% ethanol extractionNeuroprotective Reduced the loss of dopaminergic neurons. Increased tyrosine hydroxylase (TH) and dopamine transporter (DAT) levels and reduced α-synuclein levels[48]
Boletus edulisLS180 and CCD 841 CoTr cell lines Biopolymers (polysaccharides and glycoproteins)Anticancer activityInduced G0/G1-phase arrest and inhibited the p16/cyclin D1/CDK4-6/pRb pathway[49]
Ribonucleic acidAnticancer activityIncreased Bax, TP53, and CDKN1A levels[50]
MDA- MB-231 and Ca761Cold water-soluble polysaccharide (BEP); galactose, glucose, xylose, mannose, glucuronic, and galacturonic acidAnticancer activityInduced Bax/Bcl-2 ratios, the release of cytochrome C, and activated the expression of caspase-3 and caspase-9[51]
MCF-7, SMMC-7721,hHL-60, SW480, and A549 cellsNon-isoprenoid botryane sesquiterpenoids, named boledulins A-C (1–3)Anticancer activity-[52]
MCF-7, HepG-2, CaCo, CFPAC, Hela, U-87, HT-29, SK-MEL-28, and A549 cellsBoletus edulis lectin (BEL) β-trefoil (Aqueous extraction)Antineoplastic properties-[53]
BEL-7402, HT-299, SPC-A1, and U-251 cells5-Cholestene-2,3-oxide, β-sitosterol, and stigmasterolAnticancer activityInduced cytotoxicity[54]
MCF7, HT-29, HUH-7, and L929 cellsAqueous extractionAnticancer, antimicrobial, and wound-healing activities-[55]
RAW264.7 cellsPolysaccharide (BEP)Immunomodulatory activityInduced phagocytosis and NO, IL-6, and TNF-α secretion[56]
Flammulina velutipesA549Fungal immunomodulatory protein-five (FIP-fve)Anticancer activityInduced p53 and p21 expression and inhibited EGF-induced activation of Rac1 via decreasing RACGAP1 mRNA and protein levels[57]
MCF7 and MDA-MB231 cells5% ethanol extractionAnticancer activityInduced DNA damage (γ-H2AX foci formation), G2/M phase arrest, cytochrome c release, and caspase cleavage activity[58]
BGC-823 and A549 cellsPolysaccharide (FVP-1 and FVP-2)
(Ultrasonic-assisted extraction)		Anticancer activity and antiproliferative activity-[59]
MCF-10a, MCF-7, and MDA-MB-23 cellsAqueous and methanol extractionAntiproliferative and antioxidant activities-[60]
RAW264.7, L929, and B16F10 cellsPolysaccharide (FVSP-1, FVSP-2 and FVSP-3) (Ultrasonic-assisted extraction)Anticancer activity and antiproliferative activity-[61]
SGC and LoVo cellsErgosterol and 22,23-dihydroergosterol Induced cytotoxicity[62]
HeLa and LS174 cellsEthanol extractionAntioxidant activity-[63]
HL-60, HeLa, rc ts-NRK, and FM3A cells.Enokipodins A, B, C, and DAnticancer activity-[64]
L929 cellsPolysaccharidesAntioxidant activityReduced reactive oxygen species (ROS) production[65]
HepG2 and L02 cellsAnticancer activityInduced ER stress via increasing intracellular Ca2+ concentrations by activating the phospholipase C–inositol-1,4,5-triphosphate (PLC-IP3) pathway[66]
K562 cellsFVPA1 (a novel polysaccharide)Immunomodulatory activityInduced natural killer cell activity[67]
PC12 cells (H2O2 induced)Flavonoids (arbutin, epicatechin, phillyrin, apigenin, kaempferol, and formononetin)Antioxidant propertiesIncreased cell viability, glutathione levels, and superoxide dismutase activity[68]
Ganoderma lucidumMDA-MB-231 and PC-3 cellsAqueous extractionAnticancer activityInduced AP-1 and NF-κB expression and inhibited urokinase-type plasminogen activator (uPA) expression[69]
IOSE-398, OV2008, C13*, A2780s, A2780-cp, and SKOV-3 cell line.Anticancer activityInduced cell cycle arrest at the G2/M phase and activated caspase-3 and p53 levels[70]
MCF-7 cell lineethanol extractionAnticancer activityInduced cell cycle arrest and apoptosis via increasing p21/Waf1 and decreasing cyclin D1 levels[71]
SW 480 cell linepolysaccharides and triterpenoidAnticancer activity and antioxidant activityInhibited cell proliferation[72]
HUC-PC model95% ethanol extraction Induced cell apoptosis, inhibited telomerase activity, and increased oxidative stress[73]
95-D, SMMC7721, KB-A-1, KB-3-1, and HeLa cells and human normal cell lines HLF and L-02 Ganoderic acid T (GA-T), a lanostane triterpenoidAnticancer activityInduced cell cycle arrest at the G1 phase and increased p53 and Bax levels, while decreasing the Bcl-2/Bax ratio[74]
RAW264.7 cellsTriterpeneAnti-inflammatory activityDecreased tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), inflammatory mediator nitric oxide (NO), and prostaglandin E2 (PGE2) levels[75]
BV-2 cellsGanoderenic acid C, ganoderic acid C2, ganoderic acid G, ganoderenic acid B, ganoderic acid B, ganoderic acid A, ganoderic acid H, ganoderenic acid D, ganoderic acid D, ganoderic acid F, and polysaccharidesAnti-inflammatory activityDecreased G-CSF, IL1-α, MCP-5, and MIP3α, with a higher effect on MIP3α levels, and reduced mRNA expression of CHUK, NFκB1/p150, and IKBKE (NFƙB signaling)[76]
RAW 264.7 cell line, inflamed colonic biopsy specimens of patients with Crohn’s disease and Human Peripheral Blood Mononuclear CellsTriterpene ganoderic acid C1 (GAC1) -Reduced TNF-α, IFN-γ, and IL-17A production and inhibited the NF-κB signaling pathway[77]
PC12 (corticosterone-induced) and RAW264.7 cells (LPS induced)Aromatic compounds (lucidumins A-D and lucidimine E)Neuroprotective and anti-inflammatory activities-[78]
RAW264.7 cellsTriterpenes (butyl lucidenateE2, butyl lucidenateD2 (GT-2), butyl lucidenate P, butyl lucidenate Q, Ganoderiol F, methyl ganodenate J, and butyl lucidenate N)Anti-inflammatory activityInduced HO-1 expression via the PI3K/AKT-Nrf2 pathway and decreased tumor necrosis factor-α, interleukin-6, nitric oxide synthase, and cyclooxygenase-2 expression[79]
Ergostane-type steroids, C28 steroidsAnti-inflammatory activityReduced nitric oxide production[80]
HaCaT cellsGanoderic acidsAntioxidant, antidiabetic, and anti-inflammatory activitiesDecreased the response to inflammation-related cytokines at the mRNA level[81]
Ganoderma resinaceumBV-2 cellsLanostane triterpenoids (ganoresinoids A-D) and meroterpenoid (ganoresinoid E)Anti-inflammatory, antioxidant, and anti-apoptosis activities Reduced nitric oxide (NO), IL-1β, IL-6, and TNF-α levels and inhibited the TLR-4/NF-κB and MAPK signaling pathways[82]
Ganoderma duriporaRAW 264.7 cellsFarnesyl phenolic compounds, ganoduriporols A and B Anti-inflammatory activity Inhibited tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) through suppression of the COX-2, MAPK, and NF-κB signaling pathways[83]
Ganoderma sinenseErgosterols, ganocalidophins A–C (1–3)Anti-inflammatory activity Inhibited NO production[84]
Hericium erinaceusChago-K1PeptidesAnticancer activityScavenged free radicals, induced apoptosis, and increased caspase-3, -8, and -9 levels[85]
FHC and HCT-116 cell linesPolysaccharideAnticancer activityInhibited the growth of colon cancer cells and induced S phase cell arrest[86]
RAW264.7 cell lineImmunomodulatory effectsIncreased NO, IL-6, and TNF-α production[87]
PC12 cell lineAntioxidant and neuroprotective effectsReduced ROS production and increased mitochondrial membrane potentials in amyloid beta-induced neurotoxicity[88]
GES-1 cell lineAntioxidant activityInduced cell proliferation, inhibited cell necrosis, reduced ROS levels, regulated mitochondrial membrane potential, and maintained mitochondrial membrane permeability in H2O2-induced oxidative damage[89]
MCF-7 cell lineAqueous extractionAnticancer activityInduced cell apoptosis and G1 cell cycle arrest and changed the expression of a total of 362 transcripts[90]
GES-1 and MC cell linesPolysaccharide (EP-1)Anticancer activityInduced cell apoptosis and cell cycle arrest at the G0/G1 phase and regulated Bax, Bcl-2, and caspase-3 levels[91]
SGC-7901 cell linePolysaccharide-protein HEG-5Anticancer activity Reduced Bcl2, PI3K, and AKT1 levels and increased caspase-8, caspase-3, p53, CDK4, Bax, and Bad expression[92]
EA hy926 cell lineEthanol extractionAnticancer activity Inhibition of antiangiogenic and antioxidant potentials and regulated the MMP-9/NF-κB and Nrf2-antioxidant signaling pathways[93]
U937 cell lineHot water (HWE), microwaved 50% ethanol (MWE), acidic (ACE), and alkaline (AKE) extractsAnticancer activityInduced the activation of mitochondria-mediated caspase-3 and caspase-9[94]
K562, LANCAP, and HEP2 cell linesDiterpene, 4-chloro-3,5-dimethoxybenzyl alcohol, 7α, 8β, 11-trihydroxydrimane, 3-acetyl-4-methoylbenzoic acid, 1-(5-chloro-2-hydroxyphenyl)-3-methyl-1-butanone, and 4-chloro-3, 5-dimethoxybenzoic acidAntibacterial activity and anticancer activityInhibited the growth of Helicobacter pylori[95]
U87 cell lineErinacerin O and erinacerin P, novel glioma inhibitorsAntitumor activityInduced the apoptosis rate, reduced DNA replication, and regulated the Bax/capase-3 pathway[96]
SH-SY5Y, 1321N1, Caco-2, HCT-116, OVK18, and HeLa cellsIsoindolin-1-ones, named erinacerins (M–N) Anticancer activity-[97]
Inonotus obliquusB16–F10 cell lineWater extractAntiproliferation G0/G1 cell cycle arrest. Reduction of cyclin E/D1 and Cdk 2/4 expression[98]
3LL cell lineHot water extractAnticancer activity-[99]
HT-29 cell lineAntitumor activity Induced apoptosis, inhibited tumor growth by regulation of Bcl-2, Bax, and caspase-3[100]
A549, H1264, H1299, and Calu cell linesChagabusone A and triterpenoids Anticancer activity-[101]
PC3 and MDA-MB-231 cell linesEthyl acetateAntiproliferation-[102]
RINm5F cellsPolysaccharidesAntioxidant activityInhibited insulin secretion, regulation of caspase-3, Bax, Bcl-2, NF-κB, and
MAPKs		[103]
HepG2 cellsHypoglycemic activity-[104]
SMMC7721, and Jurkat cell linesAntitumor activity-[105,106]
Lentinula edodesMRC-5 and A549 cell linesPolysaccharides:
branched
α-(1,4)-glucan (L10		-Induced THP-1
differentiation,
increased superoxide and interleukin-8, RANTES production,
decreased
angiogenin and vascular endothelial growth factor,
regulation of TLR-4/MyD88/
IKK/NFkB		[107]
Lignosus rhinocerosORL-204 cell lineHigh-molecular-mass fraction (HMM)Anti-oral cancer activityModulated tumor necrosis factor (TNF) cell signaling leading to apoptosis, proliferation inhibition (cell cycle arrest), and immunomodulation[108]
MCF-7 and A549 cell lineAntiproliferative activity-[109]
MCF-7 cell lineProtein fraction termed F5Anti-breast cancer activityIncreased extrinsic and intrinsic apoptotic pathways[110]
PC12 cell linePeptides (Thr-Leu-Ala-Pro-Thr-Phe-Leu-Ser-Ser-Leu-Gly-Pro-Cys-Leu-Leu) (Crude protein extract)Neuroprotective effectsNeuroprotective effects against 6-hydroxydopamine-induced toxicity. Enhanced cellular antioxidant activity and inhibited nuclear factor-kappa B (NF-κB) activation[111]
Water and ethanol extractsCytoprotective effectsCytoprotective effects against hydrogen peroxide (H2O2)-induced oxidative stress. Decreased apoptosis via inhibition of caspase-3/7 activities[112]
Hot water and ethanol extracts, and isolated polysaccharideNeuroprotective effectsNeurite outgrowth stimulatory effect. Upregulated the MEK/ERK1/2 signaling pathway[113]
HT22 cell lineEthanol extractAntioxidant activityProtective effects against glutamate-induced toxicity
Increased antioxidant-related genes, including catalase (CAT), superoxide dismutase (SOD1 and SOD2), and glutathione peroxidase (GPx)		[114]
(hESC)-derived neural lineagesMethanol extract-Protection against dexamethasone (DEX)-induced toxicity. Inhibited apoptosis and reduction of phospho-Akt (pAkt) levels[115]
Neuro-2a and PC-12 cell lineWater extract-Neurite outgrowth stimulatory effect[116,117]
NHDF cell line F5 thermoresponsive gelWound-healing activity-[118]
Pleurotus citrinopileatusCaco-2 cellsSphingolipids-Colon injury suppression. Reduced LPS-induced cell death by inhibiting apoptosis-related proteins[119]
HepG2 and HeLa cell linesMethanol extractAntitumor activityInduced apoptosis and cell cycle arrested at the G1 and G2/M phases[120]
HepG2 cell lineCrude polysaccharide-peptidesHepatoprotectionReduced high-fat diet-induced hepatocyte injury by inhibiting lipid accumulation and enhancing SOD enzymatic activity and the adiponectin pathway[121]
U937 cell lineA non-lectin glycoproteinAntitumor activity and immune modulationInduced a shift of T helper cells toward Th 1 response by activating TNF-R, IFN-γ, and IL-2 secretion and indirect inhibition of cell growth[122]
K562, HCT116, DU-145, and PC-3 cell linesSesquiterpenoidsAntidiabetic and antitumor activities.Reduced cancer cell viability and inhibited the protein tyrosine phosphatase 1B enzymatic activity[123]
Pleurotus eryngiiAna-1 cell lineAdenosineImmunomodulatory activityIncreased the proliferative rate of Aha-1 cells and elevated TNF-α and IL-6 levels [124]
U937 cell lineUbiquinone-9Antitumor activityInduced apoptosis by inhibiting DNA topoisomerase I activity[125]
3T3-L1 cell lineChloroform extractAnti-adipogenic activityLipid accumulation was inhibited in adipocytes by targeting PI3K/Akt/mTOR signaling, which resulted in PPAR γ and C/EBP suppression[126]
RBL-2H3 cell lineEthanol extractAllergic prevention and anti-inflammation activityDecreased pro-inflammatory cytokines and histamine levels by inhibiting NFAT-, NF-кB-, and FceRI-mediated signaling[127]
PBMCs and U937 cell linesPowderImmunomodulatory activityIncreased activated Th2 cells, dendritic cells, and macrophages in PBMCs and regulated TNF-α and IL-10 levels[128]
RAW 264.7 cell linePolysaccharidesImmunomodulatory activityProduced nitric oxide, TNF-α, IL-1, and IL-6 through the p38, JNK, and MAPK signaling pathways[129]
HepG2 cell lineAntitumor activity-[130]
Hypoglycemic activity. Restored insulin resistance by activation of the PI3K-Akt signaling pathway[131]
Mouse-derived dendritic cellsImmunomodulatory activityImmunomodulation by increasing the production of nitric oxide and TNF-α levels. Cytokines were activated through TLR2/TLR6 and dectin-1 receptors induced by β-glucan[132]
A549, BGC-823,
HepG2,
HGC-27, and RAW264.7 cell lines		Protein fractionsAntitumor activity and immunostimulant activityInduced cytotoxicity against cancer cells and stimulated lysosome activity, pinocytosis, and nitric oxide production in RAW264.7 cells with no toxicity against normal liver cells[133]
Pleurotus ostreatusMCF-7 cell lineSilver nanoparticles (Biomass)Antitumor activityInhibition of cell growth[134]
MDA-MB-231, MCF-7, MCF-10A, HCT-116, HT-29, and FHC cell linesMethanol extractAntitumor activityInhibited the cell cycle at the G0/G1 phase of breast
and colon cancer cells via p53-dependent as well as p53-independent pathways		[135]
PC12 cell line PolysaccharidesNeuroprotective effectsAmeliorated PC12 cells from H2O2-induced oxidative damage through the PI3K/Akt signaling pathway and inhibited
apoptosis-related pathway proteins		[136]
Vero, MCF-7,
HepG2, CaCo-2, and HeLa cell lines		Polar extractAntitumor activityInduced cell cycle arrest in the sub-G1 stage and apoptosis. Expression of TNF-α was increased while IL-6 expression was decreased[137]
RAW264.7 cell line Ultrasonication and heatingAnti-inflammation activityInhibited nitric oxide and TNF-α production in LPS-induced inflammation macrophages[138]
Water extractAnti-inflammation activitySuppressed LPS-induced secretion of tumor necrosis factor-a (TNF-a, interleukin-6 (IL-6), and IL-12p40[139]
Selenium-enriched polysaccharidesImmunomodulationInduced macrophages to produce proinflammatory cytokines (NO, ROS, TNF-α, IL-1β, and IL-6) by activating the NF-κB pathway[140]
HepG2, MCF-7, SKOV3, HeLa, and PC-3, L02, MCF-10A, and IOSE cell linesAntitumor activityInduced apoptosis by disrupting the Bax/Bcl-2 protein ratio and inhibiting the epithelial-to-mesenchymal transition[141]
SW480 cell line Water-soluble
protein extract		Antitumor activityInduced apoptosis in cells partially through ROS production, GSH depletion, and mitochondrial dysfunction[142]
Pleurotus pulmonariusHuh7, Hep3B, and SMMC-7721 cell linesPolysaccharide-protein complexAntitumor activityInhibited cell growth, colony formation, and invasion by suppressing the PI3K-Akt signaling pathway[143]
Trametes versicolorHeLa and Jukart cell linesPSKAntiproliferationG0/G1 cell cycle arrest, direct cytotoxicity.
Increased lymphocyte proliferation (synergistic with IL-2)		[144]
AGS, A549, B16, and Ando-2 cell lines-Induced apoptosis by regulating caspase-3
HeLaCold buffer extractAnticancer, antiproliferation-[145]
4T1 cell linePolysaccharidesAntitumor,
Antimetastasis,
Immunomodulation		-[146]
MOLT4 cell linePSPAntitumorInhibited cancer cell growth, S phase arrest, and induced apoptosis[147]
PBMC cell line -Increased proliferation, IL-1β, TNF-α, and IFN-γ
-Increased monocyte numbers by possible regulation of TLR2/6/4 and Dectin-1[148]
LN-CaP
cell line		Ethanol extractAntiproliferationReduced secretion of prostate-specific antigen (PSA) in an androgen receptor-independent manner[149]
PC-3 and DU-145 cell linesModest antiproliferation
Table 2. The beneficial activities of various mushroom-derived compounds are summarized based on the mammalian model used and the mechanism of action.
Table 2. The beneficial activities of various mushroom-derived compounds are summarized based on the mammalian model used and the mechanism of action.
Mammalian ModelMushroom NameExtract/
Compound		Protective EffectsMechanismReferences
MiceAgaricus blazei Murill 1,6-beta-glucanAntitumor activity in sarcoma 180-bearing ICR mice-[151]
Agaricus brasiliensisSodium pyroglutamateAnti-angiogenic and antimetastatic activityInhibited tumor growth.
Increased CD8+ T and natural killer cell levels and von Willebrand factor expression		[152]
β-glucanAntitumor activityInhibited tumor growth, reduced IL-10 levels, and induced IFN-gamma production[153]
Hot water and cold water extractsAntitumor activityAntitumor effect, and increases in CD4+ T and natural killer cells were observed. Reductions in cholesterol levels and blood glucose levels were also observed in sarcoma 180-bearing ICR mice and
LPS and Concanavalin A-induced inflammation and hepatic injury, respectively, in Balb/c mice		[154]
Aqueous extraction-Prevention of allergy via reducing cytokine levels. Reduction of anti-OVA Ig-E levels and Th2 relative to Th1 cytokine levels in ovalbumin-induced allergy in NIH/OlaHsd, C57Bl/6, and BALB/c mice[155]
Fucogalactan-Antinociceptive activity in acetic acid-induced abdominal contraction in male Swiss mice[156]
Agarol (an ergosterol derivativeAnticancer activityInduced cancer cell apoptosis and anti-tumor activity.
Increased ROS production, AIF levels, and Bax levels, and decreased Bcl-2 levels in SCID mice		[157]
Agaricus bisporusAqueous extractionAntitumor activityInhibited tumor growth and increased tumor cell apoptosis in BALB/c Nu-Nu athymic mice[23]
Antitumor activityInhibited tumor growth and induction of nuclear factor-κB with the production p50/105 heterodimers in male C57BL/6 murine sarcoma model (injected 180 cells)[24]
Anticancer activityInhibition of cancer cell proliferation via suppression of androgen receptor and cell cycle progression in male intact C57BL mice and tumor-derived xenograft/PDX tumor-implanted male NSG intact mice. [158]
Auricularia auricula-judaeAuricularia auricula judae polysaccharide-cisplatin complex (AAP-CDDP)Anticancer activityUpregulation of Bax, cytochrome-c, and caspase-3, downregulated Bcl-2 expression, and induced superoxide dismutase, catalase, and glutathione peroxidase activities. A decrease in mitochondria potential was also observed.
(HeLa (cervical cancer) cell line-induced cancer in female BALB/c mice).		[159]
β-D-glucanAnticancer activityInduction of apoptosis through upregulated Bax and downregulated Bcl-2 expression. (Sarcoma 180 (S-180) tumor cell-induced cancer in male BALB/c mice).[160]
Aqueous extraction-Enriched the arginine biosynthesis pathway.
Changed the gut microbiota composition.
(C57BL/6J male mice)		[161]
Melanin-Inhibition of CYP2E1 and activation of Nrf 2 along with its downstream antioxidase. Reduction of ALT, AST, TG, and MDA levels and increased antioxidant enzyme levels, such as ADH, SOD, and CAT. (50% ethanol-induced acute alcoholic liver in male C57BL/6 mice)[162]
Polysaccharide (hot water and ultrasonic-assisted extraction)Anticholestrimic effectReduction of serum total cholesterol and low-density lipoprotein cholesterol levels. Increased total antioxidant capacity and lipoprotein lipase activity.
(Cholesterol-enriched diet-fed male ICR mice)		[163]
Polysaccharide (methanol extraction)-Significantly accelerated wound closure through fibroblast and keratinocyte proliferation, migration, and invasion. Promotion of collagen synthesis and reduction of E-cadherin expression[164]
Auricularia cornea var. Li. (an evolutionary varieties of A. auricula-judae)Polysaccharide-Inhibition of aldose reductase and CYP2E1 as well as protein expression of iNOS and COX-2 in ADL mice model. Furthermore, expression of pro-inflammatory players, such as IL-1β, TNF-α, and IL-6, was found to be decreased, and SOD, GSH-Px, and CAT were found to be modulated. [165]
Auricularia polytrichaPolysaccharides (APPIIA)Antitumor activityAntitumor effect and induced macrophage activation. (180 cells injected in male BALB/c albino mice)[166]
Polysaccharides-Decreased Bax and caspase-3 expression, increased Bcl-2 expression, and anti-fibrosis effect. Protection against chronic kidney diseases.[167]
95% ethanol extractionHepatoprotective activityModulation of ALT and AST activities, impeded the TLR4/NF-κB and caspase signaling pathways, and induced the Keap1/Nrf2 signaling pathway to promote a hepatoprotective effect in dextran sulfate sodium-induced ulcerative colitis in specific pathogen-free ICR male mice.[168]
Antrodia camphorateFermented culture broth-Decreased tumor size. Reduction of cell proliferation markers such as cyclin D1 and PCNA. Reduction of Bcl-2, which resulted in the promotion of apoptosis.[169]
Phosphate-buffered saline (PBS) at the ratio of 1:25 (w/v)Hepatoprotective activityReduction of plasma aspartate aminotransferase (GOT) and alanine aminotransferase (GPT) levels and induced the activities of SOD, glutathione, and catalase in CCl4-induced liver toxicity in male ICR mice.[170]
4,7-Dimethoxy-5-methyl-1,3-benzodioxoleAnticancer activityInduced p53-mediated p27/Kip1 protein and reduced cyclin D1, D3, and A levels in COLO-205 human colon cancer cell-injected BALB/c nu/nu mouse.[171]
Ergostatrien-7,9(11),22-trien-3β-ol-Reduction of p65NF-κB and caspase-3 expression, induced PI3K/Akt, as well as inhibited GSK-3 levels in transient focal cerebral ischemia-induced male ICR mice[172]
Boletus edulisPolysaccharide Antitumor activityReal (BUN and creatin) and liver (AST and ALT) damage parameters were found to be significantly reduced in treated mice.
Acted as a mitogen in tumor-bearing mice.
Induction of antitumor activity through cytotoxic lymphocytes (NK and CTL cells).
Increased secretion of IL-2 and TNF-α.		[173]
Anti-asthmaticRestoration of lung pathology, reduced IL-4 and IFN-γ levels, and increased CD4+CD25+FOXP3+ Treg cells in ovalbumin-induced asthma in female BALB/c mice. [174]
Isolated protein (BEAP)Antitumor activitySignificantly decreased PARP and caspases-3, -8, and -9. Increased the Bax/Bcl-2 ratio, implying a tumor reduction through induction of apoptosis in A549 cell-injected female BALB/c nude mice.[175]
Fungal nitrite reductase-Inhibited nitrite-induced toxicity by reducing nitrite in blood, hence increasing the lifespan of sodium nitrite toxicity-induced male Kunming mice[176]
A water-soluble polysaccharide (BEBP); BEBP-1, BEBP-2, and BEBP-3-Increased SOD and decreased MDA levels in the serum of Kunming mice with D-galactose-induced oxidation.[177]
Flammulina velutipesStarch-free β-type glycosidic polysaccharideGut protection Reduction of morphological and physiological changes in the colon. Reduction of pro-inflammatory cytokines such as TNF-α, IL-6, MCP-1, and MIP-1α and increased the relative expression of tight junction proteins such as claudin-1, occludin, and zonula occludens. Dramatic change in gut microbiota was also observed in dextran sulfate sodium (DSS)-induced colitis in C57BL/6J male mice.[178]
Polysaccharide/polysaccharides consisting of glucose linked with β-glycosidic bonds.Gut protectionInduced production of short-chain fatty acids. Improved gut microbiota through immunomodulation of expression of TNF-α, IF-γ, IL-6, and IL-8. [179,180]
Sulfated polysaccharides (SFPS)Anti-agingDecreased levels of ALT, AST, and ALP (liver toxicity index) as well as CRE, BUN, and UA (kidney toxicity index). Improved lipid metabolism and resisted aging as well as organ damage induced by d-galactose in male Kunming strain mice.[181]
PolysaccharidesNeuroprotective activityReduction of IL-1β, TNF-α, IL-6, and IL-10 levels and decreased escape latency and total swimming distance in scopolamine-induced learning and memory impairment in male mice (C57BL/6).[180]
Gut protectionProtective effect by activation of the Akt/GSK3β/Nrf-2/HO-1 signaling pathway and modulation of gut microbiota against Pb-induced toxicity in SPF-grade Kunming male mice.[182]
Antidiabetic activity Modulation of the PI3K/Akt signaling pathway to reduce blood glucose and insulin levels and regulate dyslipidemia.[183]
Hepatoprotective activityHepatoprotection through the reduction of AST, ALT, triglyceride (TG), total cholesterol (TC), and total bile acid (TBA) contents, change in liver histopathology, and decrease in IL-6, IL-1β, and TNF-α levels in carbon tetrachloride-induced hepatic oxidative injury in male C57BL/6 mice.[184]
Immunomodulatory protein (FVE)Antitumor activityIncreased survival and inhibition of tumor size and angiogenesis through regulation of INF-γ in BNL hepatoma cell-injected female BALB/c mice.
Increased MHC class I and II and costimulatory CD80 molecules on peripheral blood mononuclear cells. 		[185]
Ganoderma applanatumTerpenesHepatoprotective activityReduced Cu/Zn-SOD, CAT, GPx, and GST activities, decreased IL-1β and COX-2, and inhibited NF-κB translocation in male Kunming strain mice with benzo(α)pyren-induced oxidative stress and inflammation, hence providing anti-inflammatory activity, antioxidant activity, and hepatoprotective effects.[186]
Ganoderma cochlear(±)-Dispirocochlearoids A–C (1–3), meroterpenoids with a 6/6/5/6/6/6 ring systemAnti-inflammatory activityInhibition of neutrophil and macrophage infiltration, decreased protein concentrations in bronchoalveolar lavage fluid, inhibition of COX-2 in lung tissue, and suppression of PEG2 and proinflammatory cytokines in LPS-induced acute lung injury mice. [187]
Ganoderma tsugae -Inhibition of allergic airway by reducing leukocyte influx, eotaxin levels, histamine levels, and PGE2. No significant reductions in NO and proinflammatory cytokines (IL-1β and IL-6) were observed in ovalbumin (OVA)-induced allergic asthma in female BALB/c mice.[188]
Ganoderma lucidum95% ethanol extraction-Reduction of E-cadherin, mTOR, eIF4G, and p70S6K and activation of extracellular regulated kinase (ERK1/2) levels in SUM-149 cell-injected female severe combined immunodeficient (SCID) mice.[189]
Aqueous extractionAntitumor activityDecreased tumor growth and volume. Regulation of NAG-1. Relative expression of P16 and RB1 (retinoblastoma gene) was found to be significantly increased. Protein mRNA expression of FOXO3a was found to be increased, also the mRNA level of P21 was found to be increased. WEE1and E2F1 mRNA expression was found to be significantly reduced as well as reductions in cyclin D1 and B, PCNA, and Ki67. Dose-dependent reductions in anti-apoptotic gene expression, such as Bcl-2, NF-κβ, and c-FOS, were also observed in HCT116-injected male BALB/C nude mice.[190]
Ganodermanontriol, a lanostanoid triterpeneAntitumor activityTumor volume and weight were found to be reduced and immunohistochemistry revealed a significant reduction in cyclin D1 in HT-29 colon cancer cell-injected male nude immunodeficient mice (nu/nu).[191]
Triterpene acids (lucidenic acids and ganoderic acids) and Sterols (fungisterol, 5,6-dihydroergosterol, ergosterol, ergosterolperoxide, 9(11)-dehydroergosterol peroxide, and demethylincisterolA3)Anti-inflammatory and antitumor activityAnti-inflammatory and antitumor-promoting effects in TPA-induced ear-edema inflammation in specific pathogen-free female ICR mice and 7,12-dimethylbenzene[a]anthracene (DMBA) and TPA-induced two-stage mouse skin carcinogenesis in SENCAR mice.[192]
Beta 1,3/1,6 glucan-Significant production of IgA in serum[193]
Ethanol extractAnti-inflammatoryReduction of malondialdehyde levels. Inhibition of acute and chronic inflammation induced by carrageenan and formalin, respectively, in Swiss albino mice[194]
Ganoderic acid A and ergosterolNeuroprotective activityPromoted motor performance and protected against loss of dopaminergic neuronal cells in MPTP-treated mice (Parkinson’s model). Protective effect through the MPK/mTOR/ULK1 and PINK1/Parkin pathways.[195]
Hericium erinaceusAqueous extraction-The extracts were found to be more active and less toxic compared to 5-FU against HT-29, NCI-87, and Huh-7 xenografts and also significantly delayed tumor doubling time. It showed similar effects in a dose-dependent manner against HepG2 xenograft in SCID mice. Reduction of tumor growth, increased NO, elevated phagocytic activity, and angiogenesis was also significantly inhibited.[196]
Antitumor activityReduction of tumors. Increased NK cell activity and elevated phagocytic activity of macrophages. Inhibition of angiogenesis by inhibiting VEGF, COX-1, 5-LOX, PGE2, and LTB4 in CT-26 colon cancer cell-transplanted in BALB/c mice.[197]
Hot water and microwaved 50% ethanol extractsAntitumor activityHistopathological evidence revealed reductions in tumor nodules and metastasis in lungs. Inhibition of metastasis by decreasing matrix metalloproteinases MMP-2, MMP-9, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) phosphorylation in CT-26 colon cancer cells transplanted in pathogen-free female BALB/c mice.[197]
Polysaccharides-Ameliorated diarrhea, rectal bleeding, reduction in weight, and colitis in 2% DSS (w/v)-induced colitis in male C57BL/6 mice. Suppressed MDA and myeloperoxidase activities, improved T-SOD levels, and IL-β, TNF-α, and IL-6 activities were greatly reduced through the attenuation of NF-κB, AKT, and MAPK phosphorylation. iNOS and COX-2 were found to be decreased in a dose-dependent manner. [198]
Erinacine AAntiproliferative effectAntiproliferative effect observed in DLD-1 cell-injected BALB/c-nu mice could be attributed to the cell cycle G1 arrest induced by the compound in DLD 1 cells (in vitro). ROS, JNK, 1/2MAPK, and mTOR pathways were also found to be involved. [199]
Nine selenium polysaccharide derivatives, sHEP1-sHEP9Immunomodulatory activityInduced DC maturation and increased MHC-II and CD86, phosphorylation of ERK, p38, and JNK, and the nuclear translocation of transcription factors p-c-Jun, p-CREB, and c-Fos in LPS-induced ICR mouse. [200]
70% ethanol extractNeuroprotective activity Significant hippocampal neuroprotection post acute seizures in pilocarpine-induced status epilepticus in male C57BL/6 mice. Increased NeuN-expressing cells. Reduced COX-2-expressing cells. [201]
Inonotus obliquusPolysaccharidesAntitumor activity Tumor growth was found to be reduced 3-fold in treated (ip post-administration) in BALB/c mice. The effect could be attributed to G0/G1 phase cell arrest and activation of caspase-3-mediated apoptosis as observed in in vitro analysis. Proteins p53, pRb, and p27 were found to be decreased in a dose-dependent manner. [98]
Anti-diabetic and Nephroprotective activity Significantly reduced fasting blood glucose levels, insulin tolerance, triglyceride levels, and elevated HDL/LDL ratio. Urine albumin-creatin levels were found to be decreased. NF-κB and TGF-β levels were found to be decreased in a dose-dependent manner in HFD/STZ-induced nephropathy in C57BL/6 mice[202]
Anti-diabetic activity IgA, TNF-α, and IL-6 were found to be significantly reduced in the intestine region. H&E staining showed improvement in histological structures of intestine tissue in extract-treated diabetic mice. The mRNA expression of Ki-67, ZO-1, and MUC2 genes was found to be significantly upregulated in a dose-dependent manner. [203]
Hepatoprotective activity ALT and AST were found to be decreased, serum SOD and liver GHS levels were found to be increased, and NO levels were found to be decreased. Serum levels of TNF-α, IFN-γ, IL-4, IL-6, and IL-1β were found to be decreased. Alleviated hepatocyte enlargement, cytoplasmic vacuolation, cellular infiltration, and necrosis. TLR-2, TLR-4, and pNF-κBp65 were found to be suppressed and p-IκBα was significantly downregulated. Nrf2 and HO-1 expression was found to be increased.[204]
Antitumor and anticancer activityTumor growth regression. Enhancement of T and B cells. Anti-cancer mechanism by promoting cytokines IL-2, IL-6, IL-12, and TNF-α. Stimulation of macrophage function. Promoted apoptosis via promoting Bax-2 and inhibiting Bcl-2 expression in a concentration-dependent manner in Jurkat tumor-bearing Kunming mice.[106]
-Metabolic regulation, reduced blood glucose, and improved lipid metabolism. Improved serum
profiling and reversed metabolites leucine and proline.		[205]
Antidiabetic activityEffectively prevented loss of body weight, controlled blood glucose, and increased insulin sensitivity. Alleviated oxidative stress induced by hyperglycemia. The PI3K/Akt pathway plays a role in modulating metabolism in high-fat diet- and STZ-induced T2DM mice. [206]
Immunomodulatory activity Restoration of damaged colon by alleviating colon tissue injury and tight junction protein deficiency. Possible modulation of Th17-, Th2-, Th1-, Treg-related cytokines through the JAK-STAT (p-STAT1, p-STAT6, p-STAT3) signaling pathway in colitis-induced mice. [207]
Hot water extract Antitumor activity Decreased tumor progression, vascularization, and metastasis. Maintenance of optimum body temperature. [99]
Trp-Gly-Cys tripeptide-Platelet aggregation inhibitor [208]
Ethanol extractAnticancer activityIncreased expression of p53, p21, Bax, and caspase-9 was observed.
EBV viral proteins BZLF-1 (key factor for EVB lysis reactivation) and LMP-2 (essential for EVB latency) were found to be moderately repressed in NOD/SCID mice implanted with EBV+ human gastric carcinoma (SNU719).		[209]
Lentinula edodesMycelia extract (hot water)-Lowered the increased TGF-β and IL-6 plasma levels in C57BL⁄6 (H-2b) BALB⁄c Nu⁄Nu (H-2 d) mice inoculated with C26. Inhibition of Th17 cells and myeloid-derived suppressor cells.[210]
Mycelia extract Antitumor activityT cell-dependent antitumor activity. Decreased Tregs and TGF-β[211]
Lignosus rhinocerusHot water extractAntiasthmatic activity Inhibition of airway hyperresponsiveness (AHR) in asthma model in house dust mite (HDM)-induced asthma in BALB/c mice. [212]
Antiasthmatic activityInhibition of airway inflammation in asthma model. Attenuated IgE, Th2 cytokines, CD4+ T cell population, leukocyte infiltration, and mucus-producing goblet cells in the lung epithelium [213]
Rhinoprolycan fractionAntitumor activityAirway relaxation effects. Antitumor activity in MCF7-xenograft NCr nude mice. [214]
PolysaccharidesImmunomodulatory activity Inhibition of immunosuppressive activity. Improved immune organs and stimulated the release of cytokines TNF-α and INF-γ in cyclophosphamide (Cy)-induced SPF Kunming mice.[215]
Pleurotus citrinopileatusPolysaccharidesAntitumor activityDecreased tumor size and lowered the mortality ratio in ICR mice with Sarcoma 180 tumor-bearing.[216]
Immunomodulatory activity Increased Nrf2, Keap1, p62, HO-1, and NQO1 expression in immunocompromised mice via the p62/Keap1/Nrf2 signaling pathway. The immune activity was activated by phagocytic activity, Th1/Th2 balance, and cytokine production in male SPF-grade Kunming mice.[217]
Antitumor activityTumor weights were reduced and apoptosis increased. Cell cycle arrest at the S phase. The immunity of tumor-bearing mice was improved in the spleen index with polysaccharide treatment in male mice bearing H22 hepatoma tumors.[218]
Anti-obesity activity Improved body weight, lipid accumulation, and serum biochemistry parameters in high-fat diet-induced obese (DIO) C57BL/6J mice.[219]
LectinAntitumor activityThe tumor size was reduced and anti-HIV-1 reverse transcriptase was inhibited in mice bearing Sarcoma 180 tumors.[220]
Lipid fraction-Reduced morphological changes in the colon and reduced inflammation stress in DSS-induced chorionic crypt injury in male BALB/c mice.[119]
Water extractAnti-inflammatory activity Alcoholic steatohepatitis prevention. Decreased serum lipid profiles, cellular lipid accumulation, and inflammation by activating the SIRT1–AMPK and P2X7R–NLRP3 inflammasome in ethanol-induced male C57BL/6 mice.[221]
Pleurotus eryngiiEthanol extract-Reduced lipid absorption and carbohydrate-degrading enzyme activity (α-amylase) in male C57BL/JJmsSlc mice.[222]
PolypeptidesImmunomodulatory activity Restored the complication from cyclophosphamide-induced immunosuppression by shifting the thymus/spleen index, lymphocyte count, and gut microbiota abundances in male Kunming strain mice.[223]
Antitumor activityInhibited the tumor volume in mice and enhanced NK cell and spleen activities with higher TNF-α and IL-2 serum levels in female BALB/c mice with renal-bearing cancer. [224]
β-type glycosidic polysaccharidesAnticolitis activity and probiotic enhancementInhibited proinflammatory cytokines (TNF-α, INF-γ, and IL-10) via NF-κB and improved gut microbiota in dextran sodium sulfate (DSS)-induced colitis in male CD-1 (ICR) mice.[225]
Water extractImmunomodulatory activity Gut and liver immunity were improved by regulating NrF2, Nfkb, DNMT1, and IL-22 genes in CD1 mice and whole peripheral blood and fecal samples collected from healthy donors.[226]
Anti-obesity activity Lipid absorption was inhibited by reducing pancreatic lipase enzymatic activity in high-fat diet-fed C57BL/6 male mice.[227]
HeterogalactanImmunomodulatory activity Macrophages were activated by p38, JNK, and NF-κB via TLR2 and splenocyte activation was induced by the TLR4-PKC axis in cyclophosphamide (CTX)-immunocompromised BALB-C mice.[228]
Pleurotus ostreatusGlucansAntitumor activity Activated nitric oxide production in macrophages and inhibited tumor growth in Swiss albino mice with Sarcoma 180 (S-180) tumors.[229]
PolypeptidesImmunomodulatory activity Immune cell populations (T cells, NK cells, macrophages) were increased, activating the gut microbiota to balance system immunity in female C57BL/6 mice.[140]
Dried powderAnticancer activity Abolished the effect of BBN in mice by stimulating NK cell and lymphocyte activities in female ICR mice with BBN-induced carcinogenesis. [230]
Anti-obesity activityImproved body weight, serum lipids, blood sugar, and liver and kidney functions in high-fat diet-fed C57BL/6J male mice[231]
Ethanol extractAntidiabetic activity Reduced body weight and serum lipid profiles and increased HDL cholesterol levels and antidiabetic activity in alloxan-induced diabetic BALB/C mice.[232]
Anticancer activityPrevented colon injury and carcinogenesis via suppression of COX-2, F4/80, Ki-67, and cyclin D1 in PhIP-induced male ICR mice.[233]
ProteoglycansAnticancer activityInhibited cell growth and arrest at the G0/G1 phase. Stimulated NK cells and macrophage functions in Swiss albino mice with Sarcoma 180 (S-180) tumors. [234]
Water extractImmunomodulatory activity Immune regulation and malnutrition relief through increased total liver proteins and
DNA and protein contents in gut mucosa and stimulated humoral immunity Balb/C mice.		[235]
Immunomodulatory activitySuppressed secretion of TNF-α and IL-6 in LPS-induced inflammation and inhibited interferon-g (IFN-g), IL-2, and IL-6 in concanavalin A (ConA)-stimulated mouse splenocytes in BALB/c mice.[139]
Pleurotus pulmonariusDried powderAllergic relief Showed no effect on antigen-induced nasal rubbing and sneezing and inhibited histamine release from rat mast cells in female BALB/c mice. [236]
b-glucan-rich fractionMemory improvementSuppressed histological changes and neuronal loss and reduced neuroinflammation by reducing Iba-1-positive microglial cells in high-fat diet-fed female ICR mice. [237]
polysaccharide-protein complexAntitumor activitySuppressed the VEGF-induced PI3K/AKT signaling pathway in liver cancer cells in Huh7 tumor-bearing male BALB/c mice.[143]
GlucanColitis prevention Improved
colon damage, decreased
MPO activity levels, and decreased proinflammatory cytokines (IL-1b and TNF-α) in DSS-induced colitis female BALB/c mice. 		[238]
Colitis preventionInhibited cell proliferation, induced apoptosis, and inhibited inflammation in DSS-induced colitis FVB/N mice. [239]
Trametes versicolorPolysaccharopeptide (PSP in combination with IL-2Antitumor activityDecreased ROS production. Both early and late treatment induced IL-2 expression. An increase in TNF-α and reduction in TGF-β was observed in tumor cells in BALB/cByJ mice with H238.[240]
Polysaccharides Antitumor activitySignificant decrease in tumor weight. Preservation of bone integrity (CT images). Increases in IL-2, -6, and -12 but no change in IL-10. Increases in IFN-γ and TNF-α in BALB/c mice bearing 4T1 tumors.[146]
Immunomodulatory activity Activation of splenocytes and selective binding to CD19+ cells and CD14+ cells. Ig class switching and IL-2 production were observed. TLR4-mediated B cell activation, p38 MAPK pathway activation, and cytosolic translocation of NF-κB p65 were observed in female BALB/c, C3H/HeJ, and C3H/HeN mice.[241]
Aqueous extract in combination with metronomic zoledronic acid (mZOL)Antitumor activityDiminished tumor growth, protected bones, and inhibited metastasis in the liver and lungs in female BALB/c Nu/Nu nude mice inoculated with MDA-MB-231-TXSA. [242]
PSP-Slightly increased glutathione S-transferase (GST) activity and increased blood GPX activity. Possibly P450-mediated metabolism in male C57 mice.[243]
RatAgaricus blazei Murill, Agaricus brasiliensisAqueous, acid, and alkaline extractionAntitumor activityInhibited tumor growth and increased body weight. Increased liver catalase and superoxide dismutase activities in Walker-256 tumor-bearing rats.[244]
Agaricus bisporusPowdered mushroomAntidiabetic activity Reduction of plasma glucose and cholesterol (LDL). No change in triglyceride levels and protected against hepatic toxicity in streptozotocin-induced type 2 diabetes in male Sprague–Dawley rats.[24]
Auricularia auricula-judaeAqueous extractAntidiabetic activityReduced plasma glucose, total cholesterol, triglyceride, GOT, and GPT levels in streptozotocin-induced diabetic male Sprague–Dawley (SD) rats.[245]
Immunomodulatory activityPromoted immune modulatory effect by inducing total and differential WBCs in cyclophosphamide-induced immunodeficiency in Wistar rats. [246]
Hot water and ultrasonic-assisted extraction-Reduction of bronchoalveolar lavage fluid and lung edema, significantly inhibited myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels, decreased TNF-α and IL-6 in the blood, and alleviation of LPS-induced pathological changes in the lungs of LPS-induced inflammation in adult Sprague–Dawley rats.[247]
Auricularia polytrichaAqueous extractHepatoprotective activity Reduced AST, ALT, ALP, LDH, TB, TG, and cholesterol levels and increased total protein levels. Hepatoprotective activity in paracetamol-induced liver toxicity in Sprague–Dawley rats.[248]
Anticholestremic activity Decreased total cholesterol and LDL and increased HDL levels in reused cooking oil-induced hyperlipidemia in Wistar rats[249]
Aqueous extract- soluble polysaccharideAntihyperlipidemic effectDecreased total cholesterol and LDL and increased HDL levels in high-fat diet-induced hypercholesterolemia in male Sprague–Dawley (SD) rats[250]
Antrodia camphorateOral treatment-Suppression of iNOS and HO-1 expression and reduction of Bax and caspase-3 in thromboembolic cerebral tissue. Inhibition of OH• signals was also observed.[251]
Water extract and ethanol extractMemory improvementEnhanced long-term and short-term memory and learning ability. Significantly reduced ROS levels in hippocampus as well as p-tau and Aβ40 in Aβ-infused male Wistar rats[252]
Flammulina velutipesAqueous extractionNeuroprotective activityInduction of cell proliferation and elongation, stimulated nerve functional recovery and axonal outgrowth, and increased growth-associated protein 43 (GAP-43) and the JAK2/STAT3 pathway in female Sprague–Dawley rats[253]
Enokitake (Flammulina velutipes) fiber-Reduced LDL (VLDL), intermediate-density lipoprotein (IDL), and LDL-cholesterol concentrations in cholesterol-free diet with cellulose powder-fed male F344/DuCrj rats.[254]
Ganoderma atrumpolysaccharideAnti-inflammatory and antioxidant activityReduction of 8-OHdG levels, increased superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities and IL-10 levels, and prevented the overproduction of malondialdehyde (MDA), IL-1β, IL-6, and TNF-α in male SD rats with acrylamide-induced inflammation and oxidative damage.[255]
Ganoderma microsporumimmunomodulatory proteinAntioxidant activityReduction of oxidative damage and cognitive impairment. Increased superoxide dismutase 1 (SOD-1) and lowered astroglia proliferation in traumatic brain injury-induced female and male Sprague–Dawley rats[256]
Ganoderma lucidum Neuroprotective activityNeuroprotective effect, reduction of the cerebellar infarct area, neurological functional deficits, neuronal apoptosis, and decreased active caspase-3, -8, and -9 and Bax levels in middle cerebral artery occlusion (MCAO) in Sprague–Dawley (SD) rats and oxygen and glucose deprivation (OGD) in primary cultured rat cortical neurons[257]
Lignosus rhinocerusHot water extractAnti-asthmatic activityInhibition of airway inflammation in asthma model. Attenuated IgE, Th2 cytokines, leukocyte infiltration, and mucus-producing goblet cells in the lung epithelium of Sprague–Dawley rats with ovalbumin (OVA)-induced asthma. [212]
High-molecular-mass fraction (HMM)-Airway relaxation effects. Suppressed carbachol-, 5-hydroxytrptamine-, and calcium-induced airway contractions in Sprague–Dawley rats. [258]
Cold water extract-Bronchodilator effect mediated by the calcium signaling pathway downstream of Gαq-coupled protein receptors in Sprague– Dawley rats.[259]
Freeze-dried mushroom powderAntioxidant activityAntioxidant activity and amelioration of diabetic complications in streptozotocin-induced diabetic rats.[260]
High-molecular-mass fraction (HMM)Anti-inflammatory activityAnti-acute inflammatory activity in carrageenan-induced paw edema in Sprague–Dawley rats. [261]
Pleurotus citrinopileatusEthyl acetate and methanol extract-Reduced serum cholesterol and triglycerides in high-fat diet-fed mice and increased glutathione peroxidase and superoxide dismutase activities in the blood of female hamster rats.[262]
Pleurotus eryngiiMethanol extract-Estrogen-like activity and bone loss prevention. Trabecular bone density was increased in the extract treatment group in eleven-week-old female Sprague–Dawley rats (240–260 g) with removed ovaries.[263]
CelluloseHepatoprotective activity Fatty liver prevention. Reduced ALT, AST, TC, and TG levels in the serum of high-fat diet-fed rats and decreased fatty accumulation in the liver in male SD rats[264]
ChitinCardioprotective activity Serum lipid levels decreased and ALT, AST, and SOD enzymatic activities improved. Prevented liver steatosis and aortic atherosclerosis in male Sprague–Dawley (SD) rats.[265]
Pleurotus ostreatusWater-soluble polysaccharideGastroprotective effectInhibited oxidative stress from acetic acid-induced gastric lesions and increased mucus synthesis.[266]
Pleurotus pulmonariusMetabolitesAntitumor and immunomodulatory effectsSuppressed leukemia induction and elevated the phagocytic index of macrophages in leukemia-induced Wister rats. [267]
Mycelial hot water extract and (HWE) and acetone extracts (AE)Antidiabetic activityReduced serum lipid profiles and elevated high-density lipoprotein cholesterol in diabetes-induced Wistar albino rats.[268]
Table 3. The beneficial activities of various mushroom-derived compounds are summarized based on the zebrafish model used and the mechanism of action.
Table 3. The beneficial activities of various mushroom-derived compounds are summarized based on the zebrafish model used and the mechanism of action.
ModelMushroom NameExtract/
Compound		Protective Effects/
Mechanism		References
Danio rerioAgaricus bisporusPowdered mushroom + Lactobacillus caseiUpregulated the expression of growth-related (gh and igf1), mucosal immune-related (tnf-α, lyz, and il1b), and antioxidant-related (sod and cat) genes. [270]
β-glucanReduced lipid accumulation and triglyceride levels. Lowered C/EBP α, c SREBP1, LXR α, PPAR γ, and increased LC3 II/LC3 I. Induction of autophagy. [271]
Aqueous extract + Lactobacillus acidophilus and Lactobacillus delbrueckii subsp. BulgaricusActed as a prebiotic to Lactobacillus acidophilus (La) and Lactobacillus delbrueckii subsp. Bulgaricus (Lb). Feeding La and Lb improved growth and reproduction, as well as increased cyp19a gene expression.[272]
Glucosamine hydrochloridePromoted larval skeletal development and caudal fin regeneration and increased the expression of bone specific markers such as col1a2, col10a1a, and col2a1a. Promoted skeletal injury repair in osteoporosis model of zebrafish larvae and adults. Activation of Bmp signaling.[273]
Ethanol extractInhibited melanogenesis[274]
Antrodia cinnamomeaEthanol extractsReduced the melanin content and inhibited tyrosinase activity.[253]
Ganoderma lucidumDeacetyl ganoderic acid FAttenuated the increase in nitric oxide, which was induced by LPS.[275]
TriterpenoidsDecreased LPS-induced intracellular ROS[276]
Ganoderma applanatumExopolysaccharides and endopolysaccharidesNon-toxic to embryos. Did not delay or alter hatching, development, and heart rate.[277]
Hericium erinaceusEthanol extractsImproved locomotion pattern, reduced anxiety, and improved memory by exhibiting anti-acetylcholine esterase activity and antioxidant potential. [278]
Inonotus obliquusPolysaccharidesAlleviated oxidative stress, reduced ROS, and reduced apoptosis in developing embryos.[279]
Ameliorated the genotoxic effects in UVB-exposed zebrafish by enhancing the expression of DNA repair genes, aiding in normal development[280]
2α-hydroxy-inotodiolAlleviated H2O2-induced apoptosis in zebrafish head region.[82]
Lentinula edodesEthyl acetate fractionReduced prednisolone-induced osteoporosis[281]
Wild type and mutant mushroomReduced pigmentation in embryos[282]
UV-B exposureIncreased the hatching rate and the length of larvae along with an improved anti-inflammatory effect[283]
Pleurotus tuber-regiumSclerotiumInhibited blood vessel formation and subintestinal vessel plexus.[284]
Pleurotus tuber-regiumTotal triterpenesReduced changes in the body mass index and lipid accumulation induced by a high-fat diet. [285]
Table 4. The beneficial activities of various mushroom-derived compounds are summarized based on the Drosophila melanogaster model used and the mechanism of action.
Table 4. The beneficial activities of various mushroom-derived compounds are summarized based on the Drosophila melanogaster model used and the mechanism of action.
ModelMushroom NameExtract/
Compound		Protective Effects/
Mechanism		References
Drosophila melanogasterAntrodia camphorataErgosta-7,9(11),22-trien-3β-olImproved the life span, motor function, learning, and memory of the AD model. Reduced the biomarkers of microglia activation and inflammation, without affecting lipid peroxidation or catalase and SOD activities. [288]
Ganoderma lucidum The formulation (Panax notoginseng, Panax ginseng, and gardenoside) aided in memory improvement in the AD model[289]
Hericium erinaceusErinacine AExtended the lifespan of both male and female Drosophila.[290]
Improved survival and locomotion and regulated apoptosis of tert-butyl hydroperoxide-treated ELAV-SCA3tr-Q78 flies.[291]
Lentinus edodesHot water extractIncreased the life span and locomotive activities of male flies but showed early mortality and decreased locomotive activity in female flies.[292]
Lentinus subnudusReduced the levels of acetylcholinesterase and butyrylcholinesterase, ROS and MDA, improved catalase activity, and total thiol levels[293]
Pleurotus ostreatusDried myceliaExhibited antigenotoxic activity against mitomycin C mutagen.[294]
Trametes versicolorDried myceliaExhibited antigenotoxic activity against mitomycin C mutagen.[294]
Table 5. The beneficial activities of various mushroom-derived compounds are summarized based on the C. elegans model used and the mechanism of action.
Table 5. The beneficial activities of various mushroom-derived compounds are summarized based on the C. elegans model used and the mechanism of action.
ModelMushroom NameExtract/
Compound		Protective Effects/
Mechanism		References
C. elegansAuricularia auricula-judaeDegraded polysaccharidesExtended the lifespan under high sugar stress conditions.[296]
PolysaccharidesExtended the lifespan under oxidative stress and improved antioxidant activity[297]
MelaninExtended the lifespan and locomotive properties[298]
Auricularia polytrichaEthanol extractExtended the lifespan and improved pharyngeal pumping rate[11]
PolysaccharidesExhibited antioxidant activity by scavenging free radicals, improving antioxidant enzymes, and reducing the level of ROS during oxidative stress[299]
Extended the lifespan, enhanced antioxidant enzymes, and regulated the expression of skn-1, sod-1, sod-2, sod-3, and sir-2.1[300]
Extended the lifespan, enhanced antioxidant enzymes, and regulated the expression of daf-16 and skn-1[301]
Acid hydrosylates of polysaccharidesExtended the lifespan, enhanced antioxidant enzymes, and regulated the expression of daf-16, skn-1, sir, sod-1, and sod-2[302]
Flammulina velutipesPolysaccharidesExhibited anti-ultraviolet activity[303]
Ganoderma lucidumPolysaccharidesExtended the lifespan and activate daf-16 via TIR-1 receptor and the MAPK pathway[304]
Water extractExtended the lifespan and reduced oxidative stress and heavy metal stress. Activation of CR pathway and mTOR/S6K pathway.[305]
Water extract and polysaccharidesExtended the lifespan and improved stress resistance by modulating autophagy[306]
Lentinula edodesPolysaccharidesExtended the lifespan under heat-induced stress conditions.[307]
Lignosus rhinocerusEthanol extractInhibition of Alzheimer’s and Huntington’s diseases.[114]
Ethanol, cold water, and hot water extractAntioxidant and lifespan extension. Upregulated the DAF-16/FOXO pathway.[308]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sharika, R.; Mongkolpobsin, K.; Rangsinth, P.; Prasanth, M.I.; Nilkhet, S.; Pradniwat, P.; Tencomnao, T.; Chuchawankul, S. Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review. Nutrients 2024, 16, 2682. https://doi.org/10.3390/nu16162682

AMA Style

Sharika R, Mongkolpobsin K, Rangsinth P, Prasanth MI, Nilkhet S, Pradniwat P, Tencomnao T, Chuchawankul S. Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review. Nutrients. 2024; 16(16):2682. https://doi.org/10.3390/nu16162682

Chicago/Turabian Style

Sharika, Rajasekharan, Kuljira Mongkolpobsin, Panthakarn Rangsinth, Mani Iyer Prasanth, Sunita Nilkhet, Paweena Pradniwat, Tewin Tencomnao, and Siriporn Chuchawankul. 2024. "Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review" Nutrients 16, no. 16: 2682. https://doi.org/10.3390/nu16162682

APA Style

Sharika, R., Mongkolpobsin, K., Rangsinth, P., Prasanth, M. I., Nilkhet, S., Pradniwat, P., Tencomnao, T., & Chuchawankul, S. (2024). Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review. Nutrients, 16(16), 2682. https://doi.org/10.3390/nu16162682

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop